Jenny M female, DoB: 1965-01-01 ( Medical Record Number: MRN1234 (use: USUAL))
| Contact Detail: | 123 Main St Anytown 12345 United States |
| Language: | English |
| Contact |
|
| US Core Ethnicity Extension: |
|
| US Core Race Extension: |
|
Generated Narrative: Condition
Resource Condition "john-anyperson-chf"
Profile: US Core Condition Problems and Health Concerns Profile
assertedDate: 2019-04-01
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Chronic diastolic (congestive) heart failure (International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)#I50.32)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
Generated Narrative: Condition
Resource Condition "primary-cancer-condition-breast"
Profile: Primary Cancer Condition Profile
Histology-Morphology-Behavior Extension: Lobular carcinoma in situ (morphologic abnormality) (SNOMED CT[Intl]#77284006)
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Malignant neoplastic disease (disorder) (SNOMED CT[Intl]#363346000)
bodySite: Left breast structure (body structure) (SNOMED CT[Intl]#80248007)
subject: Patient/cancer-patient-eve-anyperson " ANYPERSON"
onset: 2019-04-01
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
| - | Summary | Assessment |
| * | American Joint Committee on Cancer stage IIIC (qualifier value) (SNOMED CT[Intl]#1222806003) | Observation/tnm-clinical-stage-group-3c |
Generated Narrative: Condition
Resource Condition "primary-cancer-condition-cll"
Profile: Primary Cancer Condition Profile
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Chronic lymphoid leukemia, disease (disorder) (SNOMED CT[Intl]#92814006)
subject: Patient/cancer-patient-adam-everyman " EVERYMAN"
onset: 2020-05-12
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
| - | Summary | Assessment |
| * | Binet Stage A (Unified Medical Language System#C2698392) | Observation/binet-stage-group-A |
Generated Narrative: Condition
Resource Condition "primary-cancer-condition-jenny-m"
Profile: Primary Cancer Condition Profile
Histology-Morphology-Behavior Extension: Adenocarcinoma, no subtype, intermediate grade (morphologic abnormality) (SNOMED CT[Intl]#413448000)
clinicalStatus: Remission (Condition Clinical Status Codes#remission)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Primary malignant neoplasm of female left breast (disorder) (SNOMED CT[Intl]#353431000119107)
subject: Patient/cancer-patient-jenny-m " M"
onset: 2018-03-16
asserter: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
| - | Summary | Assessment | Type |
| * | American Joint Committee on Cancer stage IIIC (qualifier value) (SNOMED CT[Intl]#1222806003) | Observation/tnm-clinical-stage-group-jenny-m | American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008) |
Generated Narrative: Condition
Resource Condition "primary-cancer-condition-nsclc"
Profile: Primary Cancer Condition Profile
Histology-Morphology-Behavior Extension: Adenocarcinoma (SNOMED CT[Intl]#35917007)
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Non-small cell lung cancer (disorder) (SNOMED CT[Intl]#254637007)
bodySite: Lung structure (body structure) (SNOMED CT[Intl]#39607008)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
onset: 2019-04-01
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
| - | Summary | Assessment |
| * | American Joint Committee on Cancer stage IIIC (qualifier value) (SNOMED CT[Intl]#1222806003) | Observation/tnm-clinical-stage-group-3c |
Generated Narrative: Condition
Resource Condition "secondary-cancer-condition-brain-mets"
Profile: Secondary Cancer Condition Profile
related: Condition/primary-cancer-condition-nsclc
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Secondary malignant neoplasm of brain (SNOMED CT[Intl]#94225005)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
onset: 2019-05-01
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
Generated Narrative: Condition
Resource Condition "us-core-condition-anxiety-jenny-m"
Profile: US Core Condition Problems and Health Concerns Profile
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Anxiety (finding) (SNOMED CT[Intl]#48694002)
subject: Patient/cancer-patient-jenny-m " M"
onset: 2005-01-01
Generated Narrative: Condition
Resource Condition "us-core-condition-depression-jenny-m"
Profile: US Core Condition Problems and Health Concerns Profile
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Depressive disorder (disorder) (SNOMED CT[Intl]#35489007)
subject: Patient/cancer-patient-jenny-m " M"
onset: 2005-01-01
asserter: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
Generated Narrative: Condition
Resource Condition "us-core-condition-hypertension-jenny-m"
Profile: US Core Condition Problems and Health Concerns Profile
clinicalStatus: Active (Condition Clinical Status Codes#active)
verificationStatus: Confirmed (ConditionVerificationStatus#confirmed)
category: Problem List Item (Condition Category Codes#problem-list-item)
code: Benign hypertensive heart disease without congestive heart failure (disorder) (SNOMED CT[Intl]#77970009)
subject: Patient/cancer-patient-jenny-m " M"
onset: 2012-01-01
asserter: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
Generated Narrative: DiagnosticReport
Resource DiagnosticReport "gx-genomics-report-adam-anyperson"
Profile: Genomics Report Profile
basedOn: See above (ServiceRequest/gx-order-tumornormal-tempus-inc)
status: final
category: Genetics (diagnosticServiceSectionId#GE)
code: Genetic analysis report (LOINC#51969-4)
subject: See above (Patient/gx-cancer-patient-adam-anyperson)
effective: 2022-02-15 19:28:58+0500
performer: Organization/gx-us-core-organization-tempus-inc "Tempus Labs, Inc."
resultsInterpreter: See above (Practitioner/gx-practitioner-test-pathologist)
specimen:
result:
Generated Narrative: DiagnosticReport
Resource DiagnosticReport "genomics-report-jenny-m"
Profile: Genomics Report Profile
status: final
category: Genetics (diagnosticServiceSectionId#GE)
code: Genetic analysis report (LOINC#51969-4)
subject: See above (Patient/cancer-patient-jenny-m)
effective: 2018-03-15
issued: Mar 15, 2020, 12:00:01 AM
specimen: See above (Specimen/human-specimen-left-breast-jenny-m)
result:
Generated Narrative: DiagnosticReport
Resource DiagnosticReport "us-core-diagnosticreport-lab-jenny-m"
Profile: US Core DiagnosticReport Profile for Laboratory Results Reporting
status: final
category: Laboratory (diagnosticServiceSectionId#LAB)
code: Pathology report final diagnosis Narrative (LOINC#22637-3)
subject: See above (Patient/cancer-patient-jenny-m)
effective: 2018-04-01 00:00:00+0000
issued: Apr 5, 2018, 12:00:00 AM
performer: See above (Organization/us-core-organization-physician-services-inc)
resultsInterpreter: See above (Practitioner/us-core-practitioner-peter-pathologist)
specimen: Specimen/tumor-specimen-left-breast-jenny-m
result:
| Subject | John B. Anyperson male, DoB: 1951-01-20 ( Medical Record Number: m123 (use: USUAL)) |
| When For | 2019-04-01 |
| Reported | 2019-04-01 11:45:33+1100 |
Report Details
| Code | Value | Flags | When For | Reported |
| Genetic variant assessment | Present | Positive (qualifier value) | 2019-04-01 | |
| DNA region of interest panel | 2019-04-01 |
Generated Narrative: Observation
Resource Observation "binet-stage-group-A"
Profile: Cancer Stage Group Profile
status: final
code: Disease stage (LOINC#67213-9)
subject: Patient/cancer-patient-adam-everyman " EVERYMAN"
focus: Condition/primary-cancer-condition-cll
effective: 2020-05-18
value: Binet Stage A (Unified Medical Language System#C2698392)
method: Binet staging classification for chronic lymphocytic leukemia (tumor staging) (SNOMED CT[Intl]#1149099005)
derivedFrom: Observation/lab-result-observation-hemoglobin
Generated Narrative: Observation
Resource Observation "bodyheight-jenny-m-2018-03-06"
Profile: Observation Body Height Profile
status: final
category: Vital Signs (Observation Category Codes#vital-signs)
code: Body height (LOINC#8302-2)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
value: 65 in (Details: UCUM code [in_i] = '[in_i]')
Generated Narrative: Observation
Resource Observation "bodyweight-jenny-m-2018-03-16"
Profile: Observation Body Weight Profile
status: final
category: Vital Signs (Observation Category Codes#vital-signs)
code: Body weight (LOINC#29463-7)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-06
value: 155 lb (Details: UCUM code [lb_av] = '[lb_av]')
Generated Narrative: Observation
Resource Observation "bodyweight-jenny-m-2018-04-22"
Profile: Observation Body Weight Profile
status: final
category: Vital Signs (Observation Category Codes#vital-signs)
code: Body weight (LOINC#29463-7)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-22
value: 150 lb (Details: UCUM code [lb_av] = '[lb_av]')
Generated Narrative: Observation
Resource Observation "cancer-disease-status-improved"
Profile: Cancer Disease Status Profile
Cancer Disease Status Evidence Type Extension: Anatomic pathology procedure (procedure) (SNOMED CT[Intl]#108257001)
status: final
code: Cancer disease progression (LOINC#97509-4)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
performer: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
value: Patient's condition improved (finding) (SNOMED CT[Intl]#268910001)
Generated Narrative: Observation
Resource Observation "cancer-disease-status-jenny-m"
Profile: Cancer Disease Status Profile
Cancer Disease Status Evidence Type Extension: Imaging (procedure) (SNOMED CT[Intl]#363679005)
status: final
code: Cancer Disease Progression (LOINC#97509-4)
subject: Patient/cancer-patient-jenny-m " M"
focus: Condition/primary-cancer-condition-jenny-m
effective: 2018-11-01
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: Patient's condition improved (finding) (SNOMED CT[Intl]#268910001)
Generated Narrative: Observation
Resource Observation "cancer-related-comorbidities-jenny-m"
Profile: Comorbidities Profile
Related Condition Extension: Condition/us-core-condition-depression-jenny-m
Related Condition Extension: Condition/us-core-condition-anxiety-jenny-m
Related Condition Extension: Condition/us-core-condition-hypertension-jenny-m
Related Condition Absent Extension: Obesity (disorder) (SNOMED CT[Intl]#414916001)
Related Condition Absent Extension: Disorder of lung (disorder) (SNOMED CT[Intl]#19829001)
status: final
code: Co-morbid conditions (finding) (SNOMED CT[Intl]#398192003)
subject: Patient/cancer-patient-jenny-m " M"
focus: Condition/primary-cancer-condition-jenny-m
effective: 2018-03-16
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
Generated Narrative: Observation
Resource Observation "cancer-related-comorbidities-john-anyperson"
Profile: Comorbidities Profile
Related Condition Extension: Condition/john-anyperson-chf
Related Condition Absent Extension: Obesity (disorder) (SNOMED CT[Intl]#414916001)
Related Condition Absent Extension: Disorder of lung (disorder) (SNOMED CT[Intl]#19829001)
status: final
code: Co-morbid conditions (finding) (SNOMED CT[Intl]#398192003)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
focus: Condition/primary-cancer-condition-nsclc
effective: 2019-04-01
performer: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
Generated Narrative: Observation
Resource Observation "ecog-performance-status-fully-active"
Profile: ECOG Performance Status Profile
status: final
category: Clinical Test (US Core Observation Category Extension Codes#clinical-test)
code: ECOG Performance Status score (LOINC#89247-1)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
performer: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
value: 0
interpretation: Fully active, able to carry on all pre-disease performance without restriction (LOINC#LA9622-7)
method: Clinical examination (SNOMED CT[Intl]#5880005)
Generated Narrative: Observation
Resource Observation "ecog-performance-status-jenny-m"
Profile: ECOG Performance Status Profile
status: final
category: Clinical Test (US Core Observation Category Extension Codes#clinical-test)
code: ECOG Performance Status score (LOINC#89247-1)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-12
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: 0
interpretation: Fully active, able to carry on all pre-disease performance without restriction (LOINC#LA9622-7)
method: Physical examination procedure (procedure) (SNOMED CT[Intl]#5880005)
Generated Narrative: Observation
Resource Observation "genomic-region-studied-jenny-m"
Profile: Genomic Region Studied Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: DNA region of interest panel (LOINC#53041-0)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-15
issued: Mar 15, 2018, 12:00:01 AM
| - | Code | Value[x] |
| * | Gene studied [ID] (LOINC#48018-6) | BRCA1 (HUGO Gene Nomenclature Committee Genes#1100; HUGO Gene Nomenclature Committee Genes#1101 "BRCA2"; HUGO Gene Nomenclature Committee Genes#1748 "CDH1"; HUGO Gene Nomenclature Committee Genes#26144 "PALB2"; HUGO Gene Nomenclature Committee Genes#9588 "PTEN"; HUGO Gene Nomenclature Committee Genes#11389 "STK11"; HUGO Gene Nomenclature Committee Genes#11998 "TP53") |
Generated Narrative: Observation
Resource Observation "genomic-region-studied-stk11"
Profile: Genomic Region Studied Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: DNA region of interest panel (LOINC#53041-0)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
issued: Apr 1, 2019, 12:45:33 AM
| - | Code | Value[x] |
| * | Gene studied [ID] (LOINC#48018-6) | STK11 (HUGO Gene Nomenclature Committee Genes#HGNC:11389) |
Generated Narrative: Observation
Resource Observation "genomic-variant-fusion"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
interpretation: Positive (qualifier value) (SNOMED CT[Intl]#10828004)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: BCR (HUGO Gene Nomenclature Committee Genes#HGNC:1014)
component
code: Gene studied [ID] (LOINC#48018-6)
value: ABL1 (HUGO Gene Nomenclature Committee Genes#HGNC:76)
component
code: Genomic DNA change (gHGVS) (LOINC#81290-9)
value: NM_005157.6(ABL1):c.1076T>G (Human Genome Variation Society nomenclature#NM_005157.6(ABL1):c.1076T>G)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
Generated Narrative: Observation
Resource Observation "genomic-variant-germline-deletion"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
interpretation: Positive (qualifier value) (SNOMED CT[Intl]#10828004)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: BRCA1 (HUGO Gene Nomenclature Committee Genes#HGNC:1100)
component
code: Genomic DNA change (gHGVS) (LOINC#81290-9)
value: NG_005905.2:g.126148_126152del (Human Genome Variation Society nomenclature#NG_005905.2:g.126148_126152del)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Germline (LOINC#LA6683-2)
Generated Narrative: Observation
Resource Observation "genomic-variant-jenny-m"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-15
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: PALB2 (HUGO Gene Nomenclature Committee Genes#HGNC:26144)
component
code: Discrete genetic variant (LOINC#81252-9)
value: NM_024675.3(PALB2):c.3549C>A (p.Tyr1183Ter) (ClinVar Variant ID#128144)
component
code: Genomic DNA change (gHGVS) (LOINC#81290-9)
value: NC_000016.10:g.23603471G>T (Human Genome Variation Society nomenclature#NC_000016.10:g.23603471G>T)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
Generated Narrative: Observation
Resource Observation "genomic-variant-somatic-single-nucleotide"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
interpretation: Positive (qualifier value) (SNOMED CT[Intl]#10828004)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: STK11 (HUGO Gene Nomenclature Committee Genes#HGNC:11389)
component
code: Discrete genetic variant (LOINC#81252-9)
value: NM_000455.5(STK11):c.725G>A (p.Gly242Glu) (ClinVar Variant ID#611264)
component
code: Genomic DNA change (gHGVS) (LOINC#81290-9)
value: NM_000455.5:c.725G>A (Human Genome Variation Society nomenclature#NM_000455.5:c.725G>A)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
Generated Narrative: Observation
Resource Observation "gx-genomic-diagnostic-implication-bap1"
Profile: Diagnostic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Diagnostic Implication (To Be Determined Codes#diagnostic-implication)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
derivedFrom: Observation/gx-genomic-variant-somatic-bap1-indel
| - | Code | Value[x] |
| * | Functional Effect (To Be Determined Codes#functional-effect) | loss of function variant (#SO:0002054) |
Generated Narrative: Observation
Resource Observation "gx-genomic-diagnostic-implication-pof1b"
Profile: Diagnostic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Diagnostic Implication (To Be Determined Codes#diagnostic-implication)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
derivedFrom: Observation/gx-genomic-variant-somatic-pof1b
| - | Code | Value[x] |
| * | Genetic variation clinical significance [Imp] (LOINC#53037-8) | Uncertain significance (LOINC#LA26333-7) |
Generated Narrative: Observation
Resource Observation "gx-genomic-diagnostic-implication-polrmt"
Profile: Diagnostic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Diagnostic Implication (To Be Determined Codes#diagnostic-implication)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
derivedFrom: Observation/gx-genomic-variant-somatic-polrmt
| - | Code | Value[x] |
| * | Genetic variation clinical significance [Imp] (LOINC#53037-8) | Uncertain significance (LOINC#LA26333-7) |
Generated Narrative: Observation
Resource Observation "gx-genomic-msi"
Profile: Microsatellite Instability
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Microsatellite instability [Interpretation] in Cancer specimen Qualitative (LOINC#81695-9)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
value: MSI-H (LOINC#LA26203-2)
Generated Narrative: Observation
Resource Observation "gx-genomic-therapeutic-implication-alectinib"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
derivedFrom: Observation/gx-genomic-variant-fusion-met-alk
component
code: Medication assessed [ID] (LOINC#51963-7)
value: alectinib (RxNorm#1727455)
component
code: Predicted Therapeutic Implication (To Be Determined Codes#predicted-therapeutic-implication)
value: Presumed responsive (LOINC#LA9661-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-therapeutic-implication-brigatinib"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
derivedFrom: Observation/gx-genomic-variant-fusion-met-alk
component
code: Medication assessed [ID] (LOINC#51963-7)
value: brigatinib (RxNorm#1921217)
component
code: Predicted Therapeutic Implication (To Be Determined Codes#predicted-therapeutic-implication)
value: Presumed responsive (LOINC#LA9661-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-therapeutic-implication-ceritinib"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
derivedFrom: Observation/gx-genomic-variant-fusion-met-alk
component
code: Medication assessed [ID] (LOINC#51963-7)
value: ceritinib (RxNorm#1535457)
component
code: Predicted Therapeutic Implication (To Be Determined Codes#predicted-therapeutic-implication)
value: Presumed responsive (LOINC#LA9661-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-therapeutic-implication-crizotinib"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
derivedFrom: Observation/gx-genomic-variant-fusion-met-alk
component
code: Medication assessed [ID] (LOINC#51963-7)
value: crizotinib (RxNorm#1148495)
component
code: Predicted Therapeutic Implication (To Be Determined Codes#predicted-therapeutic-implication)
value: Presumed responsive (LOINC#LA9661-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-therapeutic-implication-lorlatinib"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
derivedFrom: Observation/gx-genomic-variant-fusion-met-alk
component
code: Medication assessed [ID] (LOINC#51963-7)
value: lorlatinib (RxNorm#2103164)
component
code: Predicted Therapeutic Implication (To Be Determined Codes#predicted-therapeutic-implication)
value: Presumed responsive (LOINC#LA9661-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-tmb"
Profile: Tumor Mutation Burden
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Mutations/Megabase [# Ratio] in Tumor (LOINC#94076-7)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
value: 57.1 1/1000000{Base} (Details: UCUM code 1/1000000{Base} = '1/1000000{Base}')
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-fusion-met-alk"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: MET (HUGO Gene Nomenclature Committee Genes#HGNC:7029; gene#4233)
component
code: Gene studied [ID] (LOINC#48018-6)
value: ALK (HUGO Gene Nomenclature Committee Genes#HGNC:427; gene#238)
component
code: DNA Change Type (LOINC#48019-4)
value: complex chromosomal rearrangement (#SO:0002062)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-pertinent-negative-nras-kit-braf"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Absent (LOINC#LA9634-2)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: NRAS (HUGO Gene Nomenclature Committee Genes#HGNC:6342)
component
code: Gene studied [ID] (LOINC#48018-6)
value: KIT (HUGO Gene Nomenclature Committee Genes#HGNC:7989)
component
code: Gene studied [ID] (LOINC#48018-6)
value: BRAF (HUGO Gene Nomenclature Committee Genes#HGNC:1097)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-bap1-indel"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: BAP1 (HUGO Gene Nomenclature Committee Genes#HGNC:950; gene#3815)
component
code: Transcript reference sequence [ID] (LOINC#51958-7)
value: NM_004656.4 (Gene Reference Sequence Collection#NM_004656)
component
code: DNA change (c.HGVS) (LOINC#48004-6)
value: NC_000003.11(NM_004656.4):c.1768C>T (Human Genome Variation Society nomenclature#NM_004656.4:c.1768C>T)
component
code: Amino acid change (pHGVS) (LOINC#48005-3)
value: NP_004647.1:p.(Gln590Ter) (Human Genome Variation Society nomenclature#NP_004647.1:p.(Gln590Ter))
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Sample variant allelic frequency [NFr] (LOINC#81258-6)
value: 57.4 % (Details: UCUM code % = '%')
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: stop_gained (#SO:0001587)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-cdkn2a-cnv"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: CDKN2A (HUGO Gene Nomenclature Committee Genes#HGNC:1787; gene#1029)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: copy_number_loss (#SO:0001743)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-cdkn2b-cnv"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: CDKN2B (HUGO Gene Nomenclature Committee Genes#HGNC:1788; gene#1030)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: copy_number_loss (#SO:0001743)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-kdm5d"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: KDM5D (HUGO Gene Nomenclature Committee Genes#HGNC:11115; gene#8284)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: copy_number_loss (#SO:0001743)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-mtap"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: MTAP (HUGO Gene Nomenclature Committee Genes#HGNC:7413; gene#4507)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: copy_number_loss (#SO:0001743)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-mycn"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: MYCN (HUGO Gene Nomenclature Committee Genes#HGNC:7559; gene#4613)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: copy_number_gain (#SO:0001742)
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-pof1b"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: POF1B (HUGO Gene Nomenclature Committee Genes#HGNC:13711; gene#79983)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: missense_variant (#SO:0001583)
component
code: Transcript reference sequence [ID] (LOINC#51958-7)
value: NM_004656 (Gene Reference Sequence Collection#NM_004656)
component
code: DNA change (c.HGVS) (LOINC#48004-6)
value: NM_001307940.2:c.430C>T (Human Genome Variation Society nomenclature#NM_001307940.2:c.430C>T)
component
code: Amino acid change (pHGVS) (LOINC#48005-3)
value: NP_001294869.1:p.(Pro144Ser) (Human Genome Variation Society nomenclature#NP_001294869.1:p.(Pro144Ser))
component
code: Sample variant allelic frequency [NFr] (LOINC#81258-6)
value: 78.6 % (Details: UCUM code % = '%')
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "gx-genomic-variant-somatic-polrmt"
Profile: Genomic Variant Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Genetic variant assessment (LOINC#69548-6)
subject: Patient/gx-cancer-patient-adam-anyperson " ANYPERSON"
effective: 2019-04-01
value: Present (LOINC#LA9633-4)
method: Sequencing (LOINC#LA26398-0)
component
code: Gene studied [ID] (LOINC#48018-6)
value: POLRMT (gene#5442)
component
code: Genomic source class [Type] (LOINC#48002-0)
value: Somatic (LOINC#LA6684-0)
component
code: Molecular Consequence (To Be Determined Codes#molecular-consequence)
value: missense_variant (#SO:0001583)
component
code: Transcript reference sequence [ID] (LOINC#51958-7)
value: NM_005035 (Gene Reference Sequence Collection#NM_004656)
component
code: DNA change (c.HGVS) (LOINC#48004-6)
value: NM_005035.4:c.598G>A (Human Genome Variation Society nomenclature#NM_005035.4:c.598G>A)
component
code: Amino acid change (pHGVS) (LOINC#48005-3)
value: NP_005026.3:p.(Gly200Arg) (Human Genome Variation Society nomenclature#NP_005026.3:p.(Gly200Arg))
component
code: Sample variant allelic frequency [NFr] (LOINC#81258-6)
value: 75.6 % (Details: UCUM code % = '%')
component
code: Human reference sequence assembly version (LOINC#62374-4)
value: GRCh37 (LOINC#LA14029-5)
Generated Narrative: Observation
Resource Observation "karnofsky-performance-status-normal-activity"
Profile: Karnofsky Performance Status Profile
status: final
category: Clinical Test (US Core Observation Category Extension Codes#clinical-test)
code: Karnofsky Performance Status score (LOINC#89243-0)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
performer: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
value: 90
interpretation: Able to carry on normal activity; minor signs or symptoms of disease (LOINC#LA29176-7)
method: Clinical examination (SNOMED CT[Intl]#5880005)
Generated Narrative: Observation
Resource Observation "lab-result-observation-hemoglobin"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Hemoglobin [Mass/volume] in Blood (LOINC#718-7)
subject: Patient/cancer-patient-adam-everyman " EVERYMAN"
effective: 2020-03-06
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: 13.5 g/dl (Details: UCUM code g/dl = 'g/dl')
Generated Narrative: Observation
Resource Observation "observation-smoking-pack-years-jenny-m"
status: final
category: Social History (Observation Category Codes#social-history)
code: Cigarette pack-years (observable entity) (SNOMED CT[Intl]#401201003)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
value: 20 Pack-Years (Details: UCUM code {PackYears} = '{PackYears}')
Generated Narrative: Observation
Resource Observation "tnm-clinical-distant-metastases-category-cM0"
status: final
code: Distant metastases.clinical [Class] Cancer (LOINC#21907-1)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: American Joint Committee on Cancer cM0 (qualifier value) (SNOMED CT[Intl]#1229901006)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-distant-metastases-category-jenny-m"
status: final
code: Distant metastases.clinical [Class] Cancer (LOINC#21907-1)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
value: American Joint Committee on Cancer cM0 (qualifier value) (SNOMED CT[Intl]#1229901006)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-primary-tumor-category-cT3"
Profile: TNM Primary Tumor Category Profile
status: final
code: Primary tumor.clinical [Class] Cancer (LOINC#21905-5)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: American Joint Committee on Cancer cT3 (qualifier value) (SNOMED CT[Intl]#1228938002)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-primary-tumor-category-jenny-m"
Profile: TNM Primary Tumor Category Profile
status: final
code: Primary tumor.clinical [Class] Cancer (LOINC#21905-5)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
value: American Joint Committee on Cancer cT3 (qualifier value) (SNOMED CT[Intl]#1228938002)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-regional-nodes-category-cN3"
Profile: TNM Regional Nodes Category Profile
status: final
code: Regional lymph nodes.clinical [Class] Cancer (LOINC#21906-3)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
value: American Joint Committee on Cancer cN3 (qualifier value) (SNOMED CT[Intl]#1229984001)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-regional-nodes-category-jenny-m"
Profile: TNM Regional Nodes Category Profile
status: final
code: Regional lymph nodes.clinical [Class] Cancer (LOINC#21906-3)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
value: American Joint Committee on Cancer cN0 (qualifier value) (SNOMED CT[Intl]#1229967007)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-clinical-stage-group-3c"
Profile: TNM Stage Group Profile
status: final
code: Stage group.clinical Cancer (LOINC#21908-9)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
focus: Condition/primary-cancer-condition-nsclc
effective: 2019-04-01
value: American Joint Committee on Cancer stage IIIC (qualifier value) (SNOMED CT[Intl]#1222806003)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
hasMember:
Generated Narrative: Observation
Resource Observation "tnm-clinical-stage-group-jenny-m"
Profile: TNM Stage Group Profile
status: final
code: Stage group.clinical Cancer (LOINC#21908-9)
subject: Patient/cancer-patient-jenny-m " M"
focus: Condition/primary-cancer-condition-jenny-m
effective: 2018-03-16
value: American Joint Committee on Cancer stage IIB (qualifier value) (SNOMED CT[Intl]#1222769001)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
hasMember:
Generated Narrative: Observation
Resource Observation "tnm-pathologic-distant-metastases-category-jenny-m"
status: final
code: Distant metastases.pathology [Class] Cancer (LOINC#21901-4)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01
value: Not Applicable (DataAbsentReason#not-applicable)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-pathologic-primary-tumor-category-jenny-m"
Profile: TNM Primary Tumor Category Profile
status: final
code: Primary tumor.pathology Cancer (LOINC#21899-0)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01
value: American Joint Committee on Cancer pT3 (qualifier value) (SNOMED CT[Intl]#1229859000)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-pathologic-regional-nodes-category-jenny-m"
Profile: TNM Regional Nodes Category Profile
status: final
code: Regional lymph nodes.pathology [Class] Cancer (LOINC#21900-6)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01
value: American Joint Committee on Cancer pN0 (qualifier value) (SNOMED CT[Intl]#1229947003)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
Generated Narrative: Observation
Resource Observation "tnm-pathologic-stage-group-jenny-m"
Profile: TNM Stage Group Profile
status: final
code: Stage group.pathology Cancer (LOINC#21902-2)
subject: Patient/cancer-patient-jenny-m " M"
focus: Condition/primary-cancer-condition-jenny-m
effective: 2018-04-05
value: American Joint Committee on Cancer stage IIB (qualifier value) (SNOMED CT[Intl]#1222769001)
method: American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) (SNOMED CT[Intl]#897275008)
hasMember:
Generated Narrative: Observation
Resource Observation "tumor-marker-test-egf"
Profile: Tumor Marker Test Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Epidermal growth factor receptor Ag [Presence] in Tissue (LOINC#39004-7)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
effective: 2019-04-01
performer: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
value: Positive (qualifier value) (SNOMED CT[Intl]#10828004)
Generated Narrative: Observation
Resource Observation "tumor-marker-test-er-jenny-m"
Profile: Tumor Marker Test Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain (LOINC#85337-4)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-10
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: Positive (LOINC#LA6576-8)
Generated Narrative: Observation
Resource Observation "tumor-marker-test-her2-jenny-m"
Profile: Tumor Marker Test Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: HER2 [Interpretation] in Tissue (LOINC#48676-1)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-10
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: Negative (LOINC#LA6577-6)
Generated Narrative: Observation
Resource Observation "tumor-marker-test-oncotype-dx-jenny-m"
Profile: Tumor Marker Test Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Oncotype DX Breast Recurrence Score Assay (gtr#509910)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-12
performer: Organization/us-core-organization-bedrock-medicine "Bedrock Medicine"
value: 47 Recurrence score (Details: UCUM code {ScoreOf} = '{ScoreOf}')
interpretation: High (ObservationInterpretation#H)
Generated Narrative: Observation
Resource Observation "tumor-marker-test-pr-jenny-m"
Profile: Tumor Marker Test Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain (LOINC#85339-0)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-10
performer: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
value: Negative (LOINC#LA6577-6)
Generated Narrative: Observation
Resource Observation "tumor-size-jenny-m"
Profile: Tumor Size Profile
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Size Tumor (LOINC#21889-1)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
method: Gross examination and sampling of tissue specimen (procedure) (SNOMED CT[Intl]#787377000)
specimen: Specimen/tumor-specimen-left-breast-jenny-m
| - | Code | Value[x] |
| * | Size.maximum dimension in Tumor (LOINC#33728-7) | 2.5 centimeters (Details: UCUM code cm = 'cm') |
Generated Narrative: Observation
Resource Observation "tumor-size-pathology"
Profile: Tumor Size Profile
status: final
code: Size Tumor (LOINC#21889-1)
subject: Patient/cancer-patient-eve-anyperson " ANYPERSON"
focus: BodyStructure/tumor-lobular-carcinoma-left-breast
effective: 2019-05-01
method: Gross examination and sampling of tissue specimen (procedure) (SNOMED CT[Intl]#787377000)
component
code: Size.maximum dimension in Tumor (LOINC#33728-7)
value: 1.2 cm (Details: UCUM code cm = 'cm')
component
code: Size additional dimension in Tumor (LOINC#33729-5)
value: 0.5 cm (Details: UCUM code cm = 'cm')
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-neutrophils-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Neutrophils [#/volume] in Blood (LOINC#26499-4)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-05-20 00:00:00+0000
value: 3000 10*3/uL (Details: UCUM code 10*3/uL = '10*3/uL')
| - | Low | High | AppliesTo |
| * | 2500 10*3/uL (Details: UCUM code 10*3/uL = '10*3/uL') | 5000 10*3/uL (Details: UCUM code 10*3/uL = '10*3/uL') | Normal Range (Observation Reference Range Meaning Codes#normal) |
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-sentinel-nodes-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Sentinel lymph nodes with metastasis [#] in Cancer specimen (LOINC#92832-5)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
specimen: Specimen/tumor-specimen-left-breast-jenny-m
| - | Code | Value[x] |
| * | Lymph nodes examined [#] in Cancer specimen by Light microscopy (LOINC#92833-3) | 3 Count (Details: UCUM code {Count} = '{Count}') |
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-tumor-dcis-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: DCIS intraductal extension in Breast cancer specimen Qualitative by Light microscopy (LOINC#85336-6)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
value: DCIS present with extensive intraductal component (EIC) (LOINC#LA27261-9)
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-tumor-grade-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Histologic grade [Score] in Breast cancer specimen Qualitative by Nottingham (LOINC#44648-4)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
value: Nottingham grade 2 (LOINC#LA27824-4)
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-tumor-invasion-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Status of invasion by tumor (SNOMED CT[Intl]#370052007)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
value: Negative (qualifier value) (SNOMED CT[Intl]#260385009)
Generated Narrative: Observation
Resource Observation "us-core-observation-lab-tumor-margins-jenny-m"
status: final
category: Laboratory (Observation Category Codes#laboratory)
code: Margin involvement in Breast tumor (LOINC#44669-0)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-01 00:00:00+0000
value: Uninvolved by invasive carcinoma (LOINC#LA27151-2)
Generated Narrative: Observation
Resource Observation "us-core-smokingstatus-jenny-m"
status: final
category: Social History (Observation Category Codes#social-history)
code: Tobacco smoking status (LOINC#72166-2)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-03-16
issued: Mar 16, 2018, 12:00:00 AM
value: Smokes tobacco daily (finding) (SNOMED CT[Intl]#449868002)
Generated Narrative: Organization
Resource Organization "us-core-organization-physician-services-inc"
Profile: US Core Organization Profile
active: true
type: Healthcare Provider (Organization type#prov)
name: Physician Services, Inc.
telecom: ph: 999-999-9999(WORK)
address: 123 Corporate Drive Anytown MA 12345 US
Generated Narrative: Organization
Resource Organization "gx-us-core-organization-tempus-inc"
Profile: US Core Organization Profile
identifier: id: 14D2114007
active: true
type: Other (Organization type#other)
name: Tempus Labs, Inc.
telecom: ph: 999-999-9999(WORK), support@tempus.com
address: 600 West Chicago Avenue, Ste 510 Chicago IL 60654 US
| - | Name |
| * | Nike Beaubier, MD, FCAP, MGP |
Generated Narrative: Organization
Resource Organization "gx-us-core-organization-test-institution"
Profile: US Core Organization Profile
active: true
type: Other (Organization type#other)
name: Test Institution
Generated Narrative: Organization
Resource Organization "us-core-organization-bedrock-medicine"
Profile: US Core Organization Profile
identifier: id: 1265710000
active: true
name: Bedrock Medicine
address: 55 Secant Street Cambridge MA 02141 USA
| - | Telecom |
| * | ph: 617-555-2200 |
Generated Narrative: Practitioner
Resource Practitioner "gx-practitioner-test-pathologist"
name: Test Pathologist, MD
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-owen-oncologist"
Profile: US Core Practitioner Profile
identifier: id: 9988776655
name: Owen Oncologist
address: 123 Corporate Drive Anytown MA 12345 US (WORK)
gender: male
| - | Code |
| * | Doctor of Medicine (degreeLicenseCertificate[2.7]#MD) |
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-peter-pathologist"
Profile: US Core Practitioner Profile
identifier: id: 1122334455
name: Peter Pathologist
address: 123 Corporate Drive Anytown MA 12345 US (WORK)
gender: female
| - | Code |
| * | Doctor of Medicine (degreeLicenseCertificate[2.7]#MD) |
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-jane-radiotech"
Profile: US Core Practitioner Profile
identifier: id: 234512367
name: Jane Radiologist
address: 123 Primary Drive Anytown MA 12345 US (WORK)
gender: female
| - | Code |
| * | Doctor of Medicine (degreeLicenseCertificate[2.7]#MD) |
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-kyle-anydoc"
Profile: US Core Practitioner Profile
identifier: id: 9988776655
name: Kyle Anydoc
address: 567 Healthcare Drive Anytown MA 12345 US (HOME)
gender: male
| - | Code |
| * | Doctor of Medicine (degreeLicenseCertificate[2.7]#MD) |
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-mary-obgyn"
Profile: US Core Practitioner Profile
identifier: id: 234512367
name: Mary Obgyn
address: 123 Primary Drive Anytown MA 12345 US (WORK)
gender: female
| - | Code |
| * | Doctor of Medicine (degreeLicenseCertificate[2.7]#MD) |
Generated Narrative: Practitioner
Resource Practitioner "us-core-practitioner-nancy-oncology-nurse"
Profile: US Core Practitioner Profile
identifier: id: 55667788
name: Nancy Nurse
address: 123 Corporate Drive Anytown MA 12345 US (WORK)
gender: female
| - | Code |
| * | Registered Nurse (degreeLicenseCertificate[2.7]#RN) |
Generated Narrative: Procedure
Resource Procedure "cancer-related-surgical-procedure-jenny-m"
Procedure Intent Extension: Curative - procedure intent (qualifier value) (SNOMED CT[Intl]#373808002)
status: completed
code: Excision of part of breast (procedure) (SNOMED CT[Intl]#64368001)
subject: Patient/cancer-patient-jenny-m " M"
performed: 2018-04-01
asserter: Practitioner/us-core-practitioner-owen-oncologist " ONCOLOGIST"
reasonReference: Condition/primary-cancer-condition-jenny-m
bodySite: Left breast structure (body structure) (SNOMED CT[Intl]#80248007)
Generated Narrative: Procedure
Resource Procedure "cancer-related-surgical-procedure-lobectomy"
Procedure Intent Extension: Curative - procedure intent (SNOMED CT[Intl]#373808002)
status: completed
code: Partial lobectomy of lung (procedure) (SNOMED CT[Intl]#359615001)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
performed: 2019-03-01
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
reasonReference: Condition/primary-cancer-condition-nsclc
bodySite: Structure of lobe of lung (body structure) (SNOMED CT[Intl]#31094006)
Generated Narrative: Procedure
Resource Procedure "radiotherapy-treatment-summary-chest-wall-jenny-m"
Profile: Radiotherapy Course Summary Profile
Radiotherapy Number of Sessions Extension: 31
Procedure Intent Extension: Curative - procedure intent (SNOMED CT[Intl]#373808002)
Radiotherapy Modality And Technique Extension
url
Radiotherapy Modality Extensionvalue: External beam radiation therapy using photons (procedure) (SNOMED CT[Intl]#1156506007)
url
Radiotherapy Technique Extensionvalue: Volumetric Modulated Arc Therapy (procedure) (SNOMED CT[Intl]#1156530009)
Radiotherapy Modality And Technique Extension
url
Radiotherapy Modality Extensionvalue: Teleradiotherapy using electrons (SNOMED CT[Intl]#45643008)
url
Radiotherapy Technique Extensionvalue: Three dimensional external beam radiation therapy (procedure) (SNOMED CT[Intl]#1162782007)
Radiotherapy Dose Delivered To Volume Extension
url
volumevalue: BodyStructure/jenny-m-chest-wall-treatment-volume
url
totalDoseDeliveredvalue: 6000 cGy (Details: UCUM code cGy = 'cGy')
url
fractionsDeliveredvalue: 30
Radiotherapy Dose Delivered To Volume Extension
url
volumevalue: BodyStructure/jenny-m-chest-wall-lymph-nodes-treatment-volume
url
totalDoseDeliveredvalue: 5000 cGy (Details: UCUM code cGy = 'cGy')
url
fractionsDeliveredvalue: 25
status: completed
category: Radiation oncology AND/OR radiotherapy (procedure) (SNOMED CT[Intl]#108290001)
code: Radiotherapy course of treatment (SNOMED CT[Intl]#1217123003)
subject: Patient/cancer-patient-jenny-m " M"
performed: 2018-08-15 --> 2018-10-25
asserter: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
reasonCode: Malignant neoplasm of overlapping sites of right female breast (International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)#C50.811)
bodySite: Chest Wall Structure (body structure) (SNOMED CT[Intl]#78904004)
Generated Narrative: Procedure
Resource Procedure "us-core-procedure-biopsy-jenny-m"
Profile: US Core Procedure Profile
status: completed
code: Biopsy of breast using ultrasonographic guidance (procedure) (SNOMED CT[Intl]#723990008)
subject: Patient/cancer-patient-jenny-m " M"
performed: 2018-03-06
asserter: Practitioner/us-core-practitioner-mary-obgyn " OBGYN"
| - | Actor |
| * | Practitioner/us-core-practitioner-mary-obgyn " OBGYN" |
reasonReference: Condition/primary-cancer-condition-jenny-m
bodySite: Left breast structure (body structure) (SNOMED CT[Intl]#80248007)
Generated Narrative: Procedure
Resource Procedure "us-core-procedure-mammogram-jenny-m"
Profile: US Core Procedure Profile
status: completed
code: Mammography (procedure) (SNOMED CT[Intl]#71651007)
subject: Patient/cancer-patient-jenny-m " M"
performed: 2018-02-01
asserter: Practitioner/us-core-practitioner-mary-obgyn " OBGYN"
| - | Actor |
| * | Practitioner/us-core-practitioner-jane-radiotech " RADIOLOGIST" |
reasonCode: Screening - procedure intent (qualifier value) (SNOMED CT[Intl]#360156006)
Generated Narrative: ServiceRequest
Resource ServiceRequest "gx-order-tumornormal-tempus-inc"
identifier: Filler Identifier: 22howe
status: completed
intent: order
code: xT - 648 gene panel (www.tempus.com#XT.V4)
subject: See above (Patient/gx-cancer-patient-adam-anyperson)
reasonCode: Malignant neoplasm of unspecified part of bronchus or lung (International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)#C34.9; International Classification of Diseases for Oncology, version 3.#C34.9 8140/3 "Lung adenocarcinoma")
Codes for assigning sex at birth as specified by the Office of the National Coordinator for Health IT (ONC)
\nThis value set includes codes from the following code systems:
http://terminology.hl7.org/CodeSystem/v3-AdministrativeGender| Code | Display | |
| F | Female | Female |
| M | Male | Male |
http://terminology.hl7.org/CodeSystem/v3-NullFlavor| Code | Display | |
| UNK | Unknown | Description:A proper value is applicable, but not known. \n \n Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: \n \n Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown')\n Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.) |
The 41 CDC ethnicity codes that are grouped under one of the 2 OMB ethnicity category codes.
\nThis value set includes codes from the following code systems:
urn:oid:2.16.840.1.113883.6.238 where concept is-a 2133-7urn:oid:2.16.840.1.113883.6.238| Code | Display | |
| 2135-2 | Hispanic or Latino | Hispanic or Latino |
| 2186-5 | Not Hispanic or Latino | Note that this term remains in the table for completeness, even though within HL7, the notion of "not otherwise coded" term is deprecated. |
The 900+ CDC Race codes that are grouped under one of the 5 OMB race category codes.
\nThis value set includes codes from the following code systems:
urn:oid:2.16.840.1.113883.6.238 where concept is-a 1000-9urn:oid:2.16.840.1.113883.6.238| Code | Display | |
| 1002-5 | American Indian or Alaska Native | American Indian or Alaska Native |
| 2028-9 | Asian | Asian |
| 2054-5 | Black or African American | Black or African American |
| 2076-8 | Native Hawaiian or Other Pacific Islander | Native Hawaiian or Other Pacific Islander |
| 2106-3 | White | White |
The codes for the ethnicity categories - 'Hispanic or Latino' and 'Non Hispanic or Latino' - as defined by the OMB Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity, Statistical Policy Directive No. 15, as revised, October 30, 1997.
\nThis value set includes codes from the following code systems:
urn:oid:2.16.840.1.113883.6.238| Code | Display | |
| 2135-2 | Hispanic or Latino | Hispanic or Latino |
| 2186-5 | Non Hispanic or Latino | Note that this term remains in the table for completeness, even though within HL7, the notion of "not otherwise coded" term is deprecated. |
The codes for the concepts 'Unknown' and 'Asked but no answer' and the the codes for the five race categories - 'American Indian' or 'Alaska Native', 'Asian', 'Black or African American', 'Native Hawaiian or Other Pacific Islander', and 'White' - as defined by the OMB Standards for Maintaining, Collecting, and Presenting Federal Data on Race and Ethnicity, Statistical Policy Directive No. 15, as revised, October 30, 1997 .
\nThis value set includes codes from the following code systems:
urn:oid:2.16.840.1.113883.6.238| Code | Display | |
| 1002-5 | American Indian or Alaska Native | American Indian or Alaska Native |
| 2028-9 | Asian | Asian |
| 2054-5 | Black or African American | Black or African American |
| 2076-8 | Native Hawaiian or Other Pacific Islander | Native Hawaiian or Other Pacific Islander |
| 2106-3 | White | White |
http://terminology.hl7.org/CodeSystem/v3-NullFlavor| Code | Display | |
| UNK | Unknown | Description:A proper value is applicable, but not known. \n \n Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: \n \n Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown')\n Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.) |
| ASKU | Asked but no answer | Information was sought but not found (e.g., patient was asked but didn't know) |
This value set includes codes from BCP-47. This value set matches the ONC 2015 Edition LanguageCommunication data element value set within C-CDA to use a 2 character language code if one exists, and a 3 character code if a 2 character code does not exist. It points back to RFC 5646, however only the language codes are required, all other elements are optional.
\nThis value set includes codes from the following code systems:
urn:ietf:bcp:47 where ext-lang doesn't exist, script doesn't exist, variant doesn't exist, extension doesn't exist and private-use doesn't existDocumentation of substances suspected of (or not suspected of) causing an allergy or intolerance reaction in an individual. Inclusion Criteria: specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction; assertions refuting these suspicions. This includes: 1. Common dietary substances for allergy and intolerance documentation (SNOMEDCT) 2. Common drug classes for allergy and intolerance documentation (SNOMEDCT) 3. Common drug substances for allergy and intolerance documentation (RXNORM) 4. Common environmental substances for allergy and intolerance documentation (SNOMEDCT) 5. Common refutations and null values for substance causes for allergy and intolerance documentation (SNOMEDCT) Exclusion Criteria: actual conditions caused by exposure (reactions, allergies)
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
This value set includes codes from the following code systems:
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display | |
| 1002293 | formoterol / Mometasone | |
| 1007388 | Lactase / rennet | |
| 1008298 | Acetaminophen / Caffeine / Chlorpheniramine / Hydrocodone / Phenylephrine | |
| 1008519 | guaiacolsulfonate / Hydrocodone | |
| 1009148 | Ampicillin / Sulbactam | |
| 10109 | Streptomycin | |
| 10154 | Succinylcholine | |
| 10156 | Sucralfate | |
| 10169 | Sulfacetamide | |
| 10171 | Sulfadiazine | |
| 10180 | Sulfamethoxazole | |
| 10207 | Sulfisoxazole | |
| 10223 | Sulfur | |
| 10237 | Sulindac | |
| 10324 | Tamoxifen | |
| 10355 | Temazepam | |
| 10368 | Terbutaline | |
| 1037042 | dabigatran etexilate | |
| 10379 | Testosterone | |
| 10395 | Tetracycline | |
| 103990 | Carbidopa / Levodopa | |
| 1040028 | lurasidone | |
| 10438 | Theophylline | |
| 10472 | Thimerosal | |
| 10493 | Thiopental | |
| 10502 | Thioridazine | |
| 10510 | Thiothixene | |
| 10582 | levothyroxine | |
| 10594 | Ticlopidine | |
| 10600 | Timolol | |
| 10627 | Tobramycin | |
| 10636 | Tolmetin | |
| 10689 | Tramadol | |
| 10737 | Trazodone | |
| 10759 | Triamcinolone | |
| 107602 | Epinephrine / Lidocaine | |
| 10763 | Triamterene | |
| 10767 | Triazolam | |
| 10800 | Trifluoperazine | |
| 108118 | Mometasone | |
| 10829 | Trimethoprim | |
| 10831 | Sulfamethoxazole / Trimethoprim | |
| 11124 | Vancomycin | |
| 1114195 | rivaroxaban | |
| 1116632 | Ticagrelor | |
| 11170 | Verapamil | |
| 11248 | Vitamin B 12 | |
| 11253 | Vitamin D | |
| 11256 | Vitamin E | |
| 11289 | Warfarin | |
| 113588 | Erythromycin / Sulfisoxazole | |
| 11416 | Zinc | |
| 11423 | Zinc Oxide | |
| 114477 | Levetiracetam | |
| 114970 | zafirlukast | |
| 114979 | rabeprazole | |
| 1151 | Ascorbic Acid | |
| 115264 | Ibandronate | |
| 115552 | trovafloxacin | |
| 115698 | ziprasidone | |
| 1191 | Aspirin | |
| 119565 | tolterodine | |
| 1202 | Atenolol | |
| 121191 | rituximab | |
| 1223 | Atropine | |
| 1256 | Azathioprine | |
| 1272 | Aztreonam | |
| 1291 | Bacitracin | |
| 1292 | Baclofen | |
| 1310171 | Gadolinium | |
| 1311085 | xanthine | |
| 1311524 | Aspartame | |
| 1311629 | nickel | |
| 1314891 | Latex | |
| 1331 | Barium Sulfate | |
| 134615 | brimonidine | |
| 1347 | Beclomethasone | |
| 135447 | donepezil | |
| 135775 | zolmitriptan | |
| 1359 | Belladonna Alkaloids | |
| 1362879 | Sulfur Dioxide | |
| 1363043 | ethyl ether | |
| 136411 | sildenafil | |
| 1364430 | apixaban | |
| 138099 | gemifloxacin | |
| 139462 | moxifloxacin | |
| 1399 | Benzocaine | |
| 140587 | celecoxib | |
| 1406 | benzoin resin | |
| 141626 | colesevelam | |
| 1418 | Benzoyl Peroxide | |
| 1424 | Benztropine | |
| 1514 | Betamethasone | |
| 153970 | Hyoscyamine | |
| 1596450 | Gentamicin | |
| 15996 | Mirtazapine | |
| 161 | Acetaminophen | |
| 16681 | Acarbose | |
| 167 | Acetazolamide | |
| 17128 | lansoprazole | |
| 1727875 | Tetanus immune globulin | |
| 17300 | alfuzosin | |
| 17767 | Amlodipine | |
| 1827 | Buspirone | |
| 183379 | rivastigmine | |
| 1841 | Butorphanol | |
| 18631 | Azithromycin | |
| 187832 | pregabalin | |
| 1886 | Caffeine | |
| 18867 | benazepril | |
| 1895 | Calcium | |
| 1897 | Calcium Carbonate | |
| 18993 | benzonatate | |
| 190376 | linezolid | |
| 191831 | infliximab | |
| 19478 | bismuth subsalicylate | |
| 19552 | cefprozil | |
| 19711 | Amoxicillin / Clavulanate | |
| 19831 | Budesonide | |
| 1998 | Captopril | |
| 2002 | Carbamazepine | |
| 20352 | carvedilol | |
| 20481 | cefepime | |
| 20489 | cefpodoxime | |
| 20610 | Cetirizine | |
| 2101 | Carisoprodol | |
| 21107 | cilostazol | |
| 21183 | Citric Acid | |
| 21212 | Clarithromycin | |
| 214130 | Acetaminophen / butalbital / Caffeine | |
| 214153 | Acetaminophen / dichloralphenazone / isometheptene | |
| 214159 | Aspirin / butalbital / Caffeine | |
| 214160 | Aspirin / butalbital / Caffeine / Codeine | |
| 214181 | Acetaminophen / Diphenhydramine | |
| 214182 | Acetaminophen / Hydrocodone | |
| 214183 | Acetaminophen / Oxycodone | |
| 214199 | Albuterol / Ipratropium | |
| 214223 | Amlodipine / benazepril | |
| 214250 | Aspirin / Caffeine | |
| 214256 | Aspirin / Oxycodone | |
| 214257 | Aspirin / Pentazocine | |
| 214317 | Bisoprolol / Hydrochlorothiazide | |
| 214336 | Caffeine / Ergotamine | |
| 214354 | candesartan | |
| 214364 | carbinoxamine / Pseudoephedrine | |
| 214392 | Chlorpheniramine / Hydrocodone | |
| 214442 | Codeine / Guaifenesin | |
| 214445 | Codeine / Pseudoephedrine | |
| 214488 | Dextromethorphan / Guaifenesin | |
| 214502 | Diclofenac / Misoprostol | |
| 214555 | Etanercept | |
| 214558 | Ethinyl Estradiol / Levonorgestrel | |
| 214565 | fexofenadine / Pseudoephedrine | |
| 214599 | Guaifenesin / Pseudoephedrine | |
| 214614 | homatropine / Hydrocodone | |
| 214617 | Hydrochlorothiazide / irbesartan | |
| 214618 | Hydrochlorothiazide / Lisinopril | |
| 214619 | Hydrochlorothiazide / Losartan | |
| 214626 | Hydrochlorothiazide / valsartan | |
| 214627 | Hydrocodone / Ibuprofen | |
| 214631 | Hydrocodone / Pseudoephedrine | |
| 214682 | Loratadine / Pseudoephedrine | |
| 214721 | Naloxone / Pentazocine | |
| 214807 | Pseudoephedrine / Triprolidine | |
| 2176 | Cefaclor | |
| 217627 | Hydrocortisone / Neomycin / Polymyxin B | |
| 2177 | Cefadroxil | |
| 2180 | Cefazolin | |
| 2189 | Cefoxitin | |
| 2191 | Ceftazidime | |
| 2193 | Ceftriaxone | |
| 219314 | Polymyxin B / Trimethoprim | |
| 219315 | Iron polysaccharide | |
| 2194 | Cefuroxime | |
| 21949 | cyclobenzaprine | |
| 221147 | POLYETHYLENE GLYCOL 3350 | |
| 22299 | Daptomycin | |
| 2231 | Cephalexin | |
| 226716 | Aspirin / Dipyridamole | |
| 228476 | gatifloxacin | |
| 228790 | Dutasteride | |
| 232158 | rofecoxib | |
| 233698 | dronedarone | |
| 2348 | Chloramphenicol | |
| 2356 | Chlordiazepoxide | |
| 2358 | Chlorhexidine | |
| 236778 | Trospium | |
| 237159 | Levalbuterol | |
| 2393 | Chloroquine | |
| 2400 | Chlorpheniramine | |
| 2403 | Chlorpromazine | |
| 2409 | Chlorthalidone | |
| 2410 | Chlorzoxazone | |
| 2418 | Cholecalciferol | |
| 2447 | Cholestyramine Resin | |
| 24605 | Etodolac | |
| 24947 | ferrous sulfate | |
| 25025 | Finasteride | |
| 25033 | Cefixime | |
| 25037 | cefdinir | |
| 25120 | flunisolide | |
| 25255 | formoterol | |
| 253157 | Bee pollen | |
| 2541 | Cimetidine | |
| 25480 | gabapentin | |
| 2551 | Ciprofloxacin | |
| 2556 | Citalopram | |
| 25789 | glimepiride | |
| 2582 | Clindamycin | |
| 258337 | Hydrochlorothiazide / Triamterene | |
| 2598 | Clonazepam | |
| 2599 | Clonidine | |
| 260101 | Oseltamivir | |
| 26225 | Ondansetron | |
| 2623 | Clotrimazole | |
| 2670 | Codeine | |
| 2683 | Colchicine | |
| 2685 | Colestipol | |
| 27169 | leflunomide | |
| 274783 | Insulin Glargine | |
| 274786 | telithromycin | |
| 27723 | iodinated glycerol | |
| 278567 | valdecoxib | |
| 28031 | Itraconazole | |
| 281 | Acyclovir | |
| 283742 | Esomeprazole | |
| 283809 | travoprost | |
| 28439 | lamotrigine | |
| 284635 | fluticasone / salmeterol | |
| 2878 | Cortisone | |
| 28889 | Loratadine | |
| 28981 | loracarbef | |
| 29046 | Lisinopril | |
| 29542 | Mercury, Ammoniated | |
| 29561 | meropenem | |
| 296 | Adenosine | |
| 3008 | Cyclosporine | |
| 301542 | rosuvastatin | |
| 306674 | vardenafil | |
| 3108 | Dapsone | |
| 3143 | prasterone | |
| 31448 | nabumetone | |
| 31555 | nebivolol | |
| 31565 | nefazodone | |
| 31738 | nickel sulfate | |
| 318340 | Aloe vera preparation | |
| 321064 | olmesartan | |
| 321988 | Escitalopram | |
| 322167 | Solifenacin | |
| 3247 | Desipramine | |
| 325642 | ertapenem | |
| 32592 | oxaliplatin | |
| 32613 | oxaprozin | |
| 32624 | oxcarbazepine | |
| 3264 | Dexamethasone | |
| 32675 | oxybutynin | |
| 327361 | adalimumab | |
| 3289 | Dextromethorphan | |
| 32937 | Paroxetine | |
| 32968 | clopidogrel | |
| 3322 | Diazepam | |
| 33408 | phenyltoloxamine | |
| 3355 | Diclofenac | |
| 3356 | Dicloxacillin | |
| 3361 | Dicyclomine | |
| 33738 | pioglitazone | |
| 3393 | Diflunisal | |
| 3407 | Digoxin | |
| 341248 | ezetimibe | |
| 3418 | Dihydroergotamine | |
| 3423 | Hydromorphone | |
| 3443 | Diltiazem | |
| 3444 | Dimenhydrinate | |
| 3498 | Diphenhydramine | |
| 35208 | quinapril | |
| 3521 | Dipyridamole | |
| 352362 | Acetaminophen / Tramadol | |
| 35296 | Ramipril | |
| 35382 | resorcinol | |
| 35636 | Risperidone | |
| 358263 | tadalafil | |
| 35827 | Ketorolac | |
| 35829 | ranolazine | |
| 36108 | Salsalate | |
| 36117 | salmeterol | |
| 3616 | Dobutamine | |
| 3638 | Doxepin | |
| 3640 | Doxycycline | |
| 36437 | Sertraline | |
| 3648 | Droperidol | |
| 36567 | Simvastatin | |
| 37418 | Sumatriptan | |
| 37617 | tazobactam | |
| 37798 | Terazosin | |
| 37801 | terbinafine | |
| 3827 | Enalapril | |
| 3829 | Enalaprilat | |
| 38400 | atomoxetine | |
| 38404 | topiramate | |
| 38413 | torsemide | |
| 38574 | trichloroacetaldehyde | |
| 38685 | trimethobenzamide | |
| 389132 | Budesonide / formoterol | |
| 3966 | Ephedrine | |
| 39786 | venlafaxine | |
| 3992 | Epinephrine | |
| 39993 | zolpidem | |
| 39998 | zonisamide | |
| 40048 | Carboplatin | |
| 400674 | dexbrompheniramine / Pseudoephedrine | |
| 4025 | Ergotamine | |
| 40254 | Valproate | |
| 4053 | Erythromycin | |
| 40575 | zileuton | |
| 40790 | pantoprazole | |
| 4083 | Estradiol | |
| 4099 | Estrogens, Conjugated (USP) | |
| 41126 | fluticasone | |
| 41127 | fluvastatin | |
| 4124 | Ethinyl Estradiol | |
| 41397 | Lactase | |
| 41493 | meloxicam | |
| 42330 | Terfenadine | |
| 42331 | Misoprostol | |
| 42347 | Bupropion | |
| 42351 | Lithium Carbonate | |
| 42372 | Mupirocin | |
| 42463 | Pravastatin | |
| 4278 | Famotidine | |
| 4316 | Felodipine | |
| 4337 | Fentanyl | |
| 435 | Albuterol | |
| 43611 | latanoprost | |
| 4419 | Fish Oils | |
| 4441 | Flecainide | |
| 4450 | Fluconazole | |
| 448 | Ethanol | |
| 4492 | Fluorouracil | |
| 4493 | Fluoxetine | |
| 4496 | Fluphenazine | |
| 4500 | Flurandrenolide | |
| 4530 | Formaldehyde | |
| 4603 | Furosemide | |
| 46041 | Alendronate | |
| 461016 | Eszopiclone | |
| 4637 | Galantamine | |
| 465397 | Ciprofloxacin / Dexamethasone | |
| 466522 | Diphenhydramine / Zinc Acetate | |
| 466541 | Neomycin / Polymyxin B | |
| 466549 | Aspirin / Caffeine / Orphenadrine | |
| 466553 | penicillin G benzathine / penicillin G procaine | |
| 466566 | Acetaminophen / Dextromethorphan / Diphenhydramine / Pseudoephedrine | |
| 466584 | Acetaminophen / Aspirin / Caffeine | |
| 4719 | Gemfibrozil | |
| 475968 | liraglutide | |
| 4815 | Glyburide | |
| 48203 | Clavulanate | |
| 4821 | Glipizide | |
| 48274 | Acetaminophen / Propoxyphene | |
| 484139 | Chlorhexidine / Isopropyl Alcohol | |
| 484211 | ezetimibe / Simvastatin | |
| 4850 | Glucose | |
| 4917 | Nitroglycerin | |
| 49276 | Doxazosin | |
| 50166 | Fosinopril | |
| 5021 | Griseofulvin | |
| 5032 | Guaifenesin | |
| 5093 | Haloperidol | |
| 51272 | quetiapine | |
| 519 | Allopurinol | |
| 52175 | Losartan | |
| 5224 | heparin | |
| 52582 | mesalamine | |
| 5470 | Hydralazine | |
| 5487 | Hydrochlorothiazide | |
| 5489 | Hydrocodone | |
| 5492 | Hydrocortisone | |
| 5499 | Hydrogen Peroxide | |
| 5521 | Hydroxychloroquine | |
| 5553 | Hydroxyzine | |
| 5640 | Ibuprofen | |
| 5691 | Imipramine | |
| 56946 | Paclitaxel | |
| 57258 | tizanidine | |
| 5764 | Indapamide | |
| 5781 | Indomethacin | |
| 588250 | milnacipran | |
| 59078 | metaxalone | |
| 591622 | varenicline | |
| 5933 | Iodine | |
| 593411 | sitagliptin | |
| 594040 | Atropine / Diphenoxylate | |
| 5956 | Iohexol | |
| 596 | Alprazolam | |
| 596723 | cerivastatin | |
| 597142 | brimonidine / Timolol | |
| 5992 | Iron-Dextran Complex | |
| 60207 | dorzolamide | |
| 6038 | isoniazid | |
| 60548 | exenatide | |
| 6057 | Isosorbide | |
| 6058 | Isosorbide Dinitrate | |
| 611854 | Chlordiazepoxide / clidinium | |
| 6130 | Ketamine | |
| 6135 | Ketoconazole | |
| 61381 | olanzapine | |
| 6142 | Ketoprofen | |
| 6185 | Labetalol | |
| 620 | Amantadine | |
| 6218 | Lactulose | |
| 6227 | Lanolin | |
| 6387 | Lidocaine | |
| 6398 | Lincomycin | |
| 6448 | Lithium | |
| 645555 | Bacitracin / Polymyxin B | |
| 6468 | Loperamide | |
| 6470 | Lorazepam | |
| 6472 | Lovastatin | |
| 6574 | Magnesium | |
| 6585 | Magnesium Sulfate | |
| 662263 | dorzolamide / Timolol | |
| 6676 | Meclizine | |
| 6691 | Medroxyprogesterone | |
| 67108 | Enoxaparin | |
| 6711 | Melatonin | |
| 6719 | Memantine | |
| 6750 | Menthol | |
| 6754 | Meperidine | |
| 6809 | Metformin | |
| 6813 | Methadone | |
| 6835 | Methimazole | |
| 6845 | Methocarbamol | |
| 6851 | Methotrexate | |
| 6876 | Methyldopa | |
| 689 | Aminophylline | |
| 689467 | Oxytetracycline / Polymyxin B | |
| 689518 | Aspirin / Caffeine / Propoxyphene | |
| 689556 | Acetaminophen / Aspirin / Phenylpropanolamine | |
| 689558 | Acetaminophen / Brompheniramine / Pseudoephedrine | |
| 689561 | Acetaminophen / butalbital / Caffeine / Codeine | |
| 689582 | Acetaminophen / Chlorpheniramine / Dextromethorphan / Pseudoephedrine | |
| 689606 | Atropine / Hyoscyamine / Phenobarbital / Scopolamine | |
| 689623 | Bacitracin / Hydrocortisone / Neomycin / Polymyxin B | |
| 690077 | Benzalkonium / Lidocaine | |
| 6901 | Methylphenidate | |
| 6902 | Methylprednisolone | |
| 690693 | Diphenhydramine / Phenylephrine | |
| 690808 | Brompheniramine / Dextromethorphan / Pseudoephedrine | |
| 69120 | tiotropium | |
| 6915 | Metoclopramide | |
| 6916 | Metolazone | |
| 6918 | Metoprolol | |
| 6922 | Metronidazole | |
| 692572 | Bacitracin / Neomycin / Polymyxin B | |
| 692794 | Gramicidin / Neomycin / Polymyxin B | |
| 6932 | Miconazole | |
| 6960 | Midazolam | |
| 69749 | valsartan | |
| 6980 | Minocycline | |
| 6984 | Minoxidil | |
| 703 | Amiodarone | |
| 704 | Amitriptyline | |
| 7052 | Morphine | |
| 705258 | Acetaminophen / Dextromethorphan / Doxylamine | |
| 7213 | Ipratropium | |
| 72143 | Raloxifene | |
| 72236 | fosphenytoin | |
| 723 | Amoxicillin | |
| 72302 | ropinirole | |
| 7233 | Nafcillin | |
| 7238 | Nalbuphine | |
| 7243 | Naltrexone | |
| 725 | Amphetamine | |
| 7258 | Naproxen | |
| 72625 | duloxetine | |
| 7299 | Neomycin | |
| 73056 | Risedronate | |
| 733 | Ampicillin | |
| 73494 | telmisartan | |
| 73645 | valacyclovir | |
| 7393 | Niacin | |
| 7407 | Nicotine | |
| 74169 | Piperacillin / tazobactam | |
| 7417 | Nifedipine | |
| 7454 | Nitrofurantoin | |
| 746741 | Pramipexole | |
| 7486 | Nitrous Oxide | |
| 7517 | Norfloxacin | |
| 7531 | Nortriptyline | |
| 7597 | Nystatin | |
| 7623 | Ofloxacin | |
| 7646 | Omeprazole | |
| 7676 | Opium | |
| 7715 | Orphenadrine | |
| 77492 | tamsulosin | |
| 7804 | Oxycodone | |
| 7821 | Oxytetracycline | |
| 787390 | tapentadol | |
| 7975 | Penicillamine | |
| 797541 | Isopropyl Alcohol | |
| 7980 | Penicillin G | |
| 7984 | Penicillin V | |
| 7994 | Pentamidine | |
| 8001 | Pentazocine | |
| 8120 | Phenazopyridine | |
| 8134 | Phenobarbital | |
| 815166 | Dextromethorphan / Doxylamine | |
| 8163 | Phenylephrine | |
| 816346 | dexlansoprazole | |
| 8175 | Phenylpropanolamine | |
| 817579 | Acetaminophen / Codeine | |
| 817958 | Aspirin / Calcium Carbonate | |
| 8183 | Phenytoin | |
| 82122 | Levofloxacin | |
| 822929 | Amphetamine aspartate / Amphetamine Sulfate / Dextroamphetamine saccharate / Dextroamphetamine Sulfate | |
| 83367 | atorvastatin | |
| 8356 | Piroxicam | |
| 83818 | irbesartan | |
| 84108 | rosiglitazone | |
| 8536 | Polymyxin B | |
| 857974 | saxagliptin | |
| 8588 | Potassium | |
| 8591 | Potassium Chloride | |
| 8610 | Povidone | |
| 8611 | Povidone-Iodine | |
| 861634 | pitavastatin | |
| 8629 | Prazosin | |
| 8638 | prednisolone | |
| 8640 | Prednisone | |
| 8687 | Primaquine | |
| 8691 | Primidone | |
| 8698 | Probenecid | |
| 8700 | Procainamide | |
| 8701 | Procaine | |
| 8703 | Fenofibrate | |
| 8704 | Prochlorperazine | |
| 8727 | Progesterone | |
| 8745 | Promethazine | |
| 8754 | Propafenone | |
| 87636 | fexofenadine | |
| 8782 | Propofol | |
| 8785 | Propoxyphene | |
| 8787 | Propranolol | |
| 8794 | Propylthiouracil | |
| 88014 | rizatriptan | |
| 88249 | montelukast | |
| 883815 | Dexamethasone / Tobramycin | |
| 8896 | Pseudoephedrine | |
| 89013 | aripiprazole | |
| 8928 | Psyllium | |
| 8948 | Purified Protein Derivative of Tuberculin | |
| 90176 | Iron | |
| 9068 | Quinidine | |
| 9071 | Quinine | |
| 91263 | Aloe Extract | |
| 9143 | Ranitidine | |
| 9384 | Rifampin | |
| 9524 | Sulfasalazine | |
| 9601 | Scopolamine | |
| 9778 | Silicones | |
| 9793 | silver sulfadiazine | |
| 9947 | Sotalol | |
| 9997 | Spironolactone |
http://snomed.info/sct| Code | Display | |
| 102259006 | Citrus fruit (substance) | |
| 102261002 | Strawberry (substance) | |
| 102262009 | Chocolate (substance) | |
| 102263004 | Eggs (edible) (substance) | |
| 102264005 | Cheese (substance) | |
| 111088007 | Latex (substance) | |
| 111151007 | Anabolic steroid (substance) | |
| 11526002 | Aspartame (substance) | |
| 116274004 | Artificial sweetener (substance) | |
| 116566001 | Steroid (substance) | |
| 13577000 | Nut (substance) | |
| 14443002 | Substance with aminoglycoside structure and antibacterial mechanism of action (substance) | |
| 226723006 | Buckwheat - cereal (substance) | |
| 226734009 | Wheatgerm (substance) | |
| 226760005 | Dairy foods (substance) | |
| 226915003 | Red meat (substance) | |
| 226916002 | Beef (substance) | |
| 226934003 | Pork (substance) | |
| 226955001 | Chicken - meat (substance) | |
| 226967004 | Turkey - meat (substance) | |
| 227144008 | Tuna fish (substance) | |
| 227151004 | Prawns (substance) | |
| 227208008 | Abalone canned in brine (substance) | |
| 227219006 | Aubergine (substance) | |
| 227313005 | Pulse vegetables (substance) | |
| 227388008 | Cinnamon (substance) | |
| 227400003 | Ginger (substance) | |
| 227421003 | Cranberries (substance) | |
| 227444000 | Raspberries (substance) | |
| 227493005 | Cashew nut (substance) | |
| 227512001 | Pistachio nut (substance) | |
| 227598003 | Honey (substance) | |
| 228102000 | Sodium nitrate (substance) | |
| 255632006 | Anticonvulsant (substance) | |
| 255637000 | Salicylate (substance) | |
| 255641001 | Caffeine (substance) | |
| 256259004 | Pollen (substance) | |
| 256277009 | Grass pollen (substance) | |
| 256306003 | Orange - fruit (substance) | |
| 256307007 | Banana (substance) | |
| 256313003 | Pineapple (substance) | |
| 256315005 | Grapefruit (substance) | |
| 256317002 | Grapes (substance) | |
| 256319004 | Carrot (substance) | |
| 256326004 | Celery (substance) | |
| 256329006 | Spinach (substance) | |
| 256350002 | Almond (substance) | |
| 256351003 | Brazil nut (substance) | |
| 256352005 | Walnut - nut (substance) | |
| 256353000 | Hazelnut (substance) | |
| 256354006 | Bean (substance) | |
| 256417003 | Horse dander (substance) | |
| 256440004 | Wasp venom (substance) | |
| 259858000 | Varicella-zoster virus antibody (substance) | |
| 260152009 | Cat dander (substance) | |
| 260154005 | Dog dander (substance) | |
| 260167008 | Sesame seed (substance) | |
| 260176001 | Kiwi fruit (substance) | |
| 260177005 | Melon (substance) | |
| 260179008 | Mango fruit (substance) | |
| 260184002 | Peas (substance) | |
| 260189007 | Pecan nut (substance) | |
| 260205009 | Sunflower seed (substance) | |
| 264287008 | Animal dander (substance) | |
| 264337003 | Seed (substance) | |
| 28230009 | Poultry (substance) | |
| 288328004 | Bee venom (substance) | |
| 28942008 | Coconut oil (substance) | |
| 29263009 | Coffee (substance) | |
| 304275008 | Corticosteroid and corticosteroid derivative (substance) | |
| 33008008 | Dust (substance) | |
| 350327004 | Diphtheria + tetanus vaccine (product) | |
| 35748005 | Wine (substance) | |
| 360201004 | Nitrofuran derivative (substance) | |
| 3692009 | Sodium sulfite (substance) | |
| 372480009 | Substance with macrolide structure and antibacterial mechanism of action (substance) | |
| 372664007 | Benzodiazepine (substance) | |
| 372665008 | Non-steroidal anti-inflammatory agent (substance) | |
| 372711004 | Sulfonylurea (substance) | |
| 372722000 | Substance with quinolone structure and antibacterial mechanism of action (substance) | |
| 372733002 | Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance) | |
| 372747003 | Thiazide diuretic (substance) | |
| 372783007 | Antiparkinsonian agent (substance) | |
| 372798009 | Barbiturate (substance) | |
| 372806008 | Substance with histamine receptor antagonist mechanism of action (substance) | |
| 372889003 | First generation cephalosporin (substance) | |
| 372912004 | Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance) | |
| 372913009 | Substance with angiotensin II receptor antagonist mechanism of action (substance) | |
| 373206009 | Substance with tetracycline structure and antibacterial mechanism of action (substance) | |
| 373253007 | Tricyclic antidepressant (substance) | |
| 373254001 | Substance with beta adrenergic receptor antagonist mechanism of action (substance) | |
| 373262009 | Substance with cephalosporin structure and antibacterial mechanism of action (substance) | |
| 373270004 | Substance with penicillin structure and antibacterial mechanism of action (substance) | |
| 373297006 | Substance with beta-lactam structure and antibacterial mechanism of action (substance) | |
| 373304005 | Substance with calcium channel blocker mechanism of action (substance) | |
| 373531009 | Gelatin (substance) | |
| 385420005 | Contrast media (substance) | |
| 386127005 | Formula milk (substance) | |
| 386962001 | Plasma protein fraction (substance) | |
| 387050005 | Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) | |
| 387406002 | Sulfonamide (substance) | |
| 391737006 | Almond oil (substance) | |
| 391739009 | Aloe (substance) | |
| 396345004 | Carbapenem (substance) | |
| 396420001 | Anthrax vaccine (substance) | |
| 396425006 | Influenza virus vaccine (substance) | |
| 396433007 | Pertussis vaccine (substance) | |
| 396439006 | Smallpox vaccine (substance) | |
| 396441007 | Typhoid vaccine (substance) | |
| 396442000 | Varicella virus vaccine (substance) | |
| 398730001 | Pneumococcal vaccine (substance) | |
| 400872007 | Hydrocolloid (substance) | |
| 404642006 | Substance with opioid receptor agonist mechanism of action (substance) | |
| 406748003 | Carbamate (substance) | |
| 409137002 | No known drug allergy (situation) | |
| 412061001 | Blueberries (substance) | |
| 412062008 | Cantaloupe (substance) | |
| 412066006 | Pepper (substance) | |
| 412068007 | Rye (substance) | |
| 412071004 | Wheat (substance) | |
| 412138001 | Horse serum protein (substance) | |
| 412357001 | Corn (substance) | |
| 412373007 | Diphtheria + pertussis + tetanus + Haemophilus influenzae type b vaccine (product) | |
| 412375000 | Tetanus vaccine (substance) | |
| 412533000 | Wheat bran (substance) | |
| 412534006 | Yeast (substance) | |
| 412583005 | Bee pollen (substance) | |
| 41598000 | Estrogen (substance) | |
| 417889008 | Arachis oil (substance) | |
| 418000008 | Methadone analog (substance) | |
| 418504009 | Oats (substance) | |
| 418920007 | Adhesive agent (substance) | |
| 419420009 | Watermelon (substance) | |
| 419933005 | Glucocorticoid (substance) | |
| 421245007 | Diphtheria + pertussis + tetanus vaccine (product) | |
| 424369009 | Product containing beta-galactosidase (medicinal product) | |
| 426722004 | Iodinated contrast media (substance) | |
| 428607008 | No known environmental allergy (situation) | |
| 429625007 | No known food allergy (situation) | |
| 43735007 | Sulfur (substance) | |
| 43921001 | Nickel compound (substance) | |
| 44027008 | Seafood (substance) | |
| 442381000124103 | Blue food coloring (substance) | |
| 442571000124108 | Tree nut (substance) | |
| 442771000124102 | Pepperoni (substance) | |
| 44588005 | Iodine (substance) | |
| 446273004 | Red food coloring (substance) | |
| 446274005 | Yellow food coloring (substance) | |
| 47703008 | Lactose (substance) | |
| 51386004 | Food preservative (substance) | |
| 51905005 | Mustard (substance) | |
| 53041004 | Alcohol (substance) | |
| 61789006 | Dye (substance) | |
| 63045006 | Berry (substance) | |
| 67324005 | Rice (substance) | |
| 67866001 | Insulin (substance) | |
| 70813002 | Milk (substance) | |
| 710179004 | Lupine seed (substance) | |
| 716184000 | No known latex allergy (situation) | |
| 716186003 | No known allergy (situation) | |
| 720687003 | Dust mite protein (substance) | |
| 72511004 | Fruit (substance) | |
| 726730005 | Yam (substance) | |
| 734881000 | Tomato (substance) | |
| 735006003 | Squid (substance) | |
| 735009005 | Salmon (substance) | |
| 735029006 | Shellfish (substance) | |
| 735030001 | Garlic (substance) | |
| 735043001 | Mackerel (substance) | |
| 735045008 | Mushroom (substance) | |
| 735047000 | Onion (substance) | |
| 735049002 | Peach (substance) | |
| 735050002 | Pear (substance) | |
| 735051003 | Plum (substance) | |
| 735053000 | Potato (substance) | |
| 735123009 | Broccoli (substance) | |
| 735124003 | Barley (substance) | |
| 735211005 | Coconut (substance) | |
| 735212003 | Papaya (substance) | |
| 735213008 | Cucumber (substance) | |
| 735214002 | Apricot (substance) | |
| 735215001 | Apple (substance) | |
| 735248001 | Cherry (substance) | |
| 735249009 | Avocado (substance) | |
| 735340006 | Lemon (substance) | |
| 735959004 | Marine mollusk (substance) | |
| 735971005 | Fish (substance) | |
| 735977009 | Marine crustacean (substance) | |
| 736027000 | Scallop (substance) | |
| 736030007 | Clam (substance) | |
| 736031006 | Oyster (substance) | |
| 736159005 | Crab (substance) | |
| 736162008 | Lobster (substance) | |
| 74801000 | Sugar (substance) | |
| 75665004 | Monosodium glutamate (substance) | |
| 762952008 | Peanut (substance) | |
| 7791007 | Soy protein (substance) | |
| 80259003 | Food flavoring agent (substance) | |
| 84489001 | Mold (organism) | |
| 89119000 | Nitrate salt (substance) | |
| 89707004 | Sesame oil (substance) | |
| 89811004 | Gluten (substance) |
Provider roles codes consist of NUCC Health Care Provider Taxonomy Code Set for providers and SNOMED-CT for - non clinical and organization roles including codes from the SCTID 223366009 Healthcare professional (occupation) heirarchy and the SCTID 224930009 Services (qualifier value) heirarchy.
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. This value set includes content from NUCC Health Care Provider Taxonomy Code Set for providers which is copyright © 2016+ American Medical Association. For commercial use, including sales or licensing, a license must be obtained.
This value set includes codes from the following code systems:
http://nucc.org/provider-taxonomyhttp://snomed.info/sct where concept is-a 223366009 (Healthcare professional)http://snomed.info/sct where concept is-a 224930009 (Services)The US Core Clinical Note Type Value Set is a 'starter set' of types supported for fetching and storing clinical notes.
\nCopyright Statement: This content LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use
This value set includes codes from the following code systems:
The US Core Condition Category Codes support the separate concepts of problems and health concerns in Condition.category in order for API consumers to be able to separate health concerns and problems. However this is not mandatory for 2015 certification
\nThis value set includes codes from the following code systems:
http://terminology.hl7.org/CodeSystem/condition-categoryhttp://hl7.org/fhir/us/core/CodeSystem/condition-category| Code | Display | |
| health-concern | Health Concern | Additional health concerns from other stakeholders which are outside the provider’s problem list. |
This describes the problem. Diagnosis/Problem List is broadly defined as a series of brief statements that catalog a patient's medical, nursing, dental, social, preventative and psychiatric events and issues that are relevant to that patient's healthcare (e.g., signs, symptoms, and defined conditions). ICD-10 is appropriate for Diagnosis information, and ICD-9 for historical information.
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. ICD-9 and ICD-10 are copyrighted by the World Health Organization (WHO) which owns and publishes the classification. See https://www.who.int/classifications/icd/en. WHO has authorized the development of an adaptation of ICD-9 and ICD-10 to ICD-9-CM to ICD-10-CM for use in the United States for U.S. government purposes.
This value set includes codes from the following code systems:
http://snomed.info/sct| Code | Display | |
| 160245001 | No current problems or disability |
http://snomed.info/sct where concept is-a 404684003 (Clinical finding (finding))http://snomed.info/sct where concept is-a 243796009 (Context-dependent category)http://hl7.org/fhir/sid/icd-10-cmhttp://hl7.org/fhir/sid/icd-9-cmThe US Core Diagnostic Report Category Value Set is a 'starter set' of categories supported for fetching and Diagnostic Reports and notes.
\nCopyright Statement: This content LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use
This value set includes codes from the following code systems:
http://loinc.org| Code | Display | |
| LP29684-5 | Radiology | |
| LP29708-2 | Cardiology | |
| LP7839-6 | Pathology |
The Document Type value set includes all LOINC values whose CLASSTYPE is LABORATORY in the LOINC database
\nCopyright Statement: This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use.
This value set includes codes from the following code systems:
http://loinc.org where CLASSTYPE = 1This value set currently contains all of LOINC. The codes selected should represent discrete and narrative diagnostic observations and reports
\nCopyright Statement: This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use.
This value set includes codes from the following code systems:
http://loinc.orgThe US Core DocumentReferences Category Value Set is a 'starter set' of categories supported for fetching and storing clinical notes.
\nThis value set includes codes from the following code systems:
http://hl7.org/fhir/us/core/CodeSystem/us-core-documentreference-categoryThe US Core DocumentReference Type Value Set includes all LOINC values whose SCALE is DOC in the LOINC database and the HL7 v3 Code System NullFlavor concept 'unknown'
\nCopyright Statement: This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use.
This value set includes codes from the following code systems:
http://terminology.hl7.org/CodeSystem/v3-NullFlavor| Code | Display | |
| UNK | unknown | Description:A proper value is applicable, but not known. \n \n Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: \n \n Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown')\n Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.) |
http://loinc.org where SCALE_TYP = DOCThe type of encounter: a specific code indicating type of service provided. This value set includes codes from SNOMED CT decending from the concept 308335008 (Patient encounter procedure (procedure)) and from the Current Procedure and Terminology(CPT) designated for Evaluation and Management (99200 – 99607) (subscription to AMA Required)
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement. This value set includes content from CPT copyright 2014 American Medical Association. All rights reserved.
This value set includes codes from the following code systems:
http://snomed.info/sct where concept is-a 308335008 (Patient encounter procedure)http://www.ama-assn.org/go/cptAll prescribable medication formulations represented using either a 'generic' or 'brand-specific' concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form)
\n\t\t\tThis value set includes codes from the following code systems:
\n\t\t\tThe US Core Narrative Status Value Set limits the text status for the resource narrative.
\nCopyright Statement: HL7
This value set includes codes from the following code systems:
http://hl7.org/fhir/narrative-status| Code | Display | |
| additional | additional | The contents of the narrative may contain additional information not found in the structured data. Note that there is no computable way to determine what the extra information is, other than by human inspection. |
| generated | generated | The contents of the narrative are entirely generated from the core elements in the content. |
This value set includes all the Vaccine National Drug Codes (NDC). This source of this data is provided by the CDC
\nThis value set includes codes from the following code systems:
http://hl7.org/fhir/sid/ndc| Code | Display | |
| 49281-0703-55 | FLUZONE INTRADERMAL | |
| 49281-0790-20 | Typhim Vi | |
| 33332-0316-01 | AFLURIA QUADRIVALENT | |
| 49281-0712-40 | FLUZONE INTRADERMAL QUADRIVALENT | |
| 66521-0112-02 | Fluvirin | |
| 58160-0816-05 | Hiberix | |
| 00006-4837-02 | PNEUMOVAX 23 | |
| 58160-0808-15 | Influenza A (H5N1) Monovalent Vaccine, Adjuvanted | |
| 58160-0842-51 | BOOSTRIX | |
| 49281-0418-50 | FLUZONE QUADRIVALENT | |
| 00006-4943-00 | PNEUMOVAX 23 | |
| 49281-0708-40 | FLUZONE INTRADERMAL QUADRIVALENT | |
| 54868-0734-00 | ENGERIX-B | |
| 58160-0819-12 | Shingrix | |
| 49281-0517-25 | FLUZONE QUADRIVALENT | |
| 00006-4133-41 | Tetanus and Diphtheria Toxoids Adsorbed | |
| 50090-3096-00 | RabAvert | |
| 33332-0118-10 | AFLURIA | |
| 19515-0909-52 | Flulaval Quadrivalent | |
| 49281-0650-10 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 58160-0820-11 | ENGERIX-B | |
| 42515-0001-01 | IXIARO | |
| 49281-0625-15 | FLUZONE QUADRIVALENT | |
| 49281-0516-25 | FLUZONE QUADRIVALENT | |
| 66521-0114-02 | FLUVIRIN | |
| 19515-0896-11 | Flulaval Quadrivalent | |
| 33332-0117-10 | AFLURIA | |
| 33332-0416-10 | AFLURIA QUADRIVALENT | |
| 66521-0118-02 | Fluvirin | |
| 58160-0821-11 | ENGERIX-B | |
| 00005-1971-05 | PREVNAR 13 | |
| 66019-0109-10 | FLUMIST | |
| 49281-0278-10 | DIPHTHERIA AND TETANUS TOXOIDS ADSORBED | |
| 49281-0011-10 | FLUZONE | |
| 54868-2219-00 | RECOMBIVAX HB | |
| 49281-0415-10 | FLUZONE QUADRIVALENT | |
| 33332-0016-01 | AFLURIA | |
| 49281-0705-55 | FLUZONE | |
| 49281-0621-15 | FLUZONE QUADRIVALENT | |
| 58160-0842-34 | BOOSTRIX | |
| 49281-0010-10 | FLUZONE | |
| 66521-0113-02 | FLUVIRIN | |
| 49281-0514-25 | FLUZONE QUADRIVALENT | |
| 58160-0842-52 | BOOSTRIX | |
| 19515-0901-52 | Flulaval Quadrivalent | |
| 62577-0613-01 | Flucelvax | |
| 66019-0303-10 | FluMist Quadrivalent | |
| 49281-0388-15 | FLUZONE | |
| 00006-4841-41 | VAQTA | |
| 58160-0900-52 | FLUARIX QUADRIVALENT | |
| 70461-0200-01 | FLUCELVAX QUADRIVALENT | |
| 49281-0915-05 | YF-VAX | |
| 49281-0650-50 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 33332-0116-10 | AFLURIA | |
| 54868-3339-01 | PNEUMOVAX 23 | |
| 49281-0418-10 | FLUZONE QUADRIVALENT | |
| 58160-0812-52 | KINRIX | |
| 49281-0286-05 | DAPTACEL | |
| 63851-0612-01 | Flucelvax | |
| 19515-0908-52 | Flulaval Quadrivalent | |
| 54868-0980-00 | M-M-R II | |
| 58160-0830-52 | CERVARIX | |
| 49281-0113-25 | FLUZONE | |
| 49281-0650-70 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 66521-0115-10 | FLUVIRIN | |
| 49281-0417-50 | FLUZONE QUADRIVALENT | |
| 33332-0113-10 | AFLURIA | |
| 49281-0629-15 | FLUZONE QUADRIVALENT | |
| 58160-0823-11 | Shingrix | |
| 00006-4897-00 | PedvaxHIB | |
| 58160-0821-34 | ENGERIX-B | |
| 66521-0115-02 | FLUVIRIN | |
| 33332-0014-01 | AFLURIA | |
| 49281-0562-10 | QUADRACEL | |
| 42874-0014-10 | Flublok | |
| 42874-0013-10 | Flublok | |
| 33332-0115-10 | AFLURIA | |
| 00006-4963-00 | ZOSTAVAX | |
| 49281-0010-25 | FLUZONE | |
| 33332-0519-01 | Influenza A | |
| 58160-0898-52 | FLUARIX QUADRIVALENT | |
| 49281-0112-25 | FLUZONE | |
| 19515-0898-11 | Flulaval Quadrivalent | |
| 00006-4109-09 | GARDASIL | |
| 49281-0414-50 | FLUZONE QUADRIVALENT | |
| 00006-4095-09 | VAQTA | |
| 00006-4045-00 | GARDASIL | |
| 19515-0912-52 | Flulaval Quadrivalent | |
| 58160-0801-11 | Menhibrix | |
| 49281-0489-01 | MENOMUNE - A/C/Y/W-135 COMBINED | |
| 42874-0017-10 | Flublok | |
| 66521-0116-02 | Fluvirin | |
| 46028-0208-01 | Menveo | |
| 49281-0627-15 | FLUZONE QUADRIVALENT | |
| 00005-0100-02 | Trumenba | |
| 69401-0000-01 | Vivotif | |
| 21695-0413-01 | Tetanus and Diphtheria Toxoids Adsorbed | |
| 49281-0416-10 | FLUZONE QUADRIVALENT | |
| 49281-0650-25 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 49281-0800-83 | TETANUS TOXOID ADSORBED | |
| 49281-0291-83 | DECAVAC | |
| 00006-4095-02 | VAQTA | |
| 58160-0854-52 | ROTARIX | |
| 19515-0889-07 | FLULAVAL | |
| 49281-0392-15 | FLUZONE | |
| 19515-0891-11 | Flulaval Quadrivalent | |
| 49281-0400-05 | Adacel | |
| 49281-0913-01 | STAMARIL | |
| 49281-0640-15 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 49281-0513-25 | FLUZONE QUADRIVALENT | |
| 00006-4171-00 | ProQuad | |
| 00006-4096-09 | VAQTA | |
| 58160-0830-34 | CERVARIX | |
| 00006-4980-00 | RECOMBIVAX HB | |
| 17478-0131-01 | Tetanus and Diphtheria Toxoids Adsorbed | |
| 49281-0414-10 | FLUZONE QUADRIVALENT | |
| 43528-0002-05 | HEPLISAV-B | |
| 66521-0200-02 | Influenza A (H1N1) 2009 Monovalent Vaccine | |
| 49281-0011-50 | FLUZONE | |
| 70461-0120-10 | Fluvirin | |
| 66019-0304-10 | FluMist Quadrivalent | |
| 58160-0976-20 | Bexsero | |
| 00006-4826-00 | VARIVAX | |
| 66521-0116-10 | Fluvirin | |
| 00006-4963-41 | ZOSTAVAX | |
| 49281-0510-05 | PENTACEL | |
| 42874-0012-10 | Flublok | |
| 58160-0955-09 | Menveo | |
| 00005-0100-05 | Trumenba | |
| 49281-0707-55 | FLUZONE | |
| 14362-0111-04 | Tetanus and Diphtheria Toxoids Adsorbed | |
| 66521-0112-10 | Fluvirin | |
| 66521-0117-10 | Fluvirin | |
| 00006-4045-41 | GARDASIL | |
| 49281-0389-65 | FLUZONE HIGH DOSE | |
| 69401-0000-02 | Vivotif | |
| 49281-0915-01 | YF-VAX | |
| 00006-4093-02 | RECOMBIVAX HB | |
| 58160-0815-48 | TWINRIX | |
| 70460-0001-01 | Vaxchora | |
| 58160-0826-11 | HAVRIX | |
| 00006-4992-00 | RECOMBIVAX HB | |
| 49281-0111-25 | FLUZONE | |
| 00006-4093-09 | RECOMBIVAX HB | |
| 50090-3469-00 | HEPLISAV-B | |
| 49281-0403-65 | FLUZONE High-Dose | |
| 70461-0119-10 | Fluvirin | |
| 00006-4995-00 | RECOMBIVAX HB | |
| 58160-0815-34 | TWINRIX | |
| 49281-0393-65 | FLUZONE High-Dose | |
| 00005-1970-50 | Prevnar | |
| 33332-0017-01 | AFLURIA | |
| 63851-0501-01 | RabAvert | |
| 58160-0881-52 | FLUARIX | |
| 64678-0211-01 | BioThrax | |
| 49281-0394-15 | FLUZONE | |
| 00006-4827-00 | VARIVAX | |
| 58160-0806-05 | HIBERIX | |
| 49281-0518-25 | FLUZONE QUADRIVALENT | |
| 62195-0051-10 | Ixiaro | |
| 63361-0245-10 | VAXELIS | |
| 49281-0709-55 | FLUZONE Intradermal | |
| 66019-0300-10 | FluMist Quadrivalent | |
| 49281-0215-15 | TENIVAC | |
| 58160-0825-52 | HAVRIX | |
| 00005-0100-10 | Trumenba | |
| 66521-0117-02 | Fluvirin | |
| 49281-0650-90 | INFLUENZA A (H1N1) 2009 MONOVALENT VACCINE | |
| 42874-0015-10 | Flublok | |
| 33332-0018-01 | AFLURIA | |
| 00006-4999-00 | ProQuad | |
| 00005-1971-04 | PREVNAR 13 | |
| 19515-0850-52 | FLULAVAL | |
| 00005-1971-02 | PREVNAR 13 | |
| 00006-4094-02 | RECOMBIVAX HB | |
| 00006-4096-02 | VAQTA | |
| 58160-0825-11 | HAVRIX | |
| 58160-0811-52 | PEDIARIX | |
| 42515-0002-01 | IXIARO | |
| 49281-0013-50 | FLUZONE | |
| 76420-0483-01 | Medical Provider Single Use EZ Flu Shot 2013-2014 | |
| 66521-0118-10 | Fluvirin | |
| 49281-0399-65 | FLUZONE High-Dose | |
| 49281-0396-15 | FLUZONE | |
| 66019-0107-01 | FLUMIST | |
| 19515-0890-07 | FLULAVAL | |
| 76420-0482-01 | Medical Provider Single Use EZ Flu Shot 2013-2014 | |
| 33332-0015-01 | AFLURIA | |
| 66019-0302-10 | FluMist Quadrivalent | |
| 49281-0012-10 | FLUZONE | |
| 49281-0710-40 | FLUZONE INTRADERMAL QUADRIVALENT | |
| 63851-0501-02 | RabAvert | |
| 58160-0879-52 | FLUARIX | |
| 49281-0397-65 | FLUZONE High-Dose | |
| 00006-4831-41 | VAQTA | |
| 58160-0815-46 | TWINRIX | |
| 33332-0110-10 | AFLURIA | |
| 54868-4320-00 | PNEUMOVAX 23 | |
| 42874-0016-10 | Flublok | |
| 49281-0012-50 | FLUZONE | |
| 58160-0818-11 | Hiberix | |
| 49281-0386-15 | FLUZONE | |
| 46028-0114-01 | Bexsero | |
| 00006-4898-00 | COMVAX | |
| 58160-0826-52 | HAVRIX | |
| 49281-0545-05 | ActHIB | |
| 66019-0108-10 | FLUMIST | |
| 70461-0418-10 | FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) | |
| 00006-4094-09 | RECOMBIVAX HB | |
| 49281-0298-10 | TRIPEDIA | |
| 33332-0629-10 | Influenza A | |
| 58160-0880-52 | FLUARIX | |
| 00006-4047-20 | RotaTeq | |
| 00006-4119-02 | GARDASIL 9 | |
| 58160-0842-11 | BOOSTRIX | |
| 19515-0903-11 | Flulaval Quadrivalent | |
| 00006-4981-00 | RECOMBIVAX HB | |
| 58160-0905-52 | FLUARIX QUADRIVALENT | |
| 49281-0401-65 | FLUZONE High-Dose | |
| 33332-0114-10 | AFLURIA | |
| 49281-0860-10 | IPOL | |
| 70461-0318-03 | FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) | |
| 54868-2219-01 | RECOMBIVAX HB | |
| 49281-0718-10 | Flublok Quadrivalent | |
| 49281-0400-15 | Adacel | |
| 70461-0120-02 | Fluvirin | |
| 49281-0416-50 | FLUZONE QUADRIVALENT | |
| 49281-0413-50 | FLUZONE QUADRIVALENT | |
| 58160-0883-52 | FLUARIX | |
| 49281-0790-51 | Typhim Vi | |
| 49281-0286-10 | DAPTACEL | |
| 66019-0110-10 | FluMist | |
| 46028-0114-02 | Bexsero | |
| 58160-0821-52 | ENGERIX-B | |
| 49281-0013-10 | FLUZONE | |
| 19515-0894-52 | Flulaval Quadrivalent | |
| 66019-0305-10 | FluMist Quadrivalent | |
| 49281-0400-10 | Adacel | |
| 49281-0390-15 | FLUZONE | |
| 00052-0603-02 | BCG VACCINE | |
| 51285-0138-50 | Adenovirus Type 4 and Type 7 Vaccine, Live | |
| 33332-0417-10 | AFLURIA QUADRIVALENT | |
| 49281-0395-65 | FLUZONE High-Dose | |
| 66019-0301-10 | FluMist Quadrivalent | |
| 49281-0215-10 | TENIVAC | |
| 19515-0895-11 | Flulaval Quadrivalent | |
| 70461-0201-01 | FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE) | |
| 58160-0907-52 | FLUARIX QUADRIVALENT | |
| 55045-3841-01 | HAVRIX | |
| 50090-2883-00 | INFANRIX | |
| 49281-0820-10 | TETANUS TOXOID ADSORBED | |
| 49281-0417-10 | FLUZONE QUADRIVALENT | |
| 33332-0010-01 | AFLURIA | |
| 33332-0013-01 | AFLURIA | |
| 66521-0200-10 | Influenza A (H1N1) 2009 Monovalent Vaccine | |
| 58160-0976-06 | Bexsero | |
| 58160-0809-05 | MENHIBRIX | |
| 00006-4739-00 | PNEUMOVAX 23 | |
| 70461-0018-03 | FLUAD | |
| 49281-0413-10 | FLUZONE QUADRIVALENT | |
| 13533-0131-01 | Tetanus and Diphtheria Toxoids Adsorbed | |
| 58160-0812-11 | KINRIX | |
| 49281-0391-65 | FLUZONE High-Dose | |
| 19515-0845-11 | FLULAVAL | |
| 58160-0811-51 | PEDIARIX | |
| 58160-0815-52 | TWINRIX | |
| 70461-0119-02 | Fluvirin | |
| 58160-0810-52 | INFANRIX | |
| 62577-0614-01 | Flucelvax | |
| 42874-0117-10 | Flublok Quadrivalent | |
| 49281-0489-91 | MENOMUNE - A/C/Y/W-135 COMBINED | |
| 58160-0964-12 | RabAvert | |
| 49281-0014-50 | FLUZONE | |
| 00006-4109-02 | GARDASIL | |
| 70461-0002-01 | FLUAD | |
| 49281-0286-01 | DAPTACEL | |
| 58160-0810-11 | INFANRIX | |
| 19515-0900-11 | Flulaval Quadrivalent | |
| 00006-4837-03 | PNEUMOVAX 23 | |
| 66521-0113-10 | FLUVIRIN | |
| 58160-0826-34 | HAVRIX | |
| 58160-0903-52 | FLUARIX QUADRIVALENT | |
| 00006-4841-00 | VAQTA | |
| 54868-6180-00 | FLUZONE | |
| 00006-4681-00 | M-M-R II | |
| 33332-0317-01 | AFLURIA QUADRIVALENT | |
| 70461-0001-01 | FLUAD | |
| 49281-0589-05 | Menactra | |
| 49281-0387-65 | FLUZONE | |
| 49281-0860-55 | IPOL | |
| 19515-0893-07 | FLULAVAL | |
| 33332-0519-25 | Influenza A | |
| 70461-0301-10 | FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) | |
| 66019-0200-10 | Influenza A H1N1 Intranasal | |
| 43528-0003-05 | HEPLISAV-B | |
| 58160-0820-52 | ENGERIX-B | |
| 66521-0000-01 | FLUAD | |
| 49281-0250-51 | IMOVAX RABIES | |
| 49281-0291-10 | DECAVAC | |
| 33332-0418-10 | AFLURIA QUADRIVALENT | |
| 00006-4121-02 | GARDASIL 9 | |
| 63851-0613-01 | FLUCELVAX | |
| 66521-0114-10 | FLUVIRIN | |
| 00006-4047-41 | RotaTeq | |
| 58160-0901-52 | FLUARIX QUADRIVALENT | |
| 33332-0318-01 | AFLURIA QUADRIVALENT | |
| 00006-4119-03 | GARDASIL 9 | |
| 49281-0225-10 | DIPHTHERIA AND TETANUS TOXOIDS ADSORBED | |
| 58160-0815-11 | TWINRIX | |
| 54868-6177-00 | FLUZONE | |
| 49281-0010-50 | FLUZONE | |
| 49281-0400-20 | Adacel | |
| 49281-0545-03 | ActHIB | |
| 50090-1693-09 | IPOL | |
| 00006-4995-41 | RECOMBIVAX HB |
Codes providing the status of an observation for smoking status. Constrained to finaland entered-in-error.
This value set includes codes from the following code systems:
http://hl7.org/fhir/observation-status| Code | Display | |
| final | Final | The observation is complete and there are no further actions needed. Additional information such "released", "signed", etc would be represented using [Provenance](provenance.html) which provides not only the act but also the actors and dates and other related data. These act states would be associated with an observation status of `preliminary` until they are all completed and then a status of `final` would be applied. |
| entered-in-error | Entered in Error | The observation has been withdrawn following previous final release. This electronic record should never have existed, though it is possible that real-world decisions were based on it. (If real-world activity has occurred, the status should be "cancelled" rather than "entered-in-error".). |
This value set indicates the current smoking status of a patient.
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
This value set includes codes from the following code systems:
http://snomed.info/sct| Code | Display | |
| 449868002 | Current every day smoker | |
| 428041000124106 | Current some day smoker | |
| 8517006 | Former smoker | |
| 266919005 | Never smoker | |
| 77176002 | Smoker, current status unknown | |
| 266927001 | Unknown if ever smoked | |
| 428071000124103 | Current Heavy tobacco smoker | |
| 428061000124105 | Current Light tobacco smoker |
Snomed-CT concept codes for coded results
\nCopyright Statement: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
This value set includes codes from the following code systems:
http://snomed.info/sctThis example value set defines a set of codes that can be used to indicate the type of procedure: a specific code indicating type of procedure performed, from CPT, SNOMED CT, or HCPCS Level II Alphanumeric Codes.
\nCopyright Statement: CPT copyright 2014 American Medical Association. All rights reserved. This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement
This value set includes codes from the following code systems:
http://www.ama-assn.org/go/cpthttp://snomed.info/sct where concept is-a 71388002 (Procedure)urn:oid:2.16.840.1.113883.6.285This value set defines a set of codes from ICD10-PCS that can be used to indicate a type of procedure performed
\nCopyright Statement: The International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) was developed for the Centers for Medicare and Medicaid Services (CMS). CMS is the U.S. governmental agency responsible for overseeing all changes and modifications to the ICD-10-PCS.
This value set includes codes from the following code systems:
http://www.icd10data.com/icd10pcsThe type of participation a provenance agent played for a given target.
\nThis value set includes codes from the following code systems:
http://hl7.org/fhir/us/core/CodeSystem/us-core-provenance-participant-typehttp://terminology.hl7.org/CodeSystem/provenance-participant-typeProvider roles codes which are composed of the NUCC Health Care Provider Taxonomy Code Set classification codes for providers. Only concepts with a classification and no specialization are included.
\nCopyright Statement: This value set includes content from NUCC Health Care Provider Taxonomy Code Set for providers which is copyright © 2016+ American Medical Association. For commercial use, including sales or licensing, a license must be obtained.
This value set includes codes from the following code systems:
http://nucc.org/provider-taxonomy| Code | Display | |
| 101Y00000X | Counselor | |
| 102L00000X | Psychoanalyst | |
| 102X00000X | Poetry Therapist | |
| 103G00000X | Clinical Neuropsychologist | |
| 103K00000X | Behavior Analyst | |
| 103T00000X | Psychologist | |
| 104100000X | Social Worker | |
| 106E00000X | Assistant Behavior Analyst | |
| 106H00000X | Marriage & Family Therapist | |
| 106S00000X | Behavior Technician | |
| 111N00000X | Chiropractor | |
| 122300000X | Dentist | |
| 122400000X | Denturist | |
| 124Q00000X | Dental Hygienist | |
| 125J00000X | Dental Therapist | |
| 125K00000X | Advanced Practice Dental Therapist | |
| 125Q00000X | Oral Medicinist | |
| 126800000X | Dental Assistant | |
| 126900000X | Dental Laboratory Technician | |
| 132700000X | Dietary Manager | |
| 133N00000X | Nutritionist | |
| 133V00000X | Dietitian, Registered | |
| 136A00000X | Dietetic Technician, Registered | |
| 146D00000X | Personal Emergency Response Attendant | |
| 146L00000X | Emergency Medical Technician, Paramedic | |
| 146M00000X | Emergency Medical Technician, Intermediate | |
| 146N00000X | Emergency Medical Technician, Basic | |
| 152W00000X | Optometrist | |
| 156F00000X | Technician/Technologist | |
| 163W00000X | Registered Nurse | |
| 164W00000X | Licensed Practical Nurse | |
| 164X00000X | Licensed Vocational Nurse | |
| 167G00000X | Licensed Psychiatric Technician | |
| 170100000X | Medical Genetics, Ph.D. Medical Genetics | |
| 170300000X | Genetic Counselor, MS | |
| 171000000X | Military Health Care Provider | |
| 171100000X | Acupuncturist | |
| 171M00000X | Case Manager/Care Coordinator | |
| 171R00000X | Interpreter | |
| 171W00000X | Contractor | |
| 172A00000X | Driver | |
| 172M00000X | Mechanotherapist | |
| 172P00000X | Naprapath | |
| 172V00000X | Community Health Worker | |
| 173000000X | Legal Medicine | |
| 173C00000X | Reflexologist | |
| 173F00000X | Sleep Specialist, PhD | |
| 174200000X | Meals | |
| 174400000X | Specialist | |
| 174H00000X | Health Educator | |
| 174M00000X | Veterinarian | |
| 174N00000X | Lactation Consultant, Non-RN | |
| 174V00000X | Clinical Ethicist | |
| 175F00000X | Naturopath | |
| 175L00000X | Homeopath | |
| 175M00000X | Midwife, Lay | |
| 175T00000X | Peer Specialist | |
| 176B00000X | Midwife | |
| 176P00000X | Funeral Director | |
| 177F00000X | Lodging | |
| 183500000X | Pharmacist | |
| 183700000X | Pharmacy Technician | |
| 193200000X | Multi-Specialty | |
| 193400000X | Single Specialty | |
| 202C00000X | Independent Medical Examiner | |
| 202K00000X | Phlebology | |
| 204C00000X | Neuromusculoskeletal Medicine, Sports Medicine | |
| 204D00000X | Neuromusculoskeletal Medicine & OMM | |
| 204E00000X | Oral & Maxillofacial Surgery | |
| 204F00000X | Transplant Surgery | |
| 204R00000X | Electrodiagnostic Medicine | |
| 207K00000X | Allergy & Immunology | |
| 207L00000X | Anesthesiology | |
| 207N00000X | Dermatology | |
| 207P00000X | Emergency Medicine | |
| 207Q00000X | Family Medicine | |
| 207R00000X | Internal Medicine | |
| 207T00000X | Neurological Surgery | |
| 207U00000X | Nuclear Medicine | |
| 207V00000X | Obstetrics & Gynecology | |
| 207W00000X | Ophthalmology | |
| 207X00000X | Orthopaedic Surgery | |
| 207Y00000X | Otolaryngology | |
| 208000000X | Pediatrics | |
| 208100000X | Physical Medicine & Rehabilitation | |
| 208200000X | Plastic Surgery | |
| 208600000X | Surgery | |
| 208800000X | Urology | |
| 208C00000X | Colon & Rectal Surgery | |
| 208D00000X | General Practice | |
| 208G00000X | Thoracic Surgery (Cardiothoracic Vascular Surgery) | |
| 208M00000X | Hospitalist | |
| 208U00000X | Clinical Pharmacology | |
| 209800000X | Legal Medicine | |
| 211D00000X | Assistant, Podiatric | |
| 213E00000X | Podiatrist | |
| 221700000X | Art Therapist | |
| 222Q00000X | Developmental Therapist | |
| 222Z00000X | Orthotist | |
| 224900000X | Mastectomy Fitter | |
| 224L00000X | Pedorthist | |
| 224P00000X | Prosthetist | |
| 224Y00000X | Clinical Exercise Physiologist | |
| 224Z00000X | Occupational Therapy Assistant | |
| 225000000X | Orthotic Fitter | |
| 225100000X | Physical Therapist | |
| 225200000X | Physical Therapy Assistant | |
| 225400000X | Rehabilitation Practitioner | |
| 225500000X | Specialist/Technologist | |
| 225600000X | Dance Therapist | |
| 225700000X | Massage Therapist | |
| 225800000X | Recreation Therapist | |
| 225A00000X | Music Therapist | |
| 225B00000X | Pulmonary Function Technologist | |
| 225C00000X | Rehabilitation Counselor | |
| 225X00000X | Occupational Therapist | |
| 226000000X | Recreational Therapist Assistant | |
| 226300000X | Kinesiotherapist | |
| 227800000X | Respiratory Therapist, Certified | |
| 227900000X | Respiratory Therapist, Registered | |
| 229N00000X | Anaplastologist | |
| 231H00000X | Audiologist | |
| 235500000X | Specialist/Technologist | |
| 235Z00000X | Speech-Language Pathologist | |
| 237600000X | Audiologist-Hearing Aid Fitter | |
| 237700000X | Hearing Instrument Specialist | |
| 242T00000X | Perfusionist | |
| 243U00000X | Radiology Practitioner Assistant | |
| 246Q00000X | Specialist/Technologist, Pathology | |
| 246R00000X | Technician, Pathology | |
| 246W00000X | Technician, Cardiology | |
| 246X00000X | Specialist/Technologist Cardiovascular | |
| 246Y00000X | Specialist/Technologist, Health Information | |
| 246Z00000X | Specialist/Technologist, Other | |
| 247000000X | Technician, Health Information | |
| 247100000X | Radiologic Technologist | |
| 247200000X | Technician, Other | |
| 251300000X | Local Education Agency (LEA) | |
| 251B00000X | Case Management | |
| 251C00000X | Day Training, Developmentally Disabled Services | |
| 251E00000X | Home Health | |
| 251F00000X | Home Infusion | |
| 251G00000X | Hospice Care, Community Based | |
| 251J00000X | Nursing Care | |
| 251K00000X | Public Health or Welfare | |
| 251S00000X | Community/Behavioral Health | |
| 251T00000X | Program of All-Inclusive Care for the Elderly (PACE) Provider Organization | |
| 251V00000X | Voluntary or Charitable | |
| 251X00000X | Supports Brokerage | |
| 252Y00000X | Early Intervention Provider Agency | |
| 253J00000X | Foster Care Agency | |
| 253Z00000X | In Home Supportive Care | |
| 261Q00000X | Clinic/Center | |
| 273100000X | Epilepsy Unit | |
| 273R00000X | Psychiatric Unit | |
| 273Y00000X | Rehabilitation Unit | |
| 275N00000X | Medicare Defined Swing Bed Unit | |
| 276400000X | Rehabilitation, Substance Use Disorder Unit | |
| 281P00000X | Chronic Disease Hospital | |
| 282E00000X | Long Term Care Hospital | |
| 282J00000X | Religious Nonmedical Health Care Institution | |
| 282N00000X | General Acute Care Hospital | |
| 283Q00000X | Psychiatric Hospital | |
| 283X00000X | Rehabilitation Hospital | |
| 284300000X | Special Hospital | |
| 286500000X | Military Hospital | |
| 287300000X | Christian Science Sanitorium | |
| 291900000X | Military Clinical Medical Laboratory | |
| 291U00000X | Clinical Medical Laboratory | |
| 292200000X | Dental Laboratory | |
| 293D00000X | Physiological Laboratory | |
| 302F00000X | Exclusive Provider Organization | |
| 302R00000X | Health Maintenance Organization | |
| 305R00000X | Preferred Provider Organization | |
| 305S00000X | Point of Service | |
| 310400000X | Assisted Living Facility | |
| 310500000X | Intermediate Care Facility, Mental Illness | |
| 311500000X | Alzheimer Center (Dementia Center) | |
| 311Z00000X | Custodial Care Facility | |
| 313M00000X | Nursing Facility/Intermediate Care Facility | |
| 314000000X | Skilled Nursing Facility | |
| 315D00000X | Hospice, Inpatient | |
| 315P00000X | Intermediate Care Facility, Mentally Retarded | |
| 317400000X | Christian Science Facility | |
| 320600000X | Residential Treatment Facility, Mental Retardation and/or Developmental Disabilities | |
| 320700000X | Residential Treatment Facility, Physical Disabilities | |
| 320800000X | Community Based Residential Treatment Facility, Mental Illness | |
| 320900000X | Community Based Residential Treatment Facility, Mental Retardation and/or Developmental Disabilities | |
| 322D00000X | Residential Treatment Facility, Emotionally Disturbed Children | |
| 323P00000X | Psychiatric Residential Treatment Facility | |
| 324500000X | Substance Abuse Rehabilitation Facility | |
| 331L00000X | Blood Bank | |
| 332000000X | Military/U.S. Coast Guard Pharmacy | |
| 332100000X | Department of Veterans Affairs (VA) Pharmacy | |
| 332800000X | Indian Health Service/Tribal/Urban Indian Health (I/T/U) Pharmacy | |
| 332900000X | Non-Pharmacy Dispensing Site | |
| 332B00000X | Durable Medical Equipment & Medical Supplies | |
| 332G00000X | Eye Bank | |
| 332H00000X | Eyewear Supplier | |
| 332S00000X | Hearing Aid Equipment | |
| 332U00000X | Home Delivered Meals | |
| 333300000X | Emergency Response System Companies | |
| 333600000X | Pharmacy | |
| 335E00000X | Prosthetic/Orthotic Supplier | |
| 335G00000X | Medical Foods Supplier | |
| 335U00000X | Organ Procurement Organization | |
| 335V00000X | Portable X-ray and/or Other Portable Diagnostic Imaging Supplier | |
| 341600000X | Ambulance | |
| 341800000X | Military/U.S. Coast Guard Transport | |
| 343800000X | Secured Medical Transport (VAN) | |
| 343900000X | Non-emergency Medical Transport (VAN) | |
| 344600000X | Taxi | |
| 344800000X | Air Carrier | |
| 347B00000X | Bus | |
| 347C00000X | Private Vehicle | |
| 347D00000X | Train | |
| 347E00000X | Transportation Broker | |
| 363A00000X | Physician Assistant | |
| 363L00000X | Nurse Practitioner | |
| 364S00000X | Clinical Nurse Specialist | |
| 367500000X | Nurse Anesthetist, Certified Registered | |
| 367A00000X | Advanced Practice Midwife | |
| 367H00000X | Anesthesiologist Assistant | |
| 372500000X | Chore Provider | |
| 372600000X | Adult Companion | |
| 373H00000X | Day Training/Habilitation Specialist | |
| 374700000X | Technician | |
| 374J00000X | Doula | |
| 374K00000X | Religious Nonmedical Practitioner | |
| 374T00000X | Religious Nonmedical Nursing Personnel | |
| 374U00000X | Home Health Aide | |
| 376G00000X | Nursing Home Administrator | |
| 376J00000X | Homemaker | |
| 376K00000X | Nurse's Aide | |
| 385H00000X | Respite Care | |
| 390200000X | Student in an Organized Health Care Education/Training Program | |
| 405300000X | Prevention Professional |
Provider speciality roles codes which are composed of the NUCC Health Care Provider Taxonomy Code Set for providers
\nCopyright Statement: This value set includes content from NUCC Health Care Provider Taxonomy Code Set for providers which is copyright © 2016+ American Medical Association. For commercial use, including sales or licensing, a license must be obtained.
This value set includes codes from the following code systems:
http://nucc.org/provider-taxonomyThe US Core Smoking Status Observation Codes Value Set is a 'starter set' of concepts to capture smoking status.
\nThis value set includes codes from the following code systems:
http://loinc.org| Code | Display | |
| 72166-2 | Tobacco smoking status NHIS |
This value set defines two letter USPS alphabetic codes.
\nCopyright Statement: On July 1, 1963, the Post Office Department implemented the five-digit ZIP Code, which was placed after the state name in the last line of an address. To provide room for the ZIP Code, the Department issued two-letter abbreviations for all states and territories. Publication 59, Abbreviations for Use with ZIP Code, issued by the Department in October 1963. Currently there is no copyright restriction on this value set.
This value set includes codes from the following code systems:
https://www.usps.com/| Code | Display | |
| AK | Alaska | |
| AL | Alabama | |
| AR | Arkansas | |
| AS | American Samoa | |
| AZ | Arizona | |
| CA | California | |
| CO | Colorado | |
| CT | Connecticut | |
| DC | District of Columbia | |
| DE | Delaware | |
| FL | Florida | |
| FM | Federated States of Micronesia | |
| GA | Georgia | |
| GU | Guam | |
| HI | Hawaii | |
| IA | Iowa | |
| ID | Idaho | |
| IL | Illinois | |
| IN | Indiana | |
| KS | Kansas | |
| KY | Kentucky | |
| LA | Louisiana | |
| MA | Massachusetts | |
| MD | Maryland | |
| ME | Maine | |
| MH | Marshall Islands | |
| MI | Michigan | |
| MN | Minnesota | |
| MO | Missouri | |
| MP | Northern Mariana Islands | |
| MS | Mississippi | |
| MT | Montana | |
| NC | North Carolina | |
| ND | North Dakota | |
| NE | Nebraska | |
| NH | New Hampshire | |
| NJ | New Jersey | |
| NM | New Mexico | |
| NV | Nevada | |
| NY | New York | |
| OH | Ohio | |
| OK | Oklahoma | |
| OR | Oregon | |
| PA | Pennsylvania | |
| PR | Puerto Rico | |
| PW | Palau | |
| RI | Rhode Island | |
| SC | South Carolina | |
| SD | South Dakota | |
| TN | Tennessee | |
| TX | Texas | |
| UM | U.S. Minor Outlying Islands | |
| UT | Utah | |
| VA | Virginia | |
| VI | Virgin Islands of the U.S. | |
| VT | Vermont | |
| WA | Washington | |
| WI | Wisconsin | |
| WV | West Virginia | |
| WY | Wyoming |
This identifies the vaccine substance administered - CVX codes. Inclusion Criteria: Any CVX code with CVX 'status' (VSAC Property) = Active,Inactive, Non-US except those noted in exclusions. Exclusion Criteria: CVX codes that have a CVX 'status' of either Pending or Never Active AND CVX codes with CVX 'Nonvaccine' property = True. Available at http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx
This value set includes codes from the following code systems:
http://hl7.org/fhir/sid/cvx| Code | Display | |
| 01 | diphtheria, tetanus toxoids and pertussis vaccine | |
| 02 | trivalent poliovirus vaccine, live, oral | |
| 03 | measles, mumps and rubella virus vaccine | |
| 04 | measles and rubella virus vaccine | |
| 05 | measles virus vaccine | |
| 06 | rubella virus vaccine | |
| 07 | mumps virus vaccine | |
| 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
| 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
| 10 | poliovirus vaccine, inactivated | |
| 100 | pneumococcal conjugate vaccine, 7 valent | |
| 101 | typhoid Vi capsular polysaccharide vaccine | |
| 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | |
| 103 | meningococcal C conjugate vaccine | |
| 104 | hepatitis A and hepatitis B vaccine | |
| 105 | vaccinia (smallpox) vaccine, diluted | |
| 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | |
| 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | |
| 108 | meningococcal ACWY vaccine, unspecified formulation | |
| 109 | pneumococcal vaccine, unspecified formulation | |
| 11 | pertussis vaccine | |
| 110 | DTaP-hepatitis B and poliovirus vaccine | |
| 111 | influenza virus vaccine, live, attenuated, for intranasal use | |
| 112 | tetanus toxoid, unspecified formulation | |
| 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
| 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | |
| 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | |
| 116 | rotavirus, live, pentavalent vaccine | |
| 117 | varicella zoster immune globulin (Investigational New Drug) | |
| 118 | human papilloma virus vaccine, bivalent | |
| 119 | rotavirus, live, monovalent vaccine | |
| 12 | diphtheria antitoxin | |
| 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
| 121 | zoster vaccine, live | |
| 122 | rotavirus vaccine, unspecified formulation | |
| 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | |
| 125 | Novel Influenza-H1N1-09, live virus for nasal administration | |
| 126 | Novel influenza-H1N1-09, preservative-free, injectable | |
| 127 | Novel influenza-H1N1-09, injectable | |
| 128 | Novel influenza-H1N1-09, all formulations | |
| 129 | Japanese Encephalitis vaccine, unspecified formulation | |
| 13 | tetanus immune globulin | |
| 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | |
| 131 | Historical record of a typhus vaccination | |
| 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. | |
| 133 | pneumococcal conjugate vaccine, 13 valent | |
| 134 | Japanese Encephalitis vaccine for intramuscular administration | |
| 135 | influenza, high dose seasonal, preservative-free | |
| 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | |
| 137 | HPV, unspecified formulation | |
| 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use | |
| 139 | Td(adult) unspecified formulation | |
| 14 | immune globulin, unspecified formulation | |
| 140 | Influenza, seasonal, injectable, preservative free | |
| 141 | Influenza, seasonal, injectable | |
| 142 | tetanus toxoid, not adsorbed | |
| 143 | Adenovirus, type 4 and type 7, live, oral | |
| 144 | seasonal influenza, intradermal, preservative free | |
| 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | |
| 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | |
| 149 | influenza, live, intranasal, quadrivalent | |
| 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | |
| 150 | Influenza, injectable, quadrivalent, preservative free | |
| 151 | influenza nasal, unspecified formulation | |
| 152 | Pneumococcal Conjugate, unspecified formulation | |
| 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free | |
| 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free | |
| 156 | Rho(D) Immune globulin- IV or IM | |
| 157 | Rho(D) Immune globulin - IM | |
| 158 | influenza, injectable, quadrivalent, contains preservative | |
| 159 | Rho(D) Unspecified formulation | |
| 16 | influenza virus vaccine, whole virus | |
| 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | |
| 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | |
| 162 | meningococcal B vaccine, fully recombinant | |
| 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted | |
| 164 | meningococcal B, unspecified formulation | |
| 165 | Human Papillomavirus 9-valent vaccine | |
| 166 | influenza, intradermal, quadrivalent, preservative free, injectable | |
| 167 | meningococcal vaccine of unknown formulation and unknown serogroups | |
| 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free | |
| 169 | Hep A, live attenuated-IM | |
| 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation | |
| 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
| 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent | |
| 172 | cholera, WC-rBS | |
| 173 | cholera, BivWC | |
| 174 | cholera, live attenuated | |
| 175 | Human Rabies vaccine from human diploid cell culture | |
| 176 | Human rabies vaccine from Chicken fibroblast culture | |
| 177 | pneumococcal conjugate vaccine, 10 valent | |
| 178 | Non-US bivalent oral polio vaccine (types 1 and 3) | |
| 179 | Non-US monovalent oral polio vaccine, unspecified formulation | |
| 18 | rabies vaccine, for intramuscular injection RETIRED CODE | |
| 180 | tetanus immune globulin | |
| 181 | anthrax immune globulin | |
| 182 | Oral Polio Vaccine, Unspecified formulation | |
| 183 | Yellow fever vaccine alternative formulation | |
| 184 | Yellow fever vaccine, unspecified formulation | |
| 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free | |
| 186 | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative | |
| 187 | zoster vaccine recombinant | |
| 188 | zoster vaccine, unspecified formulation | |
| 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted | |
| 19 | Bacillus Calmette-Guerin vaccine | |
| 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
| 21 | varicella virus vaccine | |
| 22 | DTP-Haemophilus influenzae type b conjugate vaccine | |
| 23 | plague vaccine | |
| 24 | anthrax vaccine | |
| 25 | typhoid vaccine, live, oral | |
| 26 | cholera vaccine, unspecified formulation | |
| 27 | botulinum antitoxin | |
| 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
| 29 | cytomegalovirus immune globulin, intravenous | |
| 30 | hepatitis B immune globulin | |
| 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation | |
| 32 | meningococcal polysaccharide vaccine (MPSV4) | |
| 33 | pneumococcal polysaccharide vaccine, 23 valent | |
| 34 | rabies immune globulin | |
| 35 | tetanus toxoid, adsorbed | |
| 36 | varicella zoster immune globulin | |
| 37 | yellow fever vaccine | |
| 38 | rubella and mumps virus vaccine | |
| 39 | Japanese Encephalitis Vaccine SC | |
| 40 | rabies vaccine, for intradermal injection | |
| 41 | typhoid vaccine, parenteral, other than acetone-killed, dried | |
| 42 | hepatitis B vaccine, adolescent/high risk infant dosage | |
| 43 | hepatitis B vaccine, adult dosage | |
| 44 | hepatitis B vaccine, dialysis patient dosage | |
| 45 | hepatitis B vaccine, unspecified formulation | |
| 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
| 47 | Haemophilus influenzae type b vaccine, HbOC conjugate | |
| 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
| 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
| 50 | DTaP-Haemophilus influenzae type b conjugate vaccine | |
| 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
| 52 | hepatitis A vaccine, adult dosage | |
| 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
| 54 | adenovirus vaccine, type 4, live, oral | |
| 55 | adenovirus vaccine, type 7, live, oral | |
| 62 | human papilloma virus vaccine, quadrivalent | |
| 66 | Lyme disease vaccine | |
| 69 | parainfluenza-3 virus vaccine | |
| 71 | respiratory syncytial virus immune globulin, intravenous | |
| 74 | rotavirus, live, tetravalent vaccine | |
| 75 | vaccinia (smallpox) vaccine | |
| 76 | Staphylococcus bacteriophage lysate | |
| 77 | tick-borne encephalitis vaccine | |
| 78 | tularemia vaccine | |
| 79 | vaccinia immune globulin | |
| 80 | Venezuelan equine encephalitis, live, attenuated | |
| 801 | AS03 Adjuvant | |
| 81 | Venezuelan equine encephalitis, inactivated | |
| 82 | adenovirus vaccine, unspecified formulation | |
| 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
| 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
| 85 | hepatitis A vaccine, unspecified formulation | |
| 86 | immune globulin, intramuscular | |
| 87 | immune globulin, intravenous | |
| 88 | influenza virus vaccine, unspecified formulation | |
| 89 | poliovirus vaccine, unspecified formulation | |
| 90 | rabies vaccine, unspecified formulation | |
| 91 | typhoid vaccine, unspecified formulation | |
| 92 | Venezuelan equine encephalitis vaccine, unspecified formulation | |
| 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
| 94 | measles, mumps, rubella, and varicella virus vaccine | |
| 95 | tuberculin skin test; old tuberculin, multipuncture device | |
| 96 | tuberculin skin test; purified protein derivative solution, intradermal | |
| 97 | tuberculin skin test; purified protein derivative, multipuncture device | |
| 98 | tuberculin skin test; unspecified formulation | |
| 998 | no vaccine administered |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 93468003 (Hemangioma of intracranial structure)http://snomed.info/sct where concept is-a 109913001 (Benign neoplasm of meninges)http://snomed.info/sct where concept is-a 92030004 (Benign neoplasm of brain)http://snomed.info/sct where concept is-a 92048008 (Benign neoplasm of central nervous system)http://snomed.info/sct where concept is-a 92296004 (Benign neoplasm of pituitary gland)http://snomed.info/sct where concept is-a 92294001 (Benign neoplasm of pineal gland)http://snomed.info/sct where concept is-a 94963005 (Neoplasm of uncertain behavior of nervous system)http://snomed.info/sct where concept is-a 94767002 (Neoplasm of uncertain behavior of brain)http://snomed.info/sct where concept is-a 95002008 (Neoplasm of uncertain behavior of pineal gland)http://snomed.info/sct where concept is-a 95004009 (Neoplasm of uncertain behavior of pituitary gland)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D18.02 | Hemangioma of intracranial structures |
| D32 | BENIGN NEOPLASM OF MENINGES |
| D32.0 | Benign neoplasm of cerebral meninges |
| D32.1 | Benign neoplasm of spinal meninges |
| D32.9 | Benign neoplasm of meninges, unspecified |
| D33 | BENIGN NEOPLASM OF BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM |
| D33.0 | Benign neoplasm of brain, supratentorial |
| D33.1 | Benign neoplasm of brain, infratentorial |
| D33.2 | Benign neoplasm of brain, unspecified |
| D33.3 | Benign neoplasm of cranial nerves |
| D33.4 | Benign neoplasm of spinal cord |
| D33.7 | Benign neoplasm of other specified parts of central nervous system |
| D33.9 | Benign neoplasm of central nervous system, unspecified |
| D35.2 | Benign neoplasm of pituitary gland |
| D35.3 | Benign neoplasm of craniopharyngeal duct |
| D35.4 | Benign neoplasm of pineal gland |
| D42.0 | Neoplasm of uncertain behavior of cerebral meninges |
| D42.1 | Neoplasm of uncertain behavior of spinal meninges |
| D42.9 | Neoplasm of uncertain behavior of meninges, unspecified |
| D43.0 | Neoplasm of uncertain behavior of brain, supratentorial |
| D43.1 | Neoplasm of uncertain behavior of brain, infratentorial |
| D43.2 | Neoplasm of uncertain behavior of brain, unspecified |
| D43.3 | Neoplasm of uncertain behavior of cranial nerves |
| D43.4 | Neoplasm of uncertain behavior of spinal cord |
| D43.8 | Neoplasm of uncertain behavior of other specified parts of central nervous system |
| D43.9 | Neoplasm of uncertain behavior of central nervous system, unspecified |
| D44.3 | Neoplasm of uncertain behavior of pituitary gland |
| D44.4 | Neoplasm of uncertain behavior of craniopharyngeal duct |
| D44.5 | Neoplasm of uncertain behavior of pineal gland |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 106233006 (Topographical modifier)http://snomed.info/sct where concept descends from 272424004 (Relative sites)http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 255503000 | Entire (qualifier value) |
This value set includes codes based on the following rules:
This value set excludes codes based on the following rules:
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 384692006 | Intracavitary brachytherapy (procedure) |
| 1156382005 | Intensity modulated intracavitary brachytherapy (procedure) |
| 113120007 | Interstitial brachytherapy (procedure) |
| 384691004 | Intraluminal brachytherapy (procedure) |
| 168524008 | Radiotherapy - intraoperative control (procedure) |
| 14473006 | Surface brachytherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 384692006 | Intracavitary brachytherapy (procedure) |
| 1156382005 | Intensity modulated intracavitary brachytherapy (procedure) |
| 113120007 | Interstitial brachytherapy (procedure) |
| 1156383000 | Intravascular brachytherapy (procedure) |
| 384691004 | Intraluminal brachytherapy (procedure) |
| 168524008 | Radiotherapy - intraoperative control (procedure) |
| 14473006 | Surface brachytherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 384692006 | Intracavitary brachytherapy (procedure) |
| 113120007 | Interstitial brachytherapy (procedure) |
| 14473006 | Surface brachytherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 1156708005 | Low dose rate brachytherapy using temporary radioactive source (procedure) |
| 169359004 | Internal radiotherapy - permanent seeds (procedure) |
| 1156384006 | Pulsed dose rate brachytherapy (procedure) |
| 394902000 | High dose brachytherapy (procedure) |
| 438629002 | High dose rate electronic brachytherapy (procedure) |
| 440252007 | Administration of radiopharmaceutical (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 113120007 | Interstitial brachytherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 384692006 | Intracavitary brachytherapy (procedure) |
| 113120007 | Interstitial brachytherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 16560241000119104 | Oral radionuclide therapy (procedure) |
| 1156383000 | Intravascular brachytherapy (procedure) |
| 384692006 | Intracavitary brachytherapy (procedure) |
| 113120007 | Interstitial brachytherapy (procedure) |
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 123037004 (Body structure)http://terminology.hl7.org/CodeSystem/icd-o-3This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 714797009 (Histologic test (procedure))http://snomed.info/sct where concept is-a 116147009 (Cytologic test)http://snomed.info/sct where concept is-a 108257001 (Anatomic pathology procedure)http://snomed.info/sct where concept is-a 386344002 (Laboratory data interpretation (procedure))http://snomed.info/sct where concept is-a 5880005 (Clinical examination)http://snomed.info/sct where concept is-a 363679005 (Imaging (procedure))http://snomed.info/sct where concept is-a 250724005 (Tumor marker measurement)This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 387713003 (Surgical procedure (procedure))http://www.ama-assn.org/go/cpthttp://www.cms.gov/Medicare/Coding/ICD10This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 1222585009 (American Joint Committee on Cancer clinical T category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222587001 (American Joint Committee on Cancer clinical M category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222588006 (American Joint Committee on Cancer clinical N category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222589003 (American Joint Committee on Cancer pathological T category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222590007 (American Joint Committee on Cancer pathological N category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222591006 (American Joint Committee on Cancer pathological M category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222592004 (American Joint Committee on Cancer clinical stage group allowable value)http://snomed.info/sct where concept descends from 1222593009 (American Joint Committee on Cancer pathological stage group allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222594003 (American Joint Committee on Cancer yp stage group allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222595002 (American Joint Committee on Cancer ypT category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222596001 (American Joint Committee on Cancer ypN category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222598000 (American Joint Committee on Cancer clinical grade allowable value)http://snomed.info/sct where concept descends from 1222599008 (American Joint Committee on Cancer pathological grade allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222600006 (American Joint Committee on Cancer yp grade allowable value)http://snomed.info/sct where concept descends from 1222601005 (American Joint Committee on Cancer residual tumor allowable value)http://snomed.info/sct where concept descends from 258318002 (Generic anatomical site tumor invasion status)http://snomed.info/sct where concept descends from 258309004 (Generic lymph node tumor invasion status stage (tumor staging))http://snomed.info/sct where concept descends from 258233007 (Generic tumor staging descriptor (tumor staging))http://snomed.info/sct where concept descends from 258271004 (Specific tumor staging descriptor (tumor staging))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 42114005 | Walter Reed stage 1 (tumor staging) |
| 15972002 | Walter Reed stage 2 (tumor staging) |
| 13808002 | Walter Reed stage 3 (tumor staging) |
| 74542008 | Walter Reed stage 4 (tumor staging) |
| 66470009 | Walter Reed stage 5 (tumor staging) |
| 83200007 | Walter Reed stage 6 (tumor staging) |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 254292007 (Tumor staging)http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 1149162008 | International Staging System for multiple myeloma (staging scale) |
| 1149163003 | Revised International Staging System for multiple myeloma (staging scale) |
| 246165003 | Extent of disease (attribute) |
| 418414003 | The revised European-American Lymphoma classification (qualifier value) |
| 418823005 | The World Health Organization classification of lymphoid malignancies (qualifier value) |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept descends from 258318002 (Generic anatomical site tumor invasion status)http://snomed.info/sct where concept descends from 258309004 (Generic lymph node tumor invasion status stage (tumor staging))http://snomed.info/sct where concept descends from 258233007 (Generic tumor staging descriptor (tumor staging))http://snomed.info/sct where concept descends from 258271004 (Specific tumor staging descriptor (tumor staging))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 42114005 | Walter Reed stage 1 (tumor staging) |
| 15972002 | Walter Reed stage 2 (tumor staging) |
| 13808002 | Walter Reed stage 3 (tumor staging) |
| 74542008 | Walter Reed stage 4 (tumor staging) |
| 66470009 | Walter Reed stage 5 (tumor staging) |
| 83200007 | Walter Reed stage 6 (tumor staging) |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 371508000 (Tumor stage (observable entity))http://snomed.info/sct where concept is-a 385361009 (FIGO stage for gynecological malignancy)http://snomed.info/sct where concept is-a 405931009 (National Wilms Tumor Study Group Stage (observable entity))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 409720004 | International neuroblastoma staging system stage (observable entity) |
| 385357003 | Dukes stage (observable entity) |
| 103420007 | Modified Dukes stage (observable entity) |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 109355002 (Carcinoma in situ (disorder))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D00 | CARCINOMA IN SITU OF ORAL CAVITY, ESOPHAGUS AND STOMACH |
| D00.0 | Carcinoma in situ of lip, oral cavity and pharynx |
| D00.00 | Carcinoma in situ of oral cavity, unspecified site |
| D00.01 | Carcinoma in situ of labial mucosa and vermilion border |
| D00.02 | Carcinoma in situ of buccal mucosa |
| D00.03 | Carcinoma in situ of gingiva and edentulous alveolar ridge |
| D00.04 | Carcinoma in situ of soft palate |
| D00.05 | Carcinoma in situ of hard palate |
| D00.06 | Carcinoma in situ of floor of mouth |
| D00.07 | Carcinoma in situ of tongue |
| D00.08 | Carcinoma in situ of pharynx |
| D00.1 | Carcinoma in situ of esophagus |
| D00.2 | Carcinoma in situ of stomach |
| D01 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS |
| D01.0 | Carcinoma in situ of colon |
| D01.1 | Carcinoma in situ of rectosigmoid junction |
| D01.2 | Carcinoma in situ of rectum |
| D01.3 | Carcinoma in situ of anus and anal canal |
| D01.4 | Carcinoma in situ of other and unspecified parts of intestine |
| D01.40 | Carcinoma in situ of unspecified part of intestine |
| D01.49 | Carcinoma in situ of other parts of intestine |
| D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
| D01.7 | Carcinoma in situ of other specified digestive organs |
| D01.9 | Carcinoma in situ of digestive organ, unspecified |
| D02 | CARCINOMA IN SITU OF MIDDLE EAR AND RESPIRATORY SYSTEM |
| D02.0 | Carcinoma in situ of larynx |
| D02.1 | Carcinoma in situ of trachea |
| D02.2 | Carcinoma in situ of bronchus and lung |
| D02.20 | Carcinoma in situ of unspecified bronchus and lung |
| D02.21 | Carcinoma in situ of right bronchus and lung |
| D02.22 | Carcinoma in situ of left bronchus and lung |
| D02.3 | Carcinoma in situ of other parts of respiratory system |
| D02.4 | Carcinoma in situ of respiratory system, unspecified |
| D05 | CARCINOMA IN SITU OF BREAST |
| D05.0 | Lobular carcinoma in situ of breast |
| D05.00 | Lobular carcinoma in situ of unspecified breast |
| D05.01 | Lobular carcinoma in situ of right breast |
| D05.02 | Lobular carcinoma in situ of left breast |
| D05.1 | Intraductal carcinoma in situ of breast |
| D05.10 | Intraductal carcinoma in situ of unspecified breast |
| D05.11 | Intraductal carcinoma in situ of right breast |
| D05.12 | Intraductal carcinoma in situ of left breast |
| D05.8 | Other specified type of carcinoma in situ of breast |
| D05.80 | Other specified type of carcinoma in situ of unspecified breast |
| D05.81 | Other specified type of carcinoma in situ of right breast |
| D05.82 | Other specified type of carcinoma in situ of left breast |
| D05.9 | Unspecified type of carcinoma in situ of breast |
| D05.90 | Unspecified type of carcinoma in situ of unspecified breast |
| D05.91 | Unspecified type of carcinoma in situ of right breast |
| D05.92 | Unspecified type of carcinoma in situ of left breast |
| D07 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED GENITAL ORGANS |
| D07.0 | Carcinoma in situ of endometrium |
| D07.1 | Carcinoma in situ of vulva |
| D07.2 | Carcinoma in situ of vagina |
| D07.3 | Carcinoma in situ of other and unspecified female genital organs |
| D07.30 | Carcinoma in situ of unspecified female genital organs |
| D07.39 | Carcinoma in situ of other female genital organs |
| D07.4 | Carcinoma in situ of penis |
| D07.6 | Carcinoma in situ of other and unspecified male genital organs |
| D07.60 | Carcinoma in situ of unspecified male genital organs |
| D07.61 | Carcinoma in situ of scrotum |
| D07.69 | Carcinoma in situ of other male genital organs |
| D09 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED SITES |
| D09.0 | Carcinoma in situ of bladder |
| D09.1 | Carcinoma in situ of other and unspecified urinary organs |
| D09.10 | Carcinoma in situ of unspecified urinary organ |
| D09.19 | Carcinoma in situ of other urinary organs |
| D09.2 | Carcinoma in situ of eye |
| D09.20 | Carcinoma in situ of unspecified eye |
| D09.21 | Carcinoma in situ of right eye |
| D09.22 | Carcinoma in situ of left eye |
| D09.3 | Carcinoma in situ of thyroid and other endocrine glands |
| D09.8 | Carcinoma in situ of other specified sites |
| D09.9 | Carcinoma in situ, unspecified |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 268910001 | Patient's condition improved (finding) |
| 359746009 | Patient's condition stable (finding) |
| 271299001 | Patient's condition worsened (finding) |
| 709137006 | Patient condition undetermined (finding) |
| 550991000124107 | Malignant neoplasm in full remission (disorder) |
| 551001000124108 | Malignant neoplasm in partial remission (disorder) |
This value set includes codes based on the following rules:
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 126361000119107 | Cytological evidence of malignancy on anal Papanicolaou smear (finding) |
| 126371000119101 | Cytological evidence of malignancy on vaginal Papanicolaou smear (finding) |
http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| R85.614 | Cytologic evidence of malignancy on smear of anus |
| R87.624 | Cytologic evidence of malignancy on smear of vagina |
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/icd-o-3http://snomed.info/sct where concept is-a 367651003 (Malignant Neoplasm (Morphology))http://snomed.info/sct where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))http://snomed.info/sct where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 399878004 | Malignant neoplasm with pilar differentiation (morphologic abnormality) |
| 253035009 | In situ melanocytic morphology (morphologic abnormality) |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))http://snomed.info/sct where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)http://snomed.info/sct where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)http://snomed.info/sct where concept is-a 703548001 (Atypical hyperplasia of the endometrium)http://terminology.hl7.org/CodeSystem/v2-0487| Code | Display | Definition |
| AMN | Amniotic fluid | Amniotic fluid |
| BIFL | Bile Fluid | Bile Fluid |
| BLD | Whole blood | Whole blood |
| BLDA | Blood arterial | Blood arterial |
| BLDCO | Cord blood | Cord blood |
| BLDV | Blood venous | Blood venous |
| BON | Bone | Bone |
| CSERU | Serum, Convalescent | Serum, Convalescent |
| CSF | Cerebral spinal fluid | Cerebral spinal fluid |
| CVM | Cervical Mucus | Cervical Mucus |
| DUFL | Duodenal fluid | Duodenal fluid |
| FBLOOD | Blood, Fetal | Blood, Fetal |
| FGA | Fluid, Abdomen | Fluid, Abdomen |
| GENV | Genital vaginal | Genital vaginal |
| HYDC | Fluid, Hydrocele | Fluid, Hydrocele |
| JNTFLD | Fluid, Joint | Fluid, Joint |
| KIDFLD | Fluid, Kidney | Fluid, Kidney |
| LSAC | Fluid, Lumbar Sac | Fluid, Lumbar Sac |
| MAR | Marrow | Marrow |
| PAFL | Pancreatic fluid | Pancreatic fluid |
| PCFL | Fluid, Pericardial | Fluid, Pericardial |
| PLC | Placenta | Placenta |
| PLR | Pleural fluid (thoracentesis fluid) | Pleural fluid (thoracentesis fluid) |
| SAL | Saliva | Saliva |
| SKN | Skin | Skin |
| SMN | Seminal fluid | Seminal fluid |
| SNV | Fluid, synovial (Joint fluid) | Fluid, synovial (Joint fluid) |
| SPT | Sputum | Sputum |
| TISS | Tissue | Tissue |
| TUMOR | Tumor | Tumor |
| VITF | Vitreous Fluid | Vitreous Fluid |
| WND | Wound | Wound |
| UR | Urine | Urine |
| STL | Stool = Fecal | Stool = Fecal |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 393573009 (Hypereosinophilic syndrome)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D72.110 | Idiopathic hypereosinophilic syndrome [HES] |
| D72.111 | Lymphocytic Variant Hypereosinophilic Syndrome [LHES] |
| D72.118 | Other hypereosinophilic syndrome |
| D72.119 | Hypereosinophilic syndrome [HES], unspecified |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 51440002 | Right and left (qualifier value) |
| 399488007 | Midline (qualifier value) |
| 24028007 | Right (qualifier value) |
| 7771000 | Left (qualifier value) |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 189758001 (Melanoma in situ)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| D03 | Melanoma in situ of skin |
| D03.0 | Melanoma in situ of lip |
| D03.1 | Melanoma in situ of eyelid, including canthus |
| D03.10 | Melanoma in situ of unspecified eyelid, including canthus |
| D03.11 | Melanoma in situ of right eyelid, including canthus |
| D03.111 | Melanoma in situ of right upper eyelid, including canthus |
| D03.112 | Melanoma in situ of right lower eyelid, including canthus |
| D03.12 | Melanoma in situ of left eyelid, including canthus |
| D03.121 | Melanoma in situ of left upper eyelid, including canthus |
| D03.122 | Melanoma in situ of left lower eyelid, including canthus |
| D03.2 | Melanoma in situ of ear and external auricular canal |
| D03.20 | Melanoma in situ of unspecified ear and external auricular canal |
| D03.21 | Melanoma in situ of right ear and external auricular canal |
| D03.22 | Melanoma in situ of left ear and external auricular canal |
| D03.3 | Melanoma in situ of other and unspecified parts of face |
| D03.30 | Melanoma in situ of unspecified part of face |
| D03.39 | Melanoma in situ of other parts of face |
| D03.4 | Melanoma in situ of scalp and neck |
| D03.5 | Melanoma in situ of trunk |
| D03.51 | Melanoma in situ of anal skin |
| D03.52 | Melanoma in situ of breast (skin) (soft tissue) |
| D03.59 | Melanoma in situ of other part of trunk |
| D03.6 | Melanoma in situ of upper limb, including shoulder |
| D03.60 | Melanoma in situ of unspecified upper limb, including shoulder |
| D03.61 | Melanoma in situ of right upper limb, including shoulder |
| D03.62 | Melanoma in situ of left upper limb, including shoulder |
| D03.7 | Melanoma in situ of lower limb, including hip |
| D03.70 | Melanoma in situ of unspecified lower limb, including hip |
| D03.71 | Melanoma in situ of right lower limb, including hip |
| D03.72 | Melanoma in situ of left lower limb, including hip |
| D03.8 | Melanoma in situ of other sites |
| D03.9 | Melanoma in situ, unspecified |
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 363346000 (Malignant tumor)http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C00.0 | Malignant neoplasm of external upper lip |
| C00.1 | Malignant neoplasm of external lower lip |
| C00.2 | Malignant neoplasm of external lip, unspecified |
| C00.3 | Malignant neoplasm of upper lip, inner aspect |
| C00.4 | Malignant neoplasm of lower lip, inner aspect |
| C00.5 | Malignant neoplasm of lip, unspecified, inner aspect |
| C00.6 | Malignant neoplasm of commissure of lip, unspecified |
| C00.8 | Malignant neoplasm of overlapping sites of lip |
| C00.9 | Malignant neoplasm of lip, unspecified |
| C01 | MALIGNANT NEOPLASM OF BASE OF TONGUE |
| C02.0 | Malignant neoplasm of dorsal surface of tongue |
| C02.1 | Malignant neoplasm of border of tongue |
| C02.2 | Malignant neoplasm of ventral surface of tongue |
| C02.3 | Malignant neoplasm of anterior two-thirds of tongue, part unspecified |
| C02.4 | Malignant neoplasm of lingual tonsil |
| C02.8 | Malignant neoplasm of overlapping sites of tongue |
| C02.9 | Malignant neoplasm of tongue, unspecified |
| C03.0 | Malignant neoplasm of upper gum |
| C03.1 | Malignant neoplasm of lower gum |
| C03.9 | Malignant neoplasm of gum, unspecified |
| C04.0 | Malignant neoplasm of anterior floor of mouth |
| C04.1 | Malignant neoplasm of lateral floor of mouth |
| C04.8 | Malignant neoplasm of overlapping sites of floor of mouth |
| C04.9 | Malignant neoplasm of floor of mouth, unspecified |
| C05.0 | Malignant neoplasm of hard palate |
| C05.1 | Malignant neoplasm of soft palate |
| C05.2 | Malignant neoplasm of uvula |
| C05.8 | Malignant neoplasm of overlapping sites of palate |
| C05.9 | Malignant neoplasm of palate, unspecified |
| C06.0 | Malignant neoplasm of cheek mucosa |
| C06.1 | Malignant neoplasm of vestibule of mouth |
| C06.2 | Malignant neoplasm of retromolar area |
| C06.80 | Malignant neoplasm of overlapping sites of unspecified parts of mouth |
| C06.89 | Malignant neoplasm of overlapping sites of other parts of mouth |
| C06.9 | Malignant neoplasm of mouth, unspecified |
| C07 | MALIGNANT NEOPLASM OF PAROTID GLAND |
| C08.0 | Malignant neoplasm of submandibular gland |
| C08.1 | Malignant neoplasm of sublingual gland |
| C08.9 | Malignant neoplasm of major salivary gland, unspecified |
| C09.0 | Malignant neoplasm of tonsillar fossa |
| C09.1 | Malignant neoplasm of tonsillar pillar (anterior) (posterior) |
| C09.8 | Malignant neoplasm of overlapping sites of tonsil |
| C09.9 | Malignant neoplasm of tonsil, unspecified |
| C10.0 | Malignant neoplasm of vallecula |
| C10.1 | Malignant neoplasm of anterior surface of epiglottis |
| C10.2 | Malignant neoplasm of lateral wall of oropharynx |
| C10.3 | Malignant neoplasm of posterior wall of oropharynx |
| C10.4 | Malignant neoplasm of branchial cleft |
| C10.8 | Malignant neoplasm of overlapping sites of oropharynx |
| C10.9 | Malignant neoplasm of oropharynx, unspecified |
| C11.0 | Malignant neoplasm of superior wall of nasopharynx |
| C11.1 | Malignant neoplasm of posterior wall of nasopharynx |
| C11.2 | Malignant neoplasm of lateral wall of nasopharynx |
| C11.3 | Malignant neoplasm of anterior wall of nasopharynx |
| C11.8 | Malignant neoplasm of overlapping sites of nasopharynx |
| C11.9 | Malignant neoplasm of nasopharynx, unspecified |
| C12 | MALIGNANT NEOPLASM OF PYRIFORM SINUS |
| C13.0 | Malignant neoplasm of postcricoid region |
| C13.1 | Malignant neoplasm aryepiglottic fold, hypopharyngeal aspect |
| C13.2 | Malignant neoplasm of posterior wall of hypopharynx |
| C13.8 | Malignant neoplasm of overlapping sites of hypopharynx |
| C13.9 | Malignant neoplasm of hypopharynx, unspecified |
| C14.0 | Malignant neoplasm of pharynx, unspecified |
| C14.2 | Malignant neoplasm of Waldeyer's ring |
| C14.8 | Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx |
| C15.3 | Malignant neoplasm of upper third of esophagus |
| C15.4 | Malignant neoplasm of middle third of esophagus |
| C15.5 | Malignant neoplasm of lower third of esophagus |
| C15.8 | Malignant neoplasm of overlapping sites esophagus |
| C15.9 | Malignant neoplasm of esophagus, unspecified |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
| C17.0 | Malignant neoplasm of duodenum |
| C17.1 | Malignant neoplasm of jejunum |
| C17.2 | Malignant neoplasm of ileum |
| C17.3 | Meckel's diverticulum, malignant |
| C17.8 | Malignant neoplasm of overlapping sites of small intestine |
| C17.9 | Malignant neoplasm of small intestine, unspecified |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION |
| C20 | MALIGNANT NEOPLASM OF RECTUM |
| C21.0 | Malignant neoplasm of anus, unspecified |
| C21.1 | Malignant neoplasm of anal canal |
| C21.2 | Malignant neoplasm of cloacogenic zone |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C23 | MALIGNANT NEOPLASM OF GALLBLADDER |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C24.1 | Malignant neoplasm of Ampulla of Vater |
| C24.8 | Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 | Malignant neoplasm of biliary tract, unspecified |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C26.0 | Malignant neoplasm of intestinal tract, part unspecified |
| C26.1 | Malignant neoplasm of spleen |
| C26.9 | Malignant neoplasm of ill-defined sites within the digestive system |
| C30.0 | Malignant neoplasm of nasal cavity |
| C30.1 | Malignant neoplasm of middle ear |
| C31.0 | Malignant neoplasm of maxillary sinus |
| C31.1 | Malignant neoplasm of ethmoidal sinus |
| C31.2 | Malignant neoplasm of frontal sinus |
| C31.3 | Malignant neoplasm of sphenoid sinus |
| C31.8 | Malignant neoplasm of overlapping sites of accessory sinuses |
| C31.9 | Malignant neoplasm of accessory sinus, unspecified |
| C32.0 | Malignant neoplasm of glottis |
| C32.1 | Malignant neoplasm of supraglottis |
| C32.2 | Malignant neoplasm of subglottis |
| C32.3 | Malignant neoplasm of laryngeal cartilage |
| C32.8 | Malignant neoplasm of overlapping sites of larynx |
| C32.9 | Malignant neoplasm of larynx, unspecified |
| C33 | MALIGNANT NEOPLASM OF TRACHEA |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C37 | MALIGNANT NEOPLASM OF THYMUS |
| C38.0 | Malignant neoplasm of heart |
| C38.1 | Malignant neoplasm of anterior mediastinum |
| C38.2 | Malignant neoplasm of posterior mediastinum |
| C38.3 | Malignant neoplasm of mediastinum, part unspecified |
| C38.4 | Malignant neoplasm of pleura |
| C38.8 | Malignant neoplasm of overlapping sites of heart, mediastinum and pleura |
| C39.0 | Malignant neoplasm of upper respiratory tract, part unspecified |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| C40.00 | Malignant neoplasm of scapula and long bones of unspecified upper limb |
| C40.01 | Malignant neoplasm of scapula and long bones of right upper limb |
| C40.02 | Malignant neoplasm of scapula and long bones of left upper limb |
| C40.10 | Malignant neoplasm of short bones of unspecified upper limb |
| C40.11 | Malignant neoplasm of short bones of right upper limb |
| C40.12 | Malignant neoplasm of short bones of left upper limb |
| C40.20 | Malignant neoplasm of long bones of unspecified lower limb |
| C40.21 | Malignant neoplasm of long bones of right lower limb |
| C40.22 | Malignant neoplasm of long bones of left lower limb |
| C40.30 | Malignant neoplasm of short bones of unspecified lower limb |
| C40.31 | Malignant neoplasm of short bones of right lower limb |
| C40.32 | Malignant neoplasm of short bones of left lower limb |
| C40.80 | Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb |
| C40.81 | Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb |
| C40.82 | Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb |
| C40.90 | Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb |
| C40.91 | Malignant neoplasm of unspecified bones and articular cartilage of right limb |
| C40.92 | Malignant neoplasm of unspecified bones and articular cartilage of left limb |
| C41.0 | Malignant neoplasm of bones of skull and face |
| C41.1 | Malignant neoplasm of mandible |
| C41.2 | Malignant neoplasm of vertebral column |
| C41.3 | Malignant neoplasm of ribs, sternum and clavicle |
| C41.4 | Malignant neoplasm of pelvic bones, sacrum and coccyx |
| C41.9 | Malignant neoplasm of unspecified bones and articular cartilage of limb |
| C43.0 | Malignant melanoma of lip |
| C43.10 | Malignant melanoma of unspecified eyelid, including canthus |
| C43.111 | Malignant melanoma of right upper eyelid, including canthus |
| C43.112 | Malignant melanoma of right lower eyelid, including canthus |
| C43.121 | Malignant melanoma of left upper eyelid, including canthus |
| C43.122 | Malignant melanoma of left lower eyelid, including canthus |
| C43.20 | Malignant melanoma of unspecified ear and external auricular canal |
| C43.21 | Malignant melanoma of right ear and external auricular canal |
| C43.22 | Malignant melanoma of left ear and external auricular canal |
| C43.30 | Malignant melanoma of unspecified part of face |
| C43.31 | Malignant melanoma of nose |
| C43.39 | Malignant melanoma of other parts of face |
| C43.4 | Malignant melanoma of scalp and neck |
| C43.51 | Malignant melanoma of anal skin |
| C43.52 | Malignant melanoma of skin of breast |
| C43.59 | Malignant melanoma of other part of trunk |
| C43.60 | Malignant melanoma of unspecified upper limb, including shoulder |
| C43.61 | Malignant melanoma of right upper limb, including shoulder |
| C43.62 | Malignant melanoma of left upper limb, including shoulder |
| C43.70 | Malignant melanoma of unspecified lower limb, including hip |
| C43.71 | Malignant melanoma of right lower limb, including hip |
| C43.72 | Malignant melanoma of left lower limb, including hip |
| C43.8 | Malignant melanoma of overlapping sites of skin |
| C43.9 | Malignant melanoma of skin, unspecified |
| C44.131 | Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus |
| C44.1321 | Sebaceous cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1322 | Sebaceous cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1391 | Sebaceous cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1392 | Sebaceous cell carcinoma of skin of left lower eyelid, including canthus |
| C44.90 | Unspecified malignant neoplasm of skin, unspecified |
| C44.99 | Other specified malignant neoplasm of skin, unspecified |
| C45.0 | Mesothelioma of pleura |
| C45.1 | Mesothelioma of peritoneum |
| C45.2 | Mesothelioma of pericardium |
| C45.7 | Mesothelioma of other sites |
| C45.9 | Mesothelioma, unspecified |
| C46.0 | Kaposi's sarcoma of skin |
| C46.1 | Kaposi's sarcoma of soft tissue |
| C46.2 | Kaposi's sarcoma of palate |
| C46.3 | Kaposi's sarcoma of lymph nodes |
| C46.4 | Kaposi’s sarcoma of gastrointestinal sites |
| C46.50 | Kaposi's sarcoma of unspecified lung |
| C46.51 | Kaposi's sarcoma of right lung |
| C46.52 | Kaposi's sarcoma of left lung |
| C46.7 | Kaposi's sarcoma of other sites |
| C46.9 | Kaposi's sarcoma, unspecified |
| C47.0 | Malignant neoplasm of peripheral nerves of head, face and neck |
| C47.1 | Malignant neoplasm of peripheral nerves of upper limb, including shoulder |
| C47.10 | Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder |
| C47.11 | Malignant neoplasm of peripheral nerves of right upper limb, including shoulder |
| C47.12 | Malignant neoplasm of peripheral nerves of left upper limb, including shoulder |
| C47.20 | Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip |
| C47.21 | Malignant neoplasm of peripheral nerves of right lower limb, including hip |
| C47.22 | Malignant neoplasm of peripheral nerves of left lower limb, including hip |
| C47.3 | Malignant neoplasm of peripheral nerves of thorax |
| C47.4 | Malignant neoplasm of peripheral nerves of abdomen |
| C47.5 | Malignant neoplasm of peripheral nerves of pelvis |
| C47.6 | Malignant neoplasm of peripheral nerves of trunk, unspecified |
| C47.8 | Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system |
| C47.9 | Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified |
| C48.0 | Malignant neoplasm of retroperitoneum |
| C48.1 | Malignant neoplasm of specified parts of peritoneum |
| C48.2 | Malignant neoplasm of peritoneum, unspecified |
| C48.8 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
| C49.0 | Malignant neoplasm of connective and soft tissue of head, face and neck |
| C49.10 | Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder |
| C49.11 | Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder |
| C49.12 | Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder |
| C49.20 | Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip |
| C49.21 | Malignant neoplasm of connective and soft tissue of right lower limb, including hip |
| C49.22 | Malignant neoplasm of connective and soft tissue of left lower limb, including hip |
| C49.3 | Malignant neoplasm of connective and soft tissue of thorax |
| C49.4 | Malignant neoplasm of connective and soft tissue of abdomen |
| C49.5 | Malignant neoplasm of connective and soft tissue of pelvis |
| C49.6 | Malignant neoplasm of connective and soft tissue of trunk, unspecified |
| C49.8 | Malignant neoplasm of overlapping sites of connective and soft tissue |
| C49.9 | Malignant neoplasm of connective and soft tissue, unspecified |
| C49.A0 | Gastrointestinal stromal tumor, unspecified site |
| C49.A1 | Gastrointestinal stromal tumor of esophagus |
| C49.A2 | Gastrointestinal stromal tumor of stomach |
| C49.A3 | Gastrointestinal stromal tumor of small intestine |
| C49.A4 | Gastrointestinal stromal tumor of large intestine |
| C49.A5 | Gastrointestinal stromal tumor of rectum |
| C49.A9 | Gastrointestinal stromal tumor of other site |
| C4A.0 | Merkel cell carcinoma of lip |
| C4A.10 | Merkel cell carcinoma of unspecified eyelid, including canthus |
| C4A.111 | Merkel cell carcinoma of right upper eyelid, including canthus |
| C4A.112 | Merkel cell carcinoma of right lower eyelid, including canthus |
| C4A.121 | Merkel cell carcinoma of left upper eyelid, including canthus |
| C4A.122 | Merkel cell carcinoma of left lower eyelid, including canthus |
| C4A.20 | Merkel cell carcinoma of unspecified ear and external auricular canal |
| C4A.21 | Merkel cell carcinoma of right ear and external auricular canal |
| C4A.22 | Merkel cell carcinoma of left ear and external auricular canal |
| C4A.30 | Merkel cell carcinoma of unspecified part of face |
| C4A.31 | Merkel cell carcinoma of nose |
| C4A.39 | Merkel cell carcinoma of other parts of face |
| C4A.4 | Merkel cell carcinoma of scalp and neck |
| C4A.51 | Merkel cell carcinoma of anal skin |
| C4A.52 | Merkel cell carcinoma of skin of breast |
| C4A.59 | Merkel cell carcinoma of other part of trunk |
| C4A.60 | Merkel cell carcinoma of unspecified upper limb, including shoulder |
| C4A.61 | Merkel cell carcinoma of right upper limb, including shoulder |
| C4A.62 | Merkel cell carcinoma of left upper limb, including shoulder |
| C4A.70 | Merkel cell carcinoma of unspecified lower limb, including hip |
| C4A.71 | Merkel cell carcinoma of right lower limb, including hip |
| C4A.72 | Merkel cell carcinoma of left lower limb, including hip |
| C4A.8 | Merkel cell carcinoma of overlapping sites |
| C4A.9 | Merkel cell carcinoma, unspecified |
| C50.011 | Malignant neoplasm of nipple and areola, right female breast |
| C50.012 | Malignant neoplasm of nipple and areola, left female breast |
| C50.019 | Malignant neoplasm of nipple and areola, unspecified female breast |
| C50.021 | Malignant neoplasm of nipple and areola, right male breast |
| C50.022 | Malignant neoplasm of nipple and areola, left male breast |
| C50.029 | Malignant neoplasm of nipple and areola, unspecified male breast |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.121 | Malignant neoplasm of central portion of right male breast |
| C50.122 | Malignant neoplasm of central portion of left male breast |
| C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.621 | Malignant neoplasm of axillary tail of right male breast |
| C50.622 | Malignant neoplasm of axillary tail of left male breast |
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.821 | Malignant neoplasm of overlapping sites of right male breast |
| C50.822 | Malignant neoplasm of overlapping sites of left male breast |
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C50.921 | Malignant neoplasm of unspecified site of right male breast |
| C50.922 | Malignant neoplasm of unspecified site of left male breast |
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
| C51.0 | Malignant neoplasm of labium majus |
| C51.1 | Malignant neoplasm of labium minus |
| C51.2 | Malignant neoplasm of clitoris |
| C51.8 | Malignant neoplasm of other specified female genital organs |
| C51.9 | Malignant neoplasm of vulva, unspecified |
| C52 | MALIGNANT NEOPLASM OF VAGINA |
| C53.0 | Malignant neoplasm of endocervix |
| C53.1 | Malignant neoplasm of exocervix |
| C53.8 | Malignant neoplasm of overlapping sites of cervix uteri |
| C53.9 | Malignant neoplasm of cervix uteri, unspecified |
| C54.0 | Malignant neoplasm of isthmus uteri |
| C54.1 | Malignant neoplasm of endometrium |
| C54.2 | Malignant neoplasm of myometrium |
| C54.3 | Malignant neoplasm of fundus uteri |
| C54.8 | Malignant neoplasm of overlapping sites of corpus uteri |
| C54.9 | Malignant neoplasm of corpus uteri, unspecified |
| C55 | MALIGNANT NEOPLASM OF UTERUS, PART UNSPECIFIED |
| C56.1 | Malignant neoplasm of right ovary |
| C56.2 | Malignant neoplasm of left ovary |
| C56.9 | Malignant neoplasm of unspecified ovary |
| C57.00 | Malignant neoplasm of unspecified fallopian tube |
| C57.01 | Malignant neoplasm of right fallopian tube |
| C57.02 | Malignant neoplasm of left fallopian tube |
| C57.10 | Malignant neoplasm of unspecified broad ligament |
| C57.11 | Malignant neoplasm of right broad ligament |
| C57.12 | Malignant neoplasm of left broad ligament |
| C57.20 | Malignant neoplasm of unspecified round ligament |
| C57.21 | Malignant neoplasm of right round ligament |
| C57.22 | Malignant neoplasm of left round ligament |
| C57.3 | Malignant neoplasm of parametrium |
| C57.4 | Malignant neoplasm of uterine adnexa, unspecified |
| C57.7 | Malignant neoplasm of overlapping sites of vulva |
| C57.8 | Malignant neoplasm of overlapping sites of female genital organs |
| C57.9 | Malignant neoplasm of female genital organ, unspecified |
| C58 | MALIGNANT NEOPLASM OF PLACENTA |
| C60.0 | Malignant neoplasm of prepuce |
| C60.1 | Malignant neoplasm of glans penis |
| C60.2 | Malignant neoplasm of body of penis |
| C60.8 | Malignant neoplasm of overlapping sites of penis |
| C60.9 | Malignant neoplasm of penis, unspecified |
| C61 | MALIGNANT NEOPLASM OF PROSTATE |
| C62.00 | Malignant neoplasm of unspecified undescended testis |
| C62.01 | Malignant neoplasm of undescended right testis |
| C62.02 | Malignant neoplasm of undescended left testis |
| C62.10 | Malignant neoplasm of unspecified descended testis |
| C62.11 | Malignant neoplasm of descended right testis |
| C62.12 | Malignant neoplasm of descended left testis |
| C62.90 | Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 | Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 | Malignant neoplasm of left testis, unspecified whether descended or undescended |
| C63.00 | Malignant neoplasm of unspecified epididymis |
| C63.01 | Malignant neoplasm of right epididymis |
| C63.02 | Malignant neoplasm of left epididymis |
| C63.10 | Malignant neoplasm of unspecified spermatic cord |
| C63.11 | Malignant neoplasm of right spermatic cord |
| C63.12 | Malignant neoplasm of left spermatic cord |
| C63.2 | Malignant neoplasm of scrotum |
| C63.7 | Malignant neoplasm of other specified male genital organs |
| C63.8 | Malignant neoplasm of overlapping sites of male genital organs |
| C63.9 | Malignant neoplasm of male genital organ, unspecified |
| C64.1 | Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 | Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 | Malignant neoplasm of unspecified kidney, except renal pelvis |
| C65.1 | Malignant neoplasm of right renal pelvis |
| C65.2 | Malignant neoplasm of left renal pelvis |
| C65.9 | Malignant neoplasm of unspecified renal pelvis |
| C66.1 | Malignant neoplasm of right ureter |
| C66.2 | Malignant neoplasm of left ureter |
| C66.9 | Malignant neoplasm of unspecified ureter |
| C67.0 | Malignant neoplasm of trigone of bladder |
| C67.1 | Malignant neoplasm of dome of bladder |
| C67.2 | Malignant neoplasm of lateral wall of bladder |
| C67.3 | Malignant neoplasm of anterior wall of bladder |
| C67.4 | Malignant neoplasm of posterior wall of bladder |
| C67.5 | Malignant neoplasm of bladder neck |
| C67.6 | Malignant neoplasm of ureteric orifice |
| C67.7 | Malignant neoplasm of urachus |
| C67.8 | Malignant neoplasm of overlapping sites of bladder |
| C67.9 | Malignant neoplasm of bladder, unspecified |
| C68.0 | Malignant neoplasm of urethra |
| C68.1 | Malignant neoplasm of paraurethral glands |
| C68.8 | Malignant neoplasm of overlapping sites of urinary organs |
| C68.9 | Malignant neoplasm of urinary organ, unspecified |
| C69.00 | Malignant neoplasm of unspecified conjunctiva |
| C69.01 | Malignant neoplasm of right conjunctiva |
| C69.02 | Malignant neoplasm of left conjunctiva |
| C69.10 | Malignant neoplasm of unspecified cornea |
| C69.11 | Malignant neoplasm of right cornea |
| C69.12 | Malignant neoplasm of left cornea |
| C69.20 | Malignant neoplasm of unspecified retina |
| C69.21 | Malignant neoplasm of right retina |
| C69.22 | Malignant neoplasm of left retina |
| C69.30 | Malignant neoplasm of unspecified choroid |
| C69.31 | Malignant neoplasm of right choroid |
| C69.32 | Malignant neoplasm of left choroid |
| C69.40 | Malignant neoplasm of unspecified ciliary body |
| C69.41 | Malignant neoplasm of right ciliary body |
| C69.42 | Malignant neoplasm of left ciliary body |
| C69.50 | Malignant neoplasm of unspecified lacrimal gland and duct |
| C69.51 | Malignant neoplasm of right lacrimal gland and duct |
| C69.52 | Malignant neoplasm of left lacrimal gland and duct |
| C69.60 | Malignant neoplasm of unspecified orbit |
| C69.61 | Malignant neoplasm of right orbit |
| C69.62 | Malignant neoplasm of left orbit |
| C69.80 | Malignant neoplasm of overlapping sites of unspecified eye and adnexa |
| C69.81 | Malignant neoplasm of overlapping sites of right eye and adnexa |
| C69.82 | Malignant neoplasm of overlapping sites of left eye and adnexa |
| C69.90 | Malignant neoplasm of unspecified site of unspecified eye |
| C69.91 | Malignant neoplasm of unspecified site of right eye |
| C69.92 | Malignant neoplasm of unspecified site of left eye |
| C70.0 | Malignant neoplasm of cerebral meninges |
| C70.1 | Malignant neoplasm of spinal meninges |
| C70.9 | Malignant neoplasm of meninges, unspecified |
| C71.0 | Malignant neoplasm of cerebrum, except lobes and ventricles |
| C71.1 | Malignant neoplasm of frontal lobe |
| C71.2 | Malignant neoplasm of temporal lobe |
| C71.3 | Malignant neoplasm of parietal lobe |
| C71.4 | Malignant neoplasm of occipital lobe |
| C71.5 | Malignant neoplasm of cerebral ventricle |
| C71.6 | Malignant neoplasm of cerebellum |
| C71.7 | Malignant neoplasm of brain stem |
| C71.8 | Malignant neoplasm of overlapping sites of brain |
| C71.9 | Malignant neoplasm of brain, unspecified |
| C72.0 | Malignant neoplasm of spinal cord |
| C72.1 | Malignant neoplasm of cauda equina |
| C72.20 | Malignant neoplasm of unspecified olfactory nerve |
| C72.21 | Malignant neoplasm of right olfactory nerve |
| C72.22 | Malignant neoplasm of left olfactory nerve |
| C72.30 | Malignant neoplasm of unspecified optic nerve |
| C72.31 | Malignant neoplasm of right optic nerve |
| C72.32 | Malignant neoplasm of left optic nerve |
| C72.40 | Malignant neoplasm of unspecified acoustic nerve |
| C72.41 | Malignant neoplasm of right acoustic nerve |
| C72.42 | Malignant neoplasm of left acoustic nerve |
| C72.50 | Malignant neoplasm of unspecified cranial nerve |
| C72.59 | Malignant neoplasm of other cranial nerves |
| C72.9 | Malignant neoplasm of central nervous system, unspecified |
| C73 | MALIGNANT NEOPLASM OF THYROID GLAND |
| C74.00 | Malignant neoplasm of cortex of unspecified adrenal gland |
| C74.01 | Malignant neoplasm of cortex of right adrenal gland |
| C74.02 | Malignant neoplasm of cortex of left adrenal gland |
| C74.10 | Malignant neoplasm of medulla of unspecified adrenal gland |
| C74.11 | Malignant neoplasm of medulla of right adrenal gland |
| C74.12 | Malignant neoplasm of medulla of left adrenal gland |
| C74.90 | Malignant neoplasm of unspecified part of unspecified adrenal gland |
| C74.91 | Malignant neoplasm of unspecified part of right adrenal gland |
| C74.92 | Malignant neoplasm of unspecified part of left adrenal gland |
| C75.0 | Malignant neoplasm of parathyroid gland |
| C75.1 | Malignant neoplasm of pituitary gland |
| C75.2 | Malignant neoplasm of craniopharyngeal duct |
| C75.3 | Malignant neoplasm of pineal gland |
| C75.4 | Malignant neoplasm of carotid body |
| C75.5 | Malignant neoplasm of aortic body and other paraganglia |
| C75.8 | Malignant neoplasm with pluriglanduar involvement, unspecified |
| C75.9 | Malignant neoplasm of endocrine gland, unspecified |
| C76.0 | Malignant neoplasm of head, face and neck |
| C76.1 | Malignant neoplasm of thorax |
| C76.2 | Malignant neoplasm of abdomen |
| C76.3 | Malignant neoplasm pelvis |
| C76.40 | Malignant neoplasm of unspecified upper limb |
| C76.41 | Malignant neoplasm of right upper limb |
| C76.42 | Malignant neoplasm of left upper limb |
| C76.50 | Malignant neoplasm of unspecified lower limb |
| C76.51 | Malignant neoplasm of right lower limb |
| C76.52 | Malignant neoplasm of left lower limb |
| C76.8 | Malignant neoplasm of overlapping sites of other and ill-defined sites |
| C7A.00 | Malignant carcinoid tumor of unspecified site |
| C7A.010 | Malignant carcinoid tumor of the duodenum |
| C7A.011 | Malignant carcinoid tumor of the jejunum |
| C7A.012 | Malignant carcinoid tumor of the ileum |
| C7A.019 | Malignant carcinoid tumor of the small intestine, unspecified portion |
| C7A.020 | Malignant carcinoid tumor of the appendix |
| C7A.021 | Malignant carcinoid tumor of the cecum |
| C7A.022 | Malignant carcinoid tumor of the ascending colon |
| C7A.023 | Malignant carcinoid tumor of the transverse colon |
| C7A.024 | Malignant carcinoid tumor of the descending colon |
| C7A.025 | Malignant carcinoid tumor of the sigmoid colon |
| C7A.026 | Malignant carcinoid tumor of the rectum |
| C7A.029 | Malignant carcinoid tumor of the large intestine, unspecified portion |
| C7A.090 | Malignant carcinoid tumor of the bronchus and lung |
| C7A.091 | Malignant carcinoid tumor of thymus |
| C7A.092 | Malignant carcinoid tumor of the stomach |
| C7A.093 | Malignant carcinoid tumor of the kidney |
| C7A.094 | Malignant carcinoid tumors of the foregut NOS |
| C7A.095 | Malignant carcinoid tumors of the midgut NOS |
| C7A.096 | Malignant carcinoid tumors of the hindgut NOS |
| C7A.098 | Malignant carcinoid tumors of other sites |
| C7A.1 | Malignant poorly differentiated neuroendocrine tumors |
| C7A.8 | Other malignant neuroendocrine tumors |
| C80.0 | Disseminated malignant neoplasm, unspecified |
| C80.1 | Malignant (primary) neoplasm, unspecified |
| C80.2 | Malignant neoplasm associated with transplanted organ |
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
| C81.01 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.02 | Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.03 | Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.04 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.05 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.06 | Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.07 | Nodular lymphocyte predominant Hodgkin lymphoma, spleen |
| C81.08 | Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.09 | Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites |
| C81.10 | Nodular sclerosis classical Hodgkin lymphoma, unspecified site |
| C81.11 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.12 | Nodular sclerosis classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.13 | Nodular sclerosis classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.14 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.15 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.16 | Nodular sclerosis classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.17 | Nodular sclerosis classical Hodgkin lymphoma, spleen |
| C81.18 | Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.19 | Nodular sclerosis classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.20 | Mixed cellularity classical Hodgkin lymphoma, unspecified site |
| C81.21 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.22 | Mixed cellularity classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.23 | Mixed cellularity classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.24 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.25 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.26 | Mixed cellularity classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.27 | Mixed cellularity classical Hodgkin lymphoma, spleen |
| C81.28 | Mixed cellularity classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.29 | Mixed cellularity classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.30 | Lymphocyte depleted classical Hodgkin lymphoma, unspecified site |
| C81.31 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.32 | Lymphocyte depleted classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.33 | Lymphocyte depleted classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.34 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.35 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.36 | Lymphocyte depleted classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.37 | Lymphocyte depleted classical Hodgkin lymphoma, spleen |
| C81.38 | Lymphocyte depleted classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.39 | Lymphocyte depleted classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.40 | Lymphocyte-rich classical Hodgkin lymphoma, unspecified site |
| C81.41 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.42 | Lymphocyte-rich classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.43 | Lymphocyte-rich classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.44 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.45 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.46 | Lymphocyte-rich classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.47 | Lymphocyte-rich classical Hodgkin lymphoma, spleen |
| C81.48 | Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.49 | Lymphocyte-rich classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.70 | Other classical Hodgkin lymphoma, unspecified site |
| C81.71 | Other classical Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.72 | Other classical Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.73 | Other classical Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.74 | Other classical Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.75 | Other classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.76 | Other classical Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.77 | Other classical Hodgkin lymphoma, spleen |
| C81.78 | Other classical Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.79 | Other classical Hodgkin lymphoma, extranodal and solid organ sites |
| C81.90 | Hodgkin lymphoma, unspecified, unspecified site |
| C81.91 | Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C81.92 | Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C81.93 | Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C81.94 | Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C81.95 | Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C81.96 | Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C81.97 | Hodgkin lymphoma, unspecified, spleen |
| C81.98 | Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C81.99 | Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C82.00 | Follicular lymphoma grade I, unspecified site |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade I, spleen |
| C82.08 | Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.10 | Follicular lymphoma grade II, unspecified site |
| C82.11 | Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade II, spleen |
| C82.18 | Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.20 | Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade III, unspecified, spleen |
| C82.28 | Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.30 | Follicular lymphoma grade IIIa, unspecified site |
| C82.31 | Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIIa, spleen |
| C82.38 | Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.40 | Follicular lymphoma grade IIIb, unspecified site |
| C82.41 | Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIIb, spleen |
| C82.48 | Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.00 | Small cell B-cell lymphoma, unspecified site |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell B-cell lymphoma, spleen |
| C83.08 | Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C83.31 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 | Diffuse large B-cell lymphoma, spleen |
| C83.38 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites |
| C83.50 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 | Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.70 | Burkitt lymphoma, unspecified site |
| C83.71 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 | Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 | Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 | Burkitt lymphoma, spleen |
| C83.78 | Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 | Burkitt lymphoma, extranodal and solid organ sites |
| C83.80 | Other non-follicular lymphoma, unspecified site |
| C83.81 | Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 | Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 | Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 | Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 | Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 | Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 | Other non-follicular lymphoma, spleen |
| C83.88 | Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 | Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.90 | Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 | Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 | Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 | Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 | Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 | Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C84.00 | Mycosis fungoides, unspecified site |
| C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 | Mycosis fungoides, spleen |
| C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 | Mycosis fungoides, extranodal and solid organ sites |
| C84.10 | Sezary disease, unspecified site |
| C84.11 | Sezary disease, lymph nodes of head, face, and neck |
| C84.12 | Sezary disease, intrathoracic lymph nodes |
| C84.13 | Sezary disease, intra-abdominal lymph nodes |
| C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 | Sezary disease, intrapelvic lymph nodes |
| C84.17 | Sezary disease, spleen |
| C84.18 | Sezary disease, lymph nodes of multiple sites |
| C84.19 | Sezary disease, extranodal and solid organ sites |
| C84.40 | Peripheral T-cell lymphoma, not classified, unspecified site |
| C84.41 | Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck |
| C84.42 | Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes |
| C84.43 | Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes |
| C84.44 | Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb |
| C84.45 | Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb |
| C84.46 | Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes |
| C84.47 | Peripheral T-cell lymphoma, not classified, spleen |
| C84.48 | Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites |
| C84.49 | Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites |
| C84.60 | Anaplastic large cell lymphoma, ALK-positive, unspecified site |
| C84.61 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck |
| C84.62 | Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes |
| C84.63 | Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes |
| C84.64 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb |
| C84.65 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb |
| C84.66 | Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes |
| C84.67 | Anaplastic large cell lymphoma, ALK-positive, spleen |
| C84.68 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites |
| C84.69 | Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites |
| C84.70 | Anaplastic large cell lymphoma, ALK-negative, unspecified site |
| C84.71 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck |
| C84.72 | Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes |
| C84.73 | Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes |
| C84.74 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb |
| C84.75 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb |
| C84.76 | Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes |
| C84.77 | Anaplastic large cell lymphoma, ALK-negative, spleen |
| C84.78 | Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites |
| C84.79 | Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites |
| C84.90 | Mature T/NK-cell lymphomas, unspecified, unspecified site |
| C84.91 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck |
| C84.92 | Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes |
| C84.93 | Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes |
| C84.94 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb |
| C84.95 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb |
| C84.96 | Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes |
| C84.97 | Mature T/NK-cell lymphomas, unspecified, spleen |
| C84.98 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites |
| C84.99 | Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites |
| C84.A0 | Cutaneous T-cell lymphoma, unspecified, unspecified site |
| C84.A1 | Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 | Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 | Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 | Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 | Cutaneous T-cell lymphoma, unspecified, spleen |
| C84.A8 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 | Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites |
| C84.Z0 | Other mature T/NK-cell lymphomas, unspecified site |
| C84.Z1 | Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck |
| C84.Z2 | Other mature T/NK-cell lymphomas, intrathoracic lymph nodes |
| C84.Z3 | Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes |
| C84.Z4 | Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb |
| C84.Z5 | Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb |
| C84.Z6 | Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C84.Z7 | Other mature T/NK-cell lymphomas, spleen |
| C84.Z8 | Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C84.Z9 | Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
| C85.10 | Unspecified B-cell lymphoma, unspecified site |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 | Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 | Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 | Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 | Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 | Unspecified B-cell lymphoma, spleen |
| C85.18 | Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 | Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.20 | Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 | Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 | Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 | Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 | Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 | Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 | Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 | Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 | Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 | Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 | Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 | Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 | Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.90 | Non-Hodgkin lymphoma, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.94 | Non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.95 | Non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.96 | Non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.97 | Non-Hodgkin lymphoma, spleen |
| C85.98 | Non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.99 | Non-Hodgkin lymphoma, extranodal and solid organ sites |
| C86.0 | Extranodal NK/T-cell lymphoma, nasal type |
| C86.1 | Hepatosplenic T-cell lymphoma |
| C86.2 | Enteropathy-type (intestinal) T-cell lymphoma |
| C86.3 | Subcutaneous panniculitis-like T-cell lymphoma |
| C86.4 | Blastic NK-cell lymphoma |
| C86.5 | Angioimmunoblastic T-cell lymphoma |
| C86.6 | Primary cutaneous CD30-positive T-cell proliferation |
| C88.0 | Waldenstrom's macroglobulinemia |
| C88.2 | Heavy chain disease |
| C88.3 | Immunoproliferative small intestinal diseases |
| C88.4 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] |
| C88.8 | Other malignant immunoproliferative diseases |
| C88.9 | Malignant immunoproliferative disease, unspecified |
| C90.00 | Multiple myeloma not having achieved remission |
| C90.01 | Multiple myeloma in remission |
| C90.02 | Multiple myeloma in relapse |
| C90.10 | Plasma cell leukemia not having achieved remission |
| C90.11 | Plasma cell leukemia in remission |
| C90.12 | Plasma cell leukemia in relapse |
| C90.20 | Extramedullary plasmacytoma not having achieved remission |
| C90.21 | Extramedullary plasmacytoma in remission |
| C90.22 | Extramedullary plasmacytoma in relapse |
| C90.30 | Solitary plasmacytoma not having achieved remission |
| C90.31 | Solitary plasmacytoma in remission |
| C90.32 | Solitary plasmacytoma in relapse |
| C91.00 | Acute lymphoblastic leukemia not having achieved remission |
| C91.01 | Acute lymphoblastic leukemia, in remission |
| C91.02 | Acute lymphoblastic leukemia, in relapse |
| C91.10 | Chronic lymphocytic leukemia of B-cell type not having achieved remission |
| C91.11 | Chronic lymphocytic leukemia of B-cell type in remission |
| C91.12 | Chronic lymphocytic leukemia of B-cell type in relapse |
| C91.30 | Prolymphocytic leukemia of B-cell type not having achieved remission |
| C91.31 | Prolymphocytic leukemia of B-cell type, in remission |
| C91.32 | Prolymphocytic leukemia of B –cell type, in relapse |
| C91.40 | Hairy cell leukemia not having achieved remission |
| C91.41 | Hairy cell leukemia, in remission |
| C91.42 | Hairy cell leukemia, in relapse |
| C91.50 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission |
| C91.51 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in remission |
| C91.52 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse |
| C91.60 | Prolymphocytic leukemia of T-cell type not having achieved remission |
| C91.61 | Prolymphocytic leukemia of T-cell type, in remission |
| C91.62 | Prolymphocytic leukemia of T –cell type, in relapse |
| C91.90 | Lymphoid leukemia, unspecified not having achieved remission |
| C91.91 | Lymphoid leukemia, unspecified, in remission |
| C91.92 | Lymphoid leukemia, unspecified, in relapse |
| C91.A0 | Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91.A1 | Mature B-cell leukemia Burkitt-type, in remission |
| C91.A2 | Mature B-cell leukemia Burkitt-type, in relapse |
| C91.Z0 | Other lymphoid leukemia not having achieved remission |
| C91.Z1 | Other lymphoid leukemia, in remission |
| C91.Z2 | Other lymphoid leukemia, in relapse |
| C92.00 | Acute myeloblastic leukemia, not having achieved remission |
| C92.01 | Acute myeloblastic leukemia, in remission |
| C92.02 | Acute myeloblastic leukemia, in relapse |
| C92.10 | Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission |
| C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in remission |
| C92.12 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse |
| C92.20 | Atypical chronic myeloid leukemia, BCR/ABL-negative not having achieved remission |
| C92.21 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C92.22 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C92.30 | Myeloid sarcoma, not having achieved remission |
| C92.31 | Myeloid sarcoma, in remission |
| C92.32 | Myeloid sarcoma, in relapse |
| C92.40 | Acute promyelocytic leukemia, not having achieved remission |
| C92.41 | Acute promyelocytic leukemia, in remission |
| C92.42 | Acute promyelocytic leukemia, in relapse |
| C92.50 | Acute myelomonocytic leukemia, not having achieved remission |
| C92.51 | Acute myelomonocytic in remission |
| C92.52 | Acute myelomonocytic in relapse |
| C92.60 | Acute myeloid leukemia with 11q23 abnormality not having achieved remission |
| C92.61 | Acute myeloid leukemia with 11q23 abnormality in remission |
| C92.62 | Acute myeloid leukemia with 11q23 abnormality in relapse |
| C92.90 | Myeloid leukemia, unspecified, not having achieved remission |
| C92.91 | Myeloid leukemia, unspecified in remission |
| C92.92 | Myeloid leukemia, unspecified in relapse |
| C92.A0 | Acute myeloid leukemia with multilineage dysplasia not having achieved remission |
| C92.A1 | Acute myeloid leukemia with multilineage dysplasia, in remission |
| C92.A2 | Acute myeloid leukemia with multilineage dysplasia, in relapse |
| C92.Z0 | Other myeloid leukemia not having achieved remission |
| C92.Z1 | Other myeloid leukemia, in remission |
| C92.Z2 | Other myeloid leukemia, in relapse |
| C93.00 | Acute monoblastic/monocytic leukemia, not having achieved remission |
| C93.01 | Acute monoblastic/monocytic leukemia, in remission |
| C93.02 | Acute monoblastic/monocytic leukemia, in relapse |
| C93.10 | Chronic myelomonocytic leukemia not having achieved remission |
| C93.11 | Chronic myelomonocytic leukemia, in remission |
| C93.12 | Chronic myelomonocytic leukemia, in relapse |
| C93.30 | Juvenile myelomonocytic leukemia not having achieved remission |
| C93.31 | Juvenile myelomonocytic leukemia, in remission |
| C93.32 | Juvenile myelomonocytic leukemia, in relapse |
| C93.90 | Monocytic leukemia, unspecified, not having achieved remission |
| C93.91 | Monocytic leukemia, unspecified in remission |
| C93.92 | Monocytic leukemia, unspecified in relapse |
| C93.Z0 | Other monocytic leukemia, not having achieved remission |
| C93.Z1 | Other monocytic leukemia in remission |
| C93.Z2 | Other monocytic leukemia in relapse |
| C94.00 | Acute erythroid leukemia, not having achieved remission |
| C94.01 | Acute erythroid leukemia, in remission |
| C94.02 | Acute erythroid leukemia, in relapse |
| C94.20 | Acute megakaryoblastic leukemia not having achieved remission |
| C94.21 | Acute megakaryoblastic leukemia, in remission |
| C94.22 | Acute megakaryoblastic leukemia, in relapse |
| C94.30 | Mast cell leukemia not having achieved remission |
| C94.31 | Mast cell leukemia, in remission |
| C94.32 | Mast cell leukemia, in relapse |
| C94.40 | Acute panmyelosis with myelofibrosis not having achieved remission |
| C94.41 | Acute panmyelosis with myelofibrosis, in remission |
| C94.42 | Acute panmyelosis with myelofibrosis, in relapse |
| C94.6 | Myelodysplastic disease, not classified |
| C94.80 | Other specified leukemias not having achieved remission |
| C94.81 | Other specified leukemias, in remission |
| C94.82 | Other specified leukemias, in relapse |
| C95.00 | Acute leukemia of unspecified cell type not having achieved remission |
| C95.01 | Acute leukemia of unspecified cell type, in remission |
| C95.02 | Acute leukemia of unspecified cell type, in relapse |
| C95.10 | Chronic leukemia of unspecified cell type not having achieved remission |
| C95.11 | Chronic leukemia of unspecified cell type, in remission |
| C95.12 | Chronic leukemia of unspecified cell type, in relapse |
| C95.90 | Leukemia, unspecified not having achieved remission |
| C95.91 | Leukemia, unspecified, in remission |
| C95.92 | Leukemia, unspecified, in relapse |
| C96.0 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis |
| C96.20 | Malignant mast cell neoplasm, unspecified |
| C96.21 | Aggressive systemic mastocytosis |
| C96.22 | Mast cell sarcoma |
| C96.29 | Other malignant cell neoplasm |
| C96.4 | Sarcoma of dendritic cells (accessory cells) Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.5 | Multifocal and unisystemic Langerhans-cell histiocytosis |
| C96.6 | Unifocal Langerhans-cell histiocytosis |
| C96.9 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.A | Histiocytic sarcoma |
| C96.Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| D45 | POLYCYTHEMIA VERA |
| D46.0 | Refractory anemia without ring sideroblasts, so stated |
| D46.1 | Refractory anemia with ring sideroblasts |
| D46.20 | Refractory anemia with excess of blasts, unspecified |
| D46.21 | Refractory anemia with excess of blasts 1 |
| D46.22 | Refractory anemia with excess of blasts 2 |
| D46.4 | Refractory anemia, unspecified |
| D46.9 | Myelodysplastic syndrome, unspecified |
| D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| D46.C | Myelodysplastic syndrome with isolated del (5q) chromosomal abnormality |
| D46.Z | Other myelodysplastic syndromes |
| D47.02 | Systemic mastocytosis |
| D47.1 | Chronic myeloproliferative disease |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| D47.4 | Osteomyelofibrosis |
| D47.9 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) |
| D47.Z9 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| D49.6 | Neoplasm of unspecified behavior of brain |
| D49.7 | Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system |
This value set excludes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 373808002 | Curative - procedure intent |
| 363676003 | Palliative - procedure intent |
| 399707004 | Supportive - procedure intent |
| 261004008 | Diagnostic intent |
| 129428001 | Preventive - intent |
| 429892002 | Guidance intent |
| 360156006 | Screening - procedure intent |
| 447295008 | Forensic intent |
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 258399006 (Lymph node level value)http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 277733009 | Level 1 (qualifier value) |
| 277734003 | Level 2 (qualifier value) |
| 277735002 | Level 3 (qualifier value) |
| 261089000 | Inferior (qualifier value) |
| 264217000 | Superior (qualifier value) |
| 261183002 | Upper (qualifier value) |
| 261122009 | Lower (qualifier value) |
| 260528009 | Middle (qualifier value) |
| 46053002 | Distal (qualifier value) |
| 40415009 | Proximal (qualifier value) |
| 255204007 | Multiple (qualifier value) |
| 255503000 | Entire (qualifier value) |
| 255609007 | Partial (qualifier value) |
| 14414005 | Peripheral (qualifier value) |
| 26216008 | Central (qualifier value) |
| 260235002 | Core (qualifier value) |
| 410679008 | Surface (qualifier value) |
| 260521003 | Internal (qualifier value) |
| 261074009 | External (qualifier value) |
| 260548002 | Oral (qualifier value) |
| 18769003 | Adjacent |
| 1217011006 | Non-adjacent (qualifier value) |
| 258400004 | Lymph node level I (qualifier value) |
| 1162616006 | Lymph node level IA (qualifier value) |
| 1162617002 | Lymph node level IB (qualifier value) |
| 258401000 | Lymph node level II (qualifier value) |
| 258402007 | Lymph node level III (qualifier value) |
| 258403002 | Lymph node level IV (qualifier value) |
| 1162620005 | Lymph node level IVA (qualifier value) |
| 1162621009 | Lymph node level IVB (qualifier value) |
| 258404008 | Lymph node level V (qualifier value) |
| 1162622002 | Lymph node level VA (qualifier value) |
| 1162623007 | Lymph node level VB (qualifier value) |
| 1162624001 | Lymph node level VC (qualifier value) |
| 258405009 | Lymph node level VI (qualifier value) |
| 1162625000 | Lymph node level VIA (qualifier value) |
| 1162626004 | Lymph node level VIB (qualifier value) |
| 395168005 | Lymph node level VII (qualifier value) |
| 1162628003 | Lymph node level VIIA (qualifier value) |
| 1162627008 | Lymph node level VIIB (qualifier value) |
| 1162618007 | Lymph node level VIII (qualifier value) |
| 1162619004 | Lymph node level IX (qualifier value) |
| 1162614009 | Lymph node level X (qualifier value) |
| 1162615005 | Lymph node level XA (qualifier value) |
| 1162613003 | Lymph node level XB (qualifier value) |
http://hl7.org/fhir/us/mcode/CodeSystem/snomed-requested-cs| Code | Display |
| USCRS-34777 | Lymph node level IIA (qualifier value) |
| USCRS-34775 | Lymph node level IIB (qualifier value) |
This value set excludes codes based on the following rules:
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 258399006 | Lymph node level value |
This value set includes codes based on the following rules:
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 15825003 | Aortic structure (body structure) |
| 54247002 | Ascending aorta structure (body Structure) |
| 425444002 | Branch of brachiocephalic artery (body structure) |
| 69105007 | Carotid artery structure (body structure) |
| 57850000 | Structure of celiac artery (body structure) |
| 41801008 | Coronary artery structure (body structure) |
| 7657000 | Structure of femoral artery (body structure) |
| 244314003 | Circumflex humeral artery (body structure) |
| 74200005 | Structure of inferior hypophyseal artery (body structure) |
| 55601007 | Structure of superior hypophyseal artery (body structure) |
| 244327004 | Circumflex iliac artery (body structure) |
| 113269004 | Structure of external iliac artery (body structure) |
| 90024005 | Structure of internal iliac artery (body structure) |
| 73634005 | Common iliac artery structure (body structure) |
| 33795007 | Structure of anterior descending branch of left coronary artery (body structure) |
| 42258001 | Superior mesenteric artery structure (body structure) |
| 81040000 | Pulmonary artery structure (body structure) |
| 36765005 | Structure of subclavian artery (body structure) |
| 85234005 | Structure of vertebral artery (body structure) |
| 37783008 | Bone structure of acetabulum (body structure) |
| 89187006 | Airway structure (body structure) |
| 123956007 | Anus part (body structure) |
| 66754008 | Appendix structure (body structure) |
| 77578007 | Arytenoid cartilage structure (body structure) |
| 59652004 | Atrial structure (body structure) |
| 79741001 | Common bile duct structure (body structure) |
| 89837001 | Urinary bladder structure (body structure) |
| 393006 | Structure of wall of urinary bladder (body structure) |
| 119186007 | Bone part (body structure) |
| 52374004 | Ethmoid bone structure (body structure) |
| 74872008 | Frontal bone structure (body structure) |
| 21387005 | Hyoid bone structure (body structure) |
| 22356005 | Bone structure of ilium (body structure) |
| 421793000 | Bone structure of incus (body structure) |
| 85710004 | Bone structure of ischium (body structure) |
| 6229007 | Lacrimal bone structure (body structure) |
| 91609006 | Bone structure of mandible (body structure) |
| 59066005 | Mastoid structure (body structure) |
| 74386004 | Nasal bone structure (body structure) |
| 31640002 | Occipital bone structure (body structure) |
| 51283005 | Palatine bone structure (body structure) |
| 24924006 | Parietal bone structure (body structure) |
| 118645006 | Structure of innominate bone and/or sacrum and/or coccyx (body structure) |
| 73117003 | Sphenoid bone structure (body structure) |
| 60911003 | Temporal bone structure (body structure) |
| 13881006 | Zygomatic bone structure (body structure) |
| 14016003 | Bone marrow structure (body structure) |
| 5798000 | Diaphragm structure (body structure) |
| 113276009 | Intestinal structure (body structure) |
| 14742008 | Structure of large intestine (body structure) |
| 30315005 | Structure of small intestine (body structure) |
| 36582005 | Brachial plexus structure (body structure) |
| 12738006 | Brain structure (body structure) |
| 15926001 | Brainstem structure (body structure) |
| 76752008 | Breast structure (body structure) |
| 955009 | Bronchial structure (body structure) |
| 102297006 | Main bronchus structure (body structure) |
| 34381000 | Anal canal structure (body structure) |
| 28700002 | Structure of carina of trachea (body structure) |
| 38848004 | Duodenal structure (body structure) |
| 7173007 | Cauda equina structure (body structure) |
| 9284003 | Corpus cavernosum structure (body structure) |
| 279549004 | Nasal cavity structure (body structure) |
| 74262004 | Oral cavity structure (body structure) |
| 32713005 | Cecum structure (body structure) |
| 113305005 | Cerebellar structure (body structure) |
| 83678007 | Structure of cerebrum (body structure) |
| 71252005 | Cervix uteri structure (body structure) |
| 78904004 | Chest wall structure (body structure) |
| 369387006 | Structure of cisterna pontis (body structure) |
| 60075002 | Cervical esophagus structure (body structure) |
| 51299004 | Bone structure of clavicle (body structure) |
| 56193007 | Oculomotor nerve structure (body structure) |
| 21161002 | Glossopharyngeal nerve structure (body structure) |
| 27612005 | Trigeminal nerve structure (body structure) |
| 80622005 | Abducens nerve structure (body structure) |
| 56052001 | Facial nerve structure (body structure) |
| 8598002 | Vestibulocochlear nerve structure (body structure) |
| 15119000 | Accessory nerve structure (body structure) |
| 37899009 | Hypoglossal nerve structure (body structure) |
| 80169004 | Cochlear structure (body structure) |
| 71854001 | Colon structure (body structure) |
| 9040008 | Ascending colon structure (body structure) |
| 32622004 | Descending colon structure (body structure) |
| 81745001 | Structure of eye proper (body structure) |
| 60184004 | Sigmoid colon structure (body structure) |
| 485005 | Transverse colon structure (body structure) |
| 28726007 | Corneal structure (body structure) |
| 36743005 | Structure of cribriform plate (body structure) |
| 8600008 | Cricoid cartilage structure (body structure) |
| 28276008 | Structure of cricopharyngeal part of inferior constrictor pharyngeus muscle (body structure) |
| 28231008 | Gallbladder structure (body structure) |
| 71934003 | Genital structure (body structure) |
| 13561001 | Lacrimal gland structure (body structure) |
| 117590005 | Ear structure (body structure) |
| 111002 | Parathyroid structure (body structure) |
| 127949000 | Elbow region structure (body structure) |
| 32849002 | Esophageal structure (body structure) |
| 88481005 | Sublingual gland structure (body structure) |
| 385296007 | Submandibular salivary gland structure (body structure) |
| 9875009 | Thymus gland structure (body structure) |
| 69748006 | Thyroid structure (body structure) |
| 2812003 | Structure of head of femur (body structure) |
| 24136001 | Hip joint structure (body structure) |
| 71341001 | Bone structure of femur (body structure) |
| 29627003 | Structure of neck of femur (body structure) |
| 41111004 | Bone structure of shaft of femur (body structure) |
| 87342007 | Bone structure of fibula (body structure) |
| 1307006 | Glottis structure (body structure) |
| 3711007 | Structure of great blood vessel (organ) (body structure) |
| 90228003 | Hard palate structure (body structure) |
| 23451007 | Adrenal structure (body structure) |
| 80891009 | Heart structure (body structure) |
| 372073000 | Cerebral hemisphere structure (body structure) |
| 5366008 | Hippocampal structure (body structure) |
| 67923007 | Hypothalamic structure (body structure) |
| 34516001 | Ileal structure (body structure) |
| 21306003 | Jejunal structure (body structure) |
| 16953009 | Elbow joint structure (body structure) |
| 85537004 | Glenohumeral joint structure (body structure) |
| 711190000 | Structure of epiphyseal plate (body structure) |
| 39352004 | Joint structure (body structure) |
| 53620006 | Temporomandibular joint structure (body structure) |
| 6566002 | Cerebellar hemisphere structure (body structure) |
| 50403003 | Structure of cortex of kidney (body structure) |
| 74033008 | Structure of hilum of kidney (body structure) |
| 85050009 | Bone structure of humerus (body structure) |
| 64033007 | Kidney structure (body structure) |
| 72696002 | Knee region structure (body structure) |
| 81502006 | Hypopharyngeal structure (body structure) |
| 4596009 | Laryngeal structure (body structure) |
| 86483002 | Structure of supraglottic space (body structure) |
| 78076003 | Structure of lens of eye (body structure) |
| 6544009 | Structure of gastrohepatic ligament (body structure) |
| 81083006 | Both lips (body structure) |
| 10200004 | Liver structure (body structure) |
| 83251001 | Frontal lobe structure (body structure) |
| 25990002 | Renal pelvis structure (body structure) |
| 31065004 | Occipital lobe structure (body structure) |
| 16630005 | Parietal lobe structure (body structure) |
| 78277001 | Temporal lobe structure (body structure) |
| 72410000 | Mediastinal structure (body structure) |
| 71616004 | Skeletal and/or smooth muscle structure (body structure) |
| 4866005 | Constrictor muscle of pharynx structure (body structure) |
| 79368004 | Masseter muscle structure (body structure) |
| 52927003 | Structure of temporalis muscle (body structure) |
| 71836000 | Nasopharyngeal structure (body structure) |
| 59441001 | Structure of lymph node (body structure) |
| 16051009 | Structure of apical axillary lymph node (body structure) |
| 283001 | Structure of central axillary lymph node (body structure) | |
| 68171009 | Axillary lymph node structure (body structure) |
| 33770006 | Structure of lateral axillary lymph node (body structure) |
| 69691007 | Structure of pectoral axillary lymph node (body structure) |
| 12196003 | Structure of subscapular axillary lymph node (body structure) |
| 196821008 | Structure of innominate lymph node (body structure) |
| 279816002 | Bronchopulmonary lymph node group (body structure) |
| 196751009 | Structure of diaphragmatic lymph node (body structure) |
| 65349008 | Structure of external iliac lymph node (body structure) |
| 245357003 | Structure of internal iliac lymph node (body structure) |
| 84219008 | Structure of iliac lymph node (body structure) |
| 245299000 | Internal iliac lymph node group (body structure) |
| 245295006 | Common iliac lymph node group (body structure) |
| 245282001 | Internal mammary lymph node group (body structure) |
| 279763008 | Inguinofemoral lymph node group (body structure) |
| 64038003 | Intercostal lymph node (body structure) |
| 127938006 | Lymph node of aortopulmonary window (body structure) |
| 62683002 | Mediastinal lymph node structure (body structure) |
| 81105003 | Cervical lymph node structure (body structure) |
| 36086000 | Structure of obturator lymph node (body structure) |
| 35783009 | Structure of aortic lymph node (body structure) |
| 368550005 | Structure of paramammary lymph node (body structure) |
| 82365008 | Structure of parasternal lymph node (body structure) |
| 245294005 | Pelvic lymph node group (body structure) |
| 245288002 | Portahepatis lymph node group (body structure) |
| 45206002 | Nasal structure (body structure) |
| 1187336003 | Presacral lymph node group (body structure) |
| 196662004 | Structure of intrapulmonary lymph node (body structure) |
| 76838003 | Structure of supraclavicular lymph node (body structure) |
| 245283006 | Tracheobronchial lymph node group (body structure) |
| 84782009 | Peripheral nerve structure (body structure) |
| 40958000 | Nerve root structure (body structure) |
| 244453006 | Structure of optic chiasma (body structure) |
| 18234004 | Optic nerve structure (body structure) |
| 39607008 | Lung structure (body structure) |
| 31094006 | Structure of lobe of lung (body structure) |
| 34080009 | Malleus structure (body structure) |
| 70925003 | Bone structure of maxilla (body structure) |
| 363654007 | Structure of orbit proper (body structure) |
| 31389004 | Oropharyngeal structure (body structure) |
| 52410001 | Digastric muscle structure (body structure) |
| 15497006 | Ovarian structure (body structure) |
| 18252004 | Structure of platysma muscle (body structure) |
| 76738006 | Structure of pterygoid muscle (body structure) |
| 22823000 | Structure of sternocleidomastoid muscle (body structure) |
| 49460000 | Soft palate structure (body structure) |
| 46607005 | Nasal turbinate structure (body structure) |
| 15776009 | Pancreatic structure (body structure) |
| 64163001 | Structure of head of pancreas (body structure) |
| 73239005 | Structure of tail of pancreas (body structure) |
| 45682005 | Structure of parametrium (body structure) |
| 45289007 | Parotid gland structure (body structure) |
| 52737000 | Structure of bulb of penis (body structure) |
| 18911002 | Penile structure (body structure) |
| 76848001 | Pericardial structure (body structure) |
| 38864007 | Perineal structure (body structure) |
| 118762006 | Peritoneal sac structure (body structure) |
| 14106009 | Cardiac pacemaker, device (physical object) |
| 54066008 | Pharyngeal structure (body structure) |
| 110822002 | Pancreas and jejunum (combined site) (body structure) |
| 45793000 | Pineal structure (body structure) |
| 56329008 | Pituitary structure (body structure) |
| 49557009 | Pontine structure (body structure) |
| 41216001 | Prostatic structure (body structure) |
| 1162492000 | Tumor bed (morphologic abnormality) |
| 88938001 | Structure of lateral pterygoid muscle (body structure) |
| 85002005 | Structure of medial pterygoid muscle (body structure) |
| 511000202101 | Rectum wall structure (body structure) |
| 34402009 | Rectum structure (body structure) |
| 62397004 | Sacral plexus structure (body structure) |
| 41695006 | Scalp structure (body structure) |
| 67183008 | Structure of condyloid process of mandible (body structure) |
| 124002 | Structure of coronoid process of mandible (body structure) |
| 12402003 | Scar (morphologic abnormality) |
| 20233005 | Scrotal structure (body structure) |
| 64739004 | Seminal vesicle structure (body structure) |
| 54215007 | Ethmoid sinus structure (body structure) |
| 82561000 | Symphysis pubis structure (body structure) |
| 62413002 | Bone structure of radius (body structure) |
| 55060009 | Frontal sinus structure (body structure) |
| 15924003 | Maxillary sinus structure (body structure) |
| 5665001 | Retinal structure (body structure) |
| 113197003 | Bone structure of rib (body structure) |
| 48535007 | Bone structure of first rib (body structure) |
| 78247007 | Bone structure of second rib (body structure) |
| 25888004 | Bone structure of third rib (body structure) |
| 25523003 | Bone structure of fourth rib (body structure) |
| 15339008 | Bone structure of fifth rib (body structure) |
| 59558009 | Bone structure of sixth rib (body structure) |
| 24915002 | Bone structure of seventh rib (body structure) |
| 5953002 | Bone structure of eighth rib (body structure) |
| 22565002 | Bone structure of ninth rib (body structure) |
| 77644006 | Bone structure of tenth rib (body structure) |
| 58830002 | Bone structure of eleventh rib (body structure) |
| 43993008 | Bone structure of twelfth rib (body structure) |
| 39937001 | Skin structure (body structure) |
| 1193560003 | Bone structure of thirteenth rib (body structure) |
| 48014002 | Skin structure of perineum (body structure) |
| 79601000 | Bone structure of scapula (body structure) |
| 75093004 | Skin structure of anterior abdominal wall (body structure) |
| 789564000 | Structure of retropharyngeal space (body structure) |
| 1193554003 | Structure of retrostyloid space (body structure) |
| 41178004 | Structure of sphincter ani muscle (body structure) |
| 61853006 | Spinal canal structure (body structure) |
| 24999009 | Sphenoid sinus structure (body structure) |
| 2748008 | Spinal cord structure (body structure) |
| 54785003 | Cervical spinal cord structure (body structure) |
| 60051002 | Lumbar spinal cord structure (body structure) |
| 89546000 | Bone structure of cranium (body structure) |
| 11478001 | Sacral spinal cord structure (body structure) |
| 50800009 | Thoracic spinal cord structure (body structure) |
| 25270003 | Corpus spongiosum structure (body structure) |
| 22718006 | Stapes structure (body structure) |
| 69695003 | Stomach structure (body structure) |
| 75415000 | Structure of suprapatellar bursa (body structure) |
| 67548002 | Structure of conjunctiva of left eye (body structure) |
| 13014005 | Structure of conjunctiva of right eye (body structure) |
| 8997002 | Space of ventricular system of brain (body structure) |
| 13024002 | Tendon structure (body structure) |
| 70567001 | Structure of quadriceps tendon (body structure) |
| 40689003 | Testis structure (body structure) |
| 37554007 | Spinal dura mater structure (body structure) |
| 1732005 | Thoracic duct structure (body structure) |
| 78961009 | Splenic structure (body structure) |
| 35378004 | Structure of hilum of spleen (body structure) |
| 21974007 | Tongue structure (body structure) |
| 181226008 | Entire tongue (body structure) |
| 47975008 | Structure of root of tongue (body structure) |
| 61344008 | Structure of body of tongue (body structure) |
| 44567001 | Tracheal structure (body structure) |
| 87953007 | Ureteric structure (body structure) |
| 13648007 | Urethral structure (body structure) |
| 71553001 | Prostatic urethra structure (body structure) |
| 35039007 | Uterine structure (body structure) |
| 72107004 | Structure of azygous vein (body structure) |
| 8887007 | Structure of brachiocephalic vein (body structure) |
| 63507001 | Structure of external iliac vein (body structure) |
| 40300007 | Structure of internal iliac vein (body structure) |
| 75573002 | Tonsillar structure (palatine) (body structure) |
| 46027005 | Structure of common iliac vein (body structure) |
| 71585003 | Structure of external jugular vein (body structure) |
| 12123001 | Internal jugular vein structure (body structure) |
| 32764006 | Portal vein structure (body structure) |
| 430757002 | Structure of pulmonary vein great vessel (body structure) |
| 9454009 | Structure of subclavian vein (body structure) |
| 35532006 | Vena caval structure (body structure) |
| 76784001 | Vaginal structure (body structure) |
| 279894000 | Inferior surface of vaginal cervix (body structure) |
| 438074005 | Vaginal cuff (morphologic abnormality) |
| 17401000 | Cardiac valve structure (body structure) |
| 63190004 | Structure of jugular vein (body structure) |
| 91134007 | Mitral valve structure (body structure) |
| 39057004 | Pulmonary valve structure (body structure) |
| 46030003 | Tricuspid valve structure (body structure) |
| 21814001 | Cardiac ventricular structure (body structure) |
| 46105003 | Vocal cord structure (body structure) |
| 45292006 | Vulval structure (body structure) |
| 263355003 | Vaginal wall (body structure) |
| 38266002 | Entire body as a whole (body structure) | |
| 75330005 | Structure of red bone marrow (body structure) |
| 52940008 | Thyroid cartilage structure (body structure) |
| 15328005 | Structure of suprasellar region (body structure) |
| 34202007 | Aortic valve structure (body structure) |
| 1172006 | Structure of odontoid process of axis (body structure) |
| 123037004 | Body structure (body structure) |
| 3572006 | Structure of body of vertebra (body structure) |
| 14806007 | Bone structure of atlas (body structure) |
| 39976000 | Bone structure of axis (body structure) |
| 91116008 | Structure of body of third cervical vertebra (body structure) |
| 14705001 | Structure of body of fourth cervical vertebra (body structure) |
| 67479001 | Structure of body of fifth cervical vertebra (body structure) |
| 88298007 | Structure of body of sixth cervical vertebra (body structure) |
| 16126006 | Structure of body of seventh cervical vertebra (body structure) |
| 73903008 | Bone structure of lumbar vertebra (body structure) |
| 61032001 | Structure of body of first lumbar vertebra (body structure) |
| 53983007 | Structure of body of second lumbar vertebra (body structure) |
| 55492004 | Structure of body of third lumbar vertebra (body structure) |
| 71996003 | Structure of body of fourth lumbar vertebra (body structure) |
| 21799000 | Structure of body of fifth lumbar vertebra (body structure) |
| 87141009 | Sacral vertebra structure (body structure) |
| 65985001 | Structure of first sacral vertebra (body structure) |
| 11808007 | Structure of second sacral vertebra (body structure) |
| 49967005 | Structure of third sacral vertebra (body structure) |
| 69950008 | Structure of fourth sacral vertebra (body structure) |
| 21452006 | Structure of fifth sacral vertebra (body structure) |
| 35769007 | Bone structure of thoracic vertebra (body structure) |
| 56094003 | Structure of body of first thoracic vertebra (body structure) |
| 50060007 | Structure of body of secon thoracic vertebra (body structure) |
| 73138009 | Structure of body of third thoracic vertebra (body structure) |
| 86197001 | Structure of body of fourth thoracic vertebra (body structure) |
| 6105006 | Structure of body of fifth thoracic vertebra (body structure) |
| 32430008 | Structure of body of sixth thoracic vertebra (body structure) |
| 71737002 | Structure of body of seventh thoracic vertebra (body structure) |
| 77435000 | Structure of body of eighth thoracic vertebra (body structure) |
| 33766003 | Structure of body of ninth thoracic vertebra (body structure) |
| 48405002 | Structure of body of tenth thoracic vertebra (body structure) |
| 52120002 | Structure of body of eleventh thoracic vertebra (body structure) |
| 280849005 | Structure of body of twelfth thoracic vertebra (body structure) |
| 1186895000 | Structure of body of thirteenth thoracic vertebra (body structure) |
| 1187337007 | Jugular Fossa (body structure) |
| 35763008 | Structure of posterior fossa of cranial cavity (body structure) |
| 87166008 | Vomer bone structure (body structure) |
http://hl7.org/fhir/us/mcode/CodeSystem/snomed-requested-cs| Code | Display |
| USCRS-34356 | Bowel space (body structure) |
| USCRS-34358 | Small bowel space (body structure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 228793007 | Planning target volume (observable entity) |
| 228791009 | Gross tumor volume (observable entity) |
| 228792002 | Clinical target volume (observable entity) |
| 1162586008 | Irradiated volume of organ at risk (observable entity) |
| 1201745009 | Internal target volume (observable entity) |
| 1201746005 | Internal gross tumor volume (observable entity) |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept is-a 128462008 (Metastatic neoplasm (disease))http://hl7.org/fhir/sid/icd-10-cm| Code | Display |
| C77 | SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C78 | SECONDARY MALIGNANT NEOPLASM OF RESPIRATORY AND DIGESTIVE ORGANS |
| C78.0 | Secondary malignant neoplasm of lung |
| C78.00 | Secondary malignant neoplasm of unspecified lung |
| C78.01 | Secondary malignant neoplasm of right lung |
| C78.02 | Secondary malignant neoplasm of left lung |
| C78.1 | Secondary malignant neoplasm of mediastinum |
| C78.2 | Secondary malignant neoplasm of pleura |
| C78.3 | Secondary malignant neoplasm of other and unspecified respiratory organs |
| C78.30 | Secondary malignant neoplasm of unspecified respiratory organ |
| C78.39 | Secondary malignant neoplasm of other respiratory organs |
| C78.4 | Secondary malignant neoplasm of small intestine |
| C78.5 | Secondary malignant neoplasm of large intestine and rectum |
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum |
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct |
| C78.8 | Secondary malignant neoplasm of other and unspecified digestive organs |
| C78.80 | Secondary malignant neoplasm of unspecified digestive organ |
| C78.89 | Secondary malignant neoplasm of other digestive organs |
| C79 | SECONDARY MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES |
| C79.0 | Secondary malignant neoplasm of kidney and renal pelvis |
| C79.00 | Secondary malignant neoplasm of unspecified kidney and renal pelvis |
| C79.01 | Secondary malignant neoplasm of right kidney and renal pelvis |
| C79.02 | Secondary malignant neoplasm of left kidney and renal pelvis |
| C79.1 | Secondary malignant neoplasm of bladder and other urinary organs |
| C79.10 | Secondary malignant neoplasm of unspecified urinary organs |
| C79.11 | Secondary malignant neoplasm of bladder |
| C79.19 | Secondary malignant neoplasm of other urinary organs |
| C79.2 | Secondary malignant neoplasm of skin |
| C79.3 | Secondary malignant neoplasm of brain cerebral meninges |
| C79.31 | Secondary malignant neoplasm of brain |
| C79.32 | Secondary malignant neoplasm of cerebral meninges |
| C79.4 | Secondary malignant neoplasm of other and unspecified of nervous system |
| C79.40 | Secondary malignant neoplasm of unspecified part of nervous system |
| C79.49 | Secondary malignant neoplasm of other parts of nervous system |
| C79.5 | Secondary malignant neoplasm of bone and bone marrow |
| C79.51 | Secondary malignant neoplasm of bone |
| C79.52 | Secondary malignant neoplasm of bone marrow |
| C79.6 | Secondary malignant neoplasm of ovary |
| C79.60 | Secondary malignant neoplasm of unspecified ovary |
| C79.61 | Secondary malignant neoplasm of right ovary |
| C79.62 | Secondary malignant neoplasm of left ovary |
| C79.7 | Secondary malignant neoplasm of adrenal gland |
| C79.70 | Secondary malignant neoplasm of unspecified adrenal gland |
| C79.71 | Secondary malignant neoplasm of right adrenal gland |
| C79.72 | Secondary malignant neoplasm of left adrenal gland |
| C79.8 | Secondary malignant neoplasm of other specified sites |
| C79.81 | Secondary malignant neoplasm of breast |
| C79.82 | Secondary malignant neoplasm of genital organs |
| C79.89 | Secondary malignant neoplasm of other specified sites |
| C79.9 | Secondary malignant neoplasm of unspecified site |
| C7B | SECONDARY NEUROENDOCRINE TUMORS |
| C7B.0 | Secondary carcinoid tumors |
| C7B.00 | Secondary carcinoid tumors, unspecified site |
| C7B.01 | Secondary carcinoid tumors of distant lymph nodes |
| C7B.02 | Secondary carcinoid tumors of liver |
| C7B.03 | Secondary carcinoid tumors of bone |
| C7B.04 | Secondary carcinoid tumors of peritoneum |
| C7B.09 | Secondary carcinoid tumors of other sites |
| C7B.1 | Secondary merkel cell carcinoma |
| C7B.8 | Other secondary neuroendocrine tumors |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 1156529004 | External beam radiation therapy using particle passive scattering technique (procedure) |
| 1156528007 | External beam radiation therapy using particle spot scanning technique (procedure) |
| 1204242009 | External beam radiation therapy using particle scanning technique (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 1162782007 | Three dimensional external beam radiation therapy (procedure) |
| 1156526006 | Two dimensional external beam radiation therapy (procedure) |
| 168524008 | Radiotherapy - intraoperative control (procedure) |
| 1163157007 | Ultra high dose rate radiotherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 10611004 | External beam radiation therapy protons (procedure) |
| 45643008 | External beam radiation therapy using electrons (procedure) |
| 80347004 | External beam radiation therapy neutrons (procedure) |
| 1156505006 | External beam radiation therapy using carbon ions (procedure) |
| 1156506007 | External beam radiation therapy using photons (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 169317000 | Neutron capture therapy (procedure) |
| 1162782007 | Three dimensional external beam radiation therapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 441799006 | Intensity modulated radiation therapy (procedure) |
| 1156530009 | Volumetric Modulated Arc Therapy (procedure) |
| 1162782007 | Three dimensional external beam radiation therapy (procedure) |
| 1156526006 | Two dimensional external beam radiation therapy (procedure) |
| 168524008 | Radiotherapy - intraoperative control (procedure) |
| 1163157007 | Ultra high dose rate radiotherapy (procedure) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 1156529004 | External beam radiation therapy using particle passive scattering technique (procedure) |
| 1156528007 | External beam radiation therapy using particle spot scanning technique (procedure) |
| 1204242009 | External beam radiation therapy using particle scanning technique (procedure) |
| 1163157007 | Ultra high dose rate radiotherapy (procedure) |
This value set includes codes based on the following rules:
This value set includes codes based on the following rules:
http://cancerstaging.orgThis value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 1222587001 (American Joint Committee on Cancer clinical M category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222591006 (American Joint Committee on Cancer pathological M category allowable value (qualifier value))http://loinc.org| Code | Display |
| 21907-1 | Distant metastases.clinical [Class] Cancer |
| 21901-4 | Distant metastases.pathology [Class] Cancer |
| 21913-9 | Distant metastases.other [Class] Cancer |
This value set includes codes based on the following rules:
http://cancerstaging.orgThis value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 1222585009 (American Joint Committee on Cancer clinical T category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222589003 (American Joint Committee on Cancer pathological T category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222595002 (American Joint Committee on Cancer ypT category allowable value (qualifier value))http://loinc.org| Code | Display |
| 21905-5 | Primary tumor.clinical [Class] Cancer |
| 21899-0 | Primary tumor.pathology Cancer |
| 21911-3 | Primary tumor.other [Class] Cancer |
This value set includes codes based on the following rules:
http://cancerstaging.orgThis value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 1222588006 (American Joint Committee on Cancer clinical N category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222590007 (American Joint Committee on Cancer pathological N category allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222596001 (American Joint Committee on Cancer ypN category allowable value (qualifier value))http://loinc.org| Code | Display |
| 21906-3 | Regional lymph nodes.clinical [Class] Cancer |
| 21900-6 | Regional lymph nodes.pathology [Class] Cancer |
| 21912-1 | Regional lymph nodes.other [Class] Cancer |
This value set includes codes based on the following rules:
http://cancerstaging.orghttp://loinc.org| Code | Display |
| 21908-9 | Stage group.clinical Cancer |
| 21902-2 | Stage group.pathology Cancer |
| 21914-7 | Stage group.other Cancer |
This value set includes codes based on the following rules:
http://snomed.info/sct where concept descends from 1222592004 (American Joint Committee on Cancer clinical stage group allowable value)http://snomed.info/sct where concept descends from 1222593009 (American Joint Committee on Cancer pathological stage group allowable value (qualifier value))http://snomed.info/sct where concept descends from 1222594003 (American Joint Committee on Cancer yp stage group allowable value (qualifier value))http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 444256004 | American Joint Commission on Cancer, Cancer Staging Manual, 6th edition neoplasm staging system (tumor staging) |
| 443830009 | American Joint Commission on Cancer, Cancer Staging Manual, 7th edition neoplasm staging system (tumor staging) |
| 897275008 | American Joint Commission on Cancer, Cancer Staging Manual, 8th edition neoplasm staging system (tumor staging) |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 182992009 | Treatment completed (situation) |
| 266721009 | No response to treatment (situation) |
| 407563006 | Treatment not tolerated (situation) |
| 160932005 | Financial problem (finding) |
| 105480006 | Refusal of treatment by patient (situation) |
| 184081006 | Patient has moved away (finding) |
| 309846006 | Treatment not available (situation) |
| 399307001 | Lost to follow-up (finding) |
| 419620001 | Death (event) |
| 7058009 | Noncompliance with treatment (finding) |
http://loinc.org| Code | Display |
| 62320-7 | T-cell receptor excision circle [#/volume] in DBS by NAA with probe detection |
| 92006-6 | T-cell receptor excision circle [Cycle Threshold #] in DBS |
| 92007-4 | T-cell receptor excision circle [Z-score] in DBS |
| 92008-2 | T-cell receptor excision circle [Multiple of the median] in DBS |
| 69361-4 | PCA3 score in Urine by Molecular genetics method |
| 69362-2 | PCA3 score in Urine Qualitative by Molecular genetics method |
| 19163-5 | Cancer Ag 19-9 [Units/volume] in Pleural fluid |
| 2009-9 | Cancer Ag 19-9 [Presence] in Serum or Plasma |
| 24108-3 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma |
| 26924-1 | Cancer Ag 19-9 [Units/volume] in Body fluid |
| 50779-8 | Cancer Ag 19-9 [Units/volume] in Cerebral spinal fluid |
| 50780-6 | Cancer Ag 19-9 [Units/volume] in Pericardial fluid |
| 50781-4 | Cancer Ag 19-9 [Units/volume] in Peritoneal fluid |
| 83084-4 | Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay |
| 97750-4 | Cancer Ag 19-9 [Units/volume] in Aspirate |
| 14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
| 19174-2 | Choriogonadotropin.beta subunit [Units/volume] in Amniotic fluid |
| 19175-9 | Choriogonadotropin.beta subunit [Moles/volume] in Amniotic fluid |
| 20415-6 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS |
| 2111-3 | Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma |
| 2113-9 | Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine |
| 2114-7 | Choriogonadotropin.beta subunit [Moles/volume] in Urine |
| 21198-7 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma |
| 29154-2 | Choriogonadotropin.beta subunit [Units/volume] in Body fluid |
| 43799-6 | Choriogonadotropin.beta subunit [Presence] in Specimen |
| 43800-2 | Choriogonadotropin.beta subunit [Presence] in Cerebral spinal fluid |
| 55868-4 | Choriogonadotropin.beta subunit [Multiple of the median] in Serum or Plasma |
| 55869-2 | Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma |
| 56497-1 | Choriogonadotropin.beta subunit [Units] in 24 hour Urine |
| 66762-6 | Choriogonadotropin.beta subunit [Units/volume] in Pleural fluid |
| 66763-4 | Choriogonadotropin.beta subunit [Units/volume] in Peritoneal fluid |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
| 15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
| 15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
| 19165-0 | Cancer Ag 125 [Units/volume] in Pleural fluid |
| 2006-5 | Cancer Ag 125 [Presence] in Serum or Plasma |
| 40618-1 | Cancer Ag 125 [Units/volume] in Peritoneal fluid |
| 48677-9 | Cancer Ag 125 [Presence] in Tissue by Immune stain |
| 50775-6 | Cancer Ag 125 [Units/volume] in Cerebral spinal fluid |
| 59040-6 | Cancer Ag 125 [Units/volume] in Peritoneal dialysis fluid |
| 68923-2 | Cancer Ag 125 [Units/volume] in Pericardial fluid |
| 83082-8 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay |
| 97743-9 | Cancer Ag 125 [Units/volume] in Aspirate |
| 15035-9 | Calcitonin [Moles/volume] in Serum or Plasma |
| 1992-7 | Calcitonin [Mass/volume] in Serum or Plasma |
| 47369-4 | Calcitonin [Mass/volume] in Body fluid |
| 75709-6 | Calcitonin [Mass/volume] in Lymph node fine needle aspirate |
| 25587-7 | Chromogranin A [Moles/volume] in Serum or Plasma |
| 30169-7 | Chromogranin A [Units/volume] in Serum or Plasma by Immunoassay |
| 53047-7 | Chromogranin A [Mass/volume] in Body fluid |
| 59220-4 | Chromogranin A [Units/volume] in Pleural fluid |
| 59226-1 | Chromogranin A [Units/volume] in Peritoneal fluid |
| 59227-9 | Chromogranin A [Units/volume] in Cerebral spinal fluid |
| 59241-0 | Chromogranin A [Units/volume] in Body fluid |
| 9811-1 | Chromogranin A [Mass/volume] in Serum or Plasma |
| 15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
| 19193-2 | Enolase.neuron specific [Units/volume] in Serum or Plasma |
| 19194-0 | Enolase.neuron specific [Units/volume] in Pleural fluid |
| 2225-1 | Enolase.neuron specific [Enzymatic activity/volume] in Serum or Plasma |
| 44802-7 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid |
| 47053-4 | Enolase.neuron specific [Mass/volume] in Cerebral spinal fluid by Immunoassay |
| 48138-2 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA) |
| 48164-8 | Enolase.neuron specific [Mass/volume] in Body fluid |
| 57371-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma by Immunoassay |
| 68939-8 | Enolase.neuron specific [Mass/volume] in Pleural fluid |
| 68952-1 | Enolase.neuron specific [Mass/volume] in Pericardial fluid |
| 69560-1 | Enolase.neuron specific [Mass/volume] in Peritoneal fluid |
| 97744-7 | Enolase.neuron specific [Mass/volume] in Aspirate |
| 15072-2 | Gastrin [Moles/volume] in Serum or Plasma |
| 2333-3 | Gastrin [Mass/volume] in Serum or Plasma |
| 2960-3 | Somatostatin [Presence] in Plasma |
| 2961-1 | Somatostatin [Mass/volume] in Plasma |
| 49792-5 | Somatostatin [Moles/volume] in Plasma |
| 14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma |
| 3013-0 | Thyroglobulin [Mass/volume] in Serum or Plasma |
| 53920-5 | Thyroglobulin [Mass/volume] in Lymph node fine needle aspirate |
| 53922-1 | Thyroglobulin [Mass/volume] in Tissue fine needle aspirate |
| 97640-7 | Thyroglobulin [Moles/volume] in Tissue fine needle aspirate |
| 10861-3 | Progesterone receptor [Mass/mass] in Tissue |
| 16113-3 | Progesterone receptor [Interpretation] in Tissue |
| 31207-4 | Progesterone receptor [Moles/mass] in Tissue |
| 10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
| 14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
| 1951-3 | Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid |
| 1952-1 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma |
| 1953-9 | Beta-2-Microglobulin [Mass/volume] in Urine |
| 32301-4 | Beta-2-Microglobulin [Moles/volume] in Cerebral spinal fluid |
| 32302-2 | Beta-2-Microglobulin [Moles/volume] in Urine |
| 39458-5 | Beta-2-Microglobulin [Moles/volume] in Body fluid |
| 43818-4 | Beta-2-Microglobulin [Presence] in Serum |
| 43819-2 | Beta-2-Microglobulin [Presence] in Urine |
| 43919-0 | Beta-2-Microglobulin [Presence] in Cerebral spinal fluid |
| 48166-3 | Beta-2-Microglobulin [Mass/volume] in Body fluid |
| 49081-3 | Beta-2-Microglobulin [Mass/volume] in Dialysis fluid |
| 50824-2 | Beta-2-Microglobulin [Moles/volume] in 24 hour Urine |
| 54356-1 | Beta-2-Microglobulin [Mass/volume] in 24 hour Urine |
| 56662-0 | Beta-2-Microglobulin [Moles/time] in 24 hour Urine |
| 59217-0 | Beta-2-Microglobulin [Mass/volume] in Peritoneal fluid |
| 59218-8 | Beta-2-Microglobulin [Mass/volume] in Pleural fluid |
| 76484-5 | Beta-2-Microglobulin [Moles/volume] in Serum or Plasma |
| 83076-0 | Beta-2-Microglobulin [Units/volume] in Serum or Plasma by Immunoassay |
| 83077-8 | Beta-2-Microglobulin [Mass/volume] in Urine by Immunoassay |
| 83078-6 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay |
| 83079-4 | Beta-2-Microglobulin [Units/volume] in Urine by Immunoassay |
| 88711-7 | Beta-2-Microglobulin [Mass/volume] in Peritoneal dialysis fluid |
| 11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
| 14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
| 14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
| 14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
| 14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
| 17041-5 | Lactate dehydrogenase [Presence] in Urine |
| 2527-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Amniotic fluid |
| 2528-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid |
| 2529-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid |
| 2530-4 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid |
| 2531-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid |
| 2532-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 2533-8 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid |
| 2534-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Urine |
| 32324-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Specimen |
| 33367-4 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid |
| 47678-8 | Lactate dehydrogenase [Enzymatic activity/volume] in 24 hour Urine |
| 47863-6 | Lactate dehydrogenase [Enzymatic activity/time] in 24 hour Urine |
| 57664-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Semen |
| 5921-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Dialysis fluid |
| 60017-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Pyruvate to lactate reaction |
| 60018-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Pyruvate to lactate reaction |
| 60019-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Pericardial fluid by Lactate to pyruvate reaction |
| 60020-5 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Pyruvate to lactate reaction |
| 60021-3 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Pyruvate to lactate reaction |
| 60022-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction |
| 60023-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Pyruvate to lactate reaction |
| 60024-7 | Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction |
| 68387-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Peritoneal fluid by Lactate to pyruvate reaction |
| 68452-2 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Pyruvate to lactate reaction |
| 68453-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Synovial fluid by Lactate to pyruvate reaction |
| 94076-7 | Mutations/Megabase [# Ratio] in Tumor |
| 2007-3 | Cancer Ag 15-3 [Presence] in Serum or Plasma |
| 29153-4 | Cancer Ag 15-3 [Units/volume] in Body fluid |
| 50776-4 | Cancer Ag 15-3 [Units/volume] in Cerebral spinal fluid |
| 50777-2 | Cancer Ag 15-3 [Units/volume] in Pericardial fluid |
| 50778-0 | Cancer Ag 15-3 [Units/volume] in Peritoneal fluid |
| 6875-9 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma |
| 83083-6 | Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay |
| 97749-6 | Cancer Ag 15-3 [Units/volume] in Aspirate |
| 2011-5 | Cancer Ag 242 [Presence] in Serum or Plasma |
| 17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
| 19187-4 | Cancer Ag 27-29 [Units/volume] in Pleural fluid |
| 2012-3 | Cancer Ag 27-29 [Presence] in Serum or Plasma |
| 50782-2 | Cancer Ag 27-29 [Units/volume] in Cerebral spinal fluid |
| 2013-1 | Cancer Ag 50 [Presence] in Serum or Plasma |
| 34256-8 | Cancer Ag 50 [Units/volume] in Serum or Plasma |
| 19189-0 | Cancer Ag 549 [Units/volume] in Serum or Plasma |
| 19190-8 | Cancer Ag 549 [Units/volume] in Pleural fluid |
| 2014-9 | Cancer Ag 549 [Presence] in Serum or Plasma |
| 17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
| 19164-3 | Cancer Ag 72-4 [Units/volume] in Pleural fluid |
| 2015-6 | Cancer Ag 72-4 [Presence] in Serum or Plasma |
| 34161-0 | Cancer Ag 72-4 [Units/volume] in Body fluid |
| 47012-0 | Cancer Ag 72-4 [Presence] in Tissue by Immune stain |
| 68924-0 | Cancer Ag 72-4 [Units/volume] in Peritoneal fluid |
| 68925-7 | Cancer Ag 72-4 [Units/volume] in Cerebral spinal fluid |
| 68926-5 | Cancer Ag 72-4 [Units/volume] in Pericardial fluid |
| 2506-4 | Isocitrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
| 72508-5 | UGT1A1 gene c.A(TA)7TAA(*28) [Presence] in Blood or Tissue by Molecular genetics method |
| 21015-3 | CD33 cells [#/volume] in Blood |
| 74837-6 | CD20 cells [#/volume] in Specimen |
| 9558-8 | CD20 cells [#/volume] in Blood |
| 10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
| 19195-7 | Prostate specific Ag [Units/volume] in Serum or Plasma |
| 19197-3 | Prostate specific Ag [Moles/volume] in Serum or Plasma |
| 19198-1 | Prostate specific Ag [Units/volume] in Semen |
| 19199-9 | Prostate specific Ag [Mass/volume] in Semen |
| 19200-5 | Prostate specific Ag [Moles/volume] in Semen |
| 2857-1 | Prostate specific Ag [Mass/volume] in Serum or Plasma |
| 34611-4 | Prostate specific Ag [Mass/volume] in Urine |
| 35741-8 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL |
| 47738-0 | Prostate specific Ag [Mass/volume] in Body fluid |
| 59221-2 | Prostate specific Ag [Mass/volume] in Pleural fluid |
| 59223-8 | Prostate specific Ag [Mass/volume] in Peritoneal fluid |
| 59230-3 | Prostate specific Ag [Mass/volume] in Cerebral spinal fluid |
| 83112-3 | Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
| 13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
| 14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
| 21013-8 | CD22 cells [#/volume] in Blood |
| 14130-9 | Estrogen receptor [Moles/mass] in Tissue |
| 16112-5 | Estrogen receptor [Interpretation] in Tissue |
| 78205-2 | ALK gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78210-2 | ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 91141-2 | TPMT activity in RBC by production of 6-MMP |
| 91142-0 | TPMT activity in RBC by production of 6-MMP riboside |
| 91143-8 | TPMT activity in RBC by production of 6-MTG riboside |
| 83059-6 | KRAS gene [VCF] in Cancer specimen by Sequencing |
| 80717-2 | B-cell CD27 and IgD subsets panel - Blood |
| 85299-6 | BRAF V600E mutant protein [Presence] in Cancer specimen by Immune stain |
| 32996-1 | HER2 [Mass/volume] in Serum |
| 42914-2 | HER2 [Mass/volume] in Serum by Immunoassay |
| 48676-1 | HER2 [Interpretation] in Tissue |
| 51981-9 | HER2 [Presence] in Serum by Immunoassay |
| 72382-5 | HER2 [Units/volume] in Tissue by Immunoassay |
| 72383-3 | HER2 [Presence] in Tissue by Immunoassay |
| 85319-2 | HER2 [Presence] in Breast cancer specimen by Immune stain |
| 28078-4 | Bladder tumor Ag [Presence] in Urine by Immunoassay |
| 28551-0 | Bladder tumor Ag [Units/volume] in Urine by Immunoassay |
| 31729-7 | Bladder tumor Ag [Presence] in Urine |
| 31730-5 | Bladder tumor Ag [Units/volume] in Urine |
| 80386-6 | Bladder tumor Ag [Presence] in Urine by Rapid immunoassay |
| 31134-0 | Nuclear matrix protein 22 [Units/volume] in Urine |
| 50666-7 | Nuclear matrix protein 22 [Presence] in Urine |
| 34444-0 | Acarboxyprothrombin [Mass/volume] in Serum or Plasma |
| 93768-0 | Acarboxyprothrombin [Units/volume] in Serum or Plasma |
| 41292-4 | Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma |
| 43368-0 | Microsatellite instability [Identifier] in Tissue by Molecular genetics method Nominal |
| 62862-8 | Microsatellite instability [Presence] in Tissue by Immune stain |
| 81695-9 | Microsatellite instability [Interpretation] in Cancer specimen Qualitative |
| 43399-5 | JAK2 gene p.Val617Phe [Presence] in Blood or Tissue by Molecular genetics method |
| 72333-8 | JAK2 gene p.Val617Phe [Presence] in Bone marrow by Molecular genetics method |
| 31150-6 | ERBB2 gene duplication [Presence] in Tissue by FISH |
| 48674-6 | Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal |
| 48684-5 | X and Y chromosome [Interpretation] in Blood or Marrow by FISH--post bone marrow transplant |
| 48730-6 | X linked heterotaxy [Identifier] in Blood or Tissue by FISH Narrative |
| 49028-4 | Microdeletion syndromes [Identifier] in Blood or Tissue by FISH Nominal |
| 49039-1 | Subtelomere analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 49040-9 | Subtelomere analysis [Interpretation] in Blood or Tissue by FISH Narrative |
| 49063-1 | Microdeletion syndromes in Specimen by FISH Nominal |
| 49683-6 | ERBB2 gene copy number/Chromosome 17 copy number in Tissue by FISH |
| 50020-7 | Microdeletion syndromes in Blood or Tissue by FISH |
| 50659-2 | Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative |
| 50684-0 | Chromosome analysis.interphase [Interpretation] in Blood by FISH Narrative |
| 51867-0 | t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Blood or Tissue by FISH |
| 53628-4 | 20q chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 55192-9 | Chromosome analysis.interphase [Interpretation] in Amniotic fluid by FISH Narrative |
| 55193-7 | Chromosome analysis.interphase [Interpretation] in Chorionic villus sample by FISH Narrative |
| 56030-0 | Karyotype [Identifier] in Urine by FISH Narrative |
| 56144-9 | CHIC2 gene 4q12 deletion in Blood or Tissue by FISH |
| 57038-2 | Chromosome 12 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57317-0 | Chromosome 13+18+21+X+Y aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57318-8 | Chromosome 13+18+21+X+Y aneuploidy in Blood or Tissue by FISH Nominal |
| 57453-3 | Chromosome 18 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57454-1 | Chromosome 13 aneuploidy in Amniotic fluid or Chorionic villus sample by FISH Nominal |
| 57802-1 | Chromosome analysis.interphase [Interpretation] in Blood or Marrow by FISH Narrative |
| 57906-0 | 9p21 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 59050-5 | Chromosome analysis.interphase [Interpretation] in Specimen by FISH Narrative |
| 59267-5 | Karyotype [Identifier] in Blood or Tissue by FISH Narrative |
| 62344-7 | Chromosome analysis.metaphase panel - Blood by FISH |
| 62345-4 | Chromosome analysis.interphase panel - Blood by FISH |
| 62346-2 | Chromosome analysis.interphase panel - Amniotic fluid by FISH |
| 62347-0 | Chromosome analysis.prenatal panel by FISH |
| 62354-6 | Chromosome analysis.metaphase panel - Amniotic fluid by FISH |
| 62367-8 | Chromosome analysis panel by FISH |
| 63068-1 | TOP2A gene copy number/Chromosome 17 copy number in Tissue by FISH |
| 63070-7 | TOP2A gene 17q21-22 deletion and duplication mutation analysis [Presence] in Tissue by FISH |
| 66950-7 | MALT1 18q21 gene rearrangements in Blood or Tissue by FISH |
| 72652-1 | Subtelomere analysis.long arm [Interpretation] in Blood or Tissue by FISH Narrative |
| 72653-9 | Subtelomere analysis.short arm [Interpretation] in Blood or Tissue by FISH Narrative |
| 72654-7 | SNRPN gene 15q11 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 72725-5 | t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
| 72726-3 | t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript [Identifier] in Blood or Tissue by FISH Nominal |
| 72728-9 | Del(13)(q14) [Identifier] in Blood or Tissue by FISH Nominal |
| 72824-6 | Del(17)(p13) [Identifier] in Blood or Tissue by FISH Nominal |
| 72827-9 | dic(9;20)(p11-13;q11)(wcp9+,wcp20+) [Identifier] in Blood or Tissue by FISH Nominal |
| 73558-9 | Staphylococcus aureus and Staphylococcus sp.coagulase negative rRNA [Identifier] by FISH in Positive blood culture |
| 73749-4 | 4p16.3 chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 73750-2 | RAI1 gene 17p11.2 deletion and duplication mutation analysis [Identifier] in Blood or Tissue by FISH Nominal |
| 73751-0 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH Nominal |
| 74034-0 | MAML2 11q21 gene rearrangements in Tissue by FISH |
| 74860-8 | ERBB2 gene copy number/nucleus in Tissue by FISH |
| 74861-6 | Chromosome 17 copy number/nucleus in Tissue by FISH |
| 74885-5 | ERBB2 gene (HER2) duplication associated observations panel - Tissue by FISH |
| 76065-2 | 6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy in Blood or Tissue by FISH |
| 77030-5 | t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript in Blood or Tissue by FISH |
| 77031-3 | t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript in Blood or Tissue by FISH |
| 77032-1 | t(8;14)(q24;q32)(MYC,IGH) fusion transcript in Blood or Tissue by FISH |
| 77033-9 | t(14;16)(q32;q23)(IGH,MAF) fusion transcript in Blood or Tissue by FISH |
| 77034-7 | inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript in Blood or Tissue by FISH |
| 77035-4 | t(14;18)(q32;q21)(IGH,MALT1) fusion transcript in Blood or Tissue by FISH |
| 77036-2 | t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript in Blood or Tissue by FISH |
| 77037-0 | t(11;14)(q13;q32)(CCND1,IGH) fusion transcript in Blood or Tissue by FISH |
| 77038-8 | t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript in Blood or Tissue by FISH |
| 77039-6 | t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript in Blood or Tissue by FISH |
| 77040-4 | t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript in Blood or Tissue by FISH |
| 77041-2 | inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript in Blood or Tissue by FISH |
| 77042-0 | t(6;9)(p22;q34)(DEK,NUP214) fusion transcript in Blood or Tissue by FISH |
| 78201-1 | 4q12 chromosome region rearrangements [Identifier] in Blood or Tissue by FISH Nominal |
| 78202-9 | 9q34 chromosome region deletion [Presence] in Blood or Tissue by FISH |
| 78203-7 | BCL6 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78204-5 | CCND1 gene duplication [Presence] in Blood or Tissue by FISH |
| 78206-0 | 4q12 chromosome region rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78207-8 | 9q34 chromosome region deletion [Interpretation] in Blood or Tissue by FISH Narrative |
| 78208-6 | BCL6 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78209-4 | CCND1 gene duplication [Interpretation] in Blood or Tissue by FISH Narrative |
| 78211-0 | Cells.4q12 chromosome region rearrangements/Cells counted in Blood or Tissue by FISH |
| 78212-8 | Cells.9q34 chromosome region deletion/Cells counted in Blood or Tissue by FISH |
| 78213-6 | Cells.BCL6 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78214-4 | Cells.CCND1 gene duplication/Cells counted in Blood or Tissue by FISH |
| 78215-1 | MYC gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78216-9 | TRA+TRD gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78217-7 | RARA gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78218-5 | BCL2 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78219-3 | MLL gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78220-1 | PDGFRB gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78221-9 | IGH gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78222-7 | MYC gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78223-5 | TRA+TRD gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78224-3 | RARA gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78225-0 | BCL2 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78226-8 | MLL gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78227-6 | PDGFRB gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78228-4 | IGH gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78229-2 | Cells.MYC gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78230-0 | Cells.RARA gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78231-8 | Cells.TRA+TRD gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78232-6 | Cells.BCL2 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78233-4 | Cells.ALK gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78234-2 | Cells.MLL gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78235-9 | Cells.PDGFRB gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78236-7 | Cells.IGH gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 78237-5 | Chromosome 8 copy number/nucleus in Blood or Tissue by FISH |
| 78238-3 | Chromosome 3 copy number/nucleus in Blood or Tissue by FISH |
| 78245-8 | MYB gene deletion [Presence] in Blood or Tissue by FISH |
| 78342-3 | MYB gene deletion [Interpretation] in Blood or Tissue by FISH Narrative |
| 78343-1 | Cells.MYB gene deletion/Cells counted in Blood or Tissue by FISH |
| 78915-6 | FGFR1 gene rearrangements [Presence] in Blood or Tissue by FISH |
| 78916-4 | FGFR1 gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative |
| 78917-2 | Cells.FGFR1 gene rearrangements/Cells counted in Blood or Tissue by FISH |
| 79206-9 | inv(2)(p21;p23)(EML4,ALK) fusion transcript [Presence] in Blood or Tissue by FISH |
| 81710-6 | PTEN gene [Presence] in Cancer specimen by FISH |
| 81746-0 | Chromosome region 17p13.1 deletion in Blood or Tissue by FISH |
| 81747-8 | Chromosome region 6q22 rearrangements in Tissue by FISH |
| 81748-6 | Chromosome region Yp11.3 deletion AndOr rearrangement in Blood or Tissue by FISH |
| 81749-4 | Chromosome region 13q14 deletion in Bone marrow by FISH |
| 81751-0 | Chromosome 17p13.1 deletion and 14q32 rearrangements in Bone marrow by FISH |
| 81752-8 | Chromosome region 1q21 duplication in Bone marrow by FISH |
| 82238-7 | Chromosome region 15q11-13 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
| 82239-5 | Chromosome region 16p13.3 deletion in Blood or Tissue by FISH |
| 82240-3 | Chromosome region 16p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 82241-1 | Chromosome region 17p11.2 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 82242-9 | Chromosome region 17p13.3 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 82243-7 | Chromosome region 17p13.3 deletion in Blood or Tissue by FISH |
| 82244-5 | Chromosome region 1p36 deletion in Blood or Tissue by FISH |
| 82245-2 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Amniotic fluid or Chorionic villus sample by FISH |
| 82246-0 | Chromosome region 22q11.2 deletion and duplication mutation analysis in Blood or Tissue by FISH |
| 82247-8 | Chromosome region 7q11.23 deletion in Amniotic fluid or Chorionic villus sample by FISH |
| 82248-6 | Chromosome region 7q11.23 deletion in Blood or Tissue by FISH |
| 82249-4 | Chromosome region 8q23.3-24.13 deletion in Blood or Tissue by FISH |
| 82250-2 | Chromosome region 1p subtelomere and 1p36 deletion and 1q25 rearrangement in Blood or Tissue by FISH |
| 82251-0 | Chromosome 3 and 7 and 17 aneuploidy and chromosome region 9p21 deletion in Urine by FISH |
| 82253-6 | JAG1 gene deletion in Blood or Tissue by FISH |
| 82256-9 | Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH |
| 82257-7 | SRY gene deletion in Blood or Tissue by FISH |
| 82258-5 | Subtelomere analysis in Bone marrow by FISH |
| 82295-7 | Chromosome region Xp22.33 AndOr Yp11.32 deletion and duplication mutation analysis in Blood or Tissue by FISH |
| 82597-6 | Chromosome painting analysis in Blood or Tissue by FISH |
| 84912-5 | Cells.chromosome region 5q31 deletion/Cells counted in Bone marrow by FISH |
| 84913-3 | Cells.chromosome 12 trisomy/Cells counted in Blood or Tissue by FISH |
| 84914-1 | Cells.chromosome region 13q14 deletion/Cells counted in Blood or Tissue by FISH |
| 84915-8 | Cells.chromosome region 11q22.3 deletion/Cells counted in Blood or Tissue by FISH |
| 84916-6 | Cells.chromosome region 17p13.1 deletion/Cells counted in Blood or Tissue by FISH |
| 84917-4 | Chromosome Y aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 84918-2 | Chromosome X aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 84919-0 | Chromosome 21 aneuploidy [Presence] in Amniotic fluid or Chorionic villus sample by FISH |
| 84920-8 | Cells.chromosome region 5q31 deletion/Cells counted in Blood or Tissue by FISH |
| 84921-6 | Cells.chromosome region 7q31 deletion/Cells counted in Blood or Tissue by FISH |
| 84922-4 | Cells.chromosome 7 monosomy/Cells counted in Blood or Tissue by FISH |
| 85318-4 | ERBB2 gene duplication [Presence] in Breast cancer specimen by FISH |
| 86239-1 | Cells.chromosome 3 monosomy/Cells counted in Cancer specimen by FISH |
| 87436-2 | Chromosome X and Y aneuploidy in Blood or Tissue by FISH |
| 90043-1 | t(14;20)(q32;q12)(IGH,MAFB) fusion transcript in Blood or Tissue by FISH |
| 90926-7 | MET gene amplification in Blood or Tissue by FISH |
| 90927-5 | RET gene rearrangements in Blood or Tissue by FISH |
| 92905-9 | Chromosome 7 copy number/nucleus in Blood or Tissue by FISH |
| 92906-7 | MET gene copy number/nucleus in Blood or Tissue by FISH |
| 92907-5 | MET gene copy number/Chromosome 7 copy number in Blood or Tissue by FISH |
| 93796-1 | MYCN gene amplification in Blood or Tissue by FISH |
| 93797-9 | MYCN gene copy number/Chromosome 2 copy number in Tissue by FISH |
| 93798-7 | MYCN gene copy number/nucleus in Tissue by FISH |
| 93799-5 | Chromosome 2 copy number/nucleus in Tissue by FISH |
| 93800-1 | 1p/1q chromosome deletion [# Ratio] in Tissue by FISH |
| 93801-9 | Chromosome 1 polysomy [Presence] in Tissue by FISH |
| 93802-7 | 19q/19p chromosome deletion [# Ratio] in Tissue by FISH |
| 93803-5 | Chromosome 19 polysomy [Presence] in Tissue by FISH |
| 93804-3 | Chromosome 12 copy number/nucleus in Tissue by FISH |
| 93805-0 | MDM2 gene copy number/nucleus in Tissue by FISH |
| 93806-8 | EWSR1 gene rearrangements in Tissue by FISH |
| 93807-6 | FOXO1 gene rearrangements in Tissue by FISH |
| 93808-4 | MDM2 gene amplification in Tissue by FISH |
| 93809-2 | MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH |
| 93810-0 | SS18 gene rearrangements in Tissue by FISH |
| 94338-1 | Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH |
| 95069-1 | Chromosome 1q and 9 and 11 and 15 aneuploidy and 13q deletion in Bone marrow by FISH |
| 95070-9 | Chromosome 9 and 11 and 15 aneuploidy in Bone marrow by FISH |
| 95071-7 | Chromosome region 14q32 rearrangements in Bone marrow by FISH |
| 95551-8 | Chromosome region 17p11.2 deletion in Blood or Tissue by FISH |
| 95552-6 | 4p16.3 chromosome deletion in Blood or Tissue by FISH |
| 95553-4 | 5p15.2 (5p-) chromosome deletion [Identifier] in Blood or Tissue by FISH |
| 95779-5 | TFE3 gene rearrangements in Tissue by FISH |
| 95780-3 | TFEB gene rearrangements in Tissue by FISH |
| 95783-7 | ETV6 gene rearrangements in Blood or Marrow by FISH |
| 95784-5 | FGFR2 gene rearrangements in Tissue by FISH |
| 96494-0 | ABL1 and ABL2 and PDGFRB gene rearrangements in Blood or Tissue by FISH |
| 96495-7 | ABL2 gene rearrangements in Blood or Tissue by FISH |
| 96893-3 | ERBB2 gene duplication in Tumor by FISH |
| 98014-4 | Plasma cell proliferation analysis in Bone marrow by FISH |
| 49490-6 | BCR-ABL1 b2a2 fusion protein [Presence] in Blood or Tissue by Molecular genetics method |
| 55180-4 | Human epididymis protein 4 [Moles/volume] in Serum or Plasma |
| 96044-3 | Human epididymis protein 4 [Mass/volume] in Serum or Plasma |
| 60588-1 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method |
| 72211-6 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method |
| 72215-7 | t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method |
| 10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
| 10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
| 12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
| 19166-8 | Carcinoembryonic Ag [Units/volume] in Serum or Plasma |
| 19167-6 | Carcinoembryonic Ag [Moles/volume] in Serum or Plasma |
| 19168-4 | Carcinoembryonic Ag [Units/volume] in Pleural fluid |
| 19169-2 | Carcinoembryonic Ag [Mass/volume] in Pleural fluid |
| 19170-0 | Carcinoembryonic Ag [Moles/volume] in Pleural fluid |
| 2037-0 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid |
| 2038-8 | Carcinoembryonic Ag [Mass/volume] in Semen |
| 2039-6 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma |
| 40621-5 | Carcinoembryonic Ag [Mass/volume] in Pericardial fluid |
| 40622-3 | Carcinoembryonic Ag [Mass/volume] in Peritoneal fluid |
| 83085-1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay |
| 14230-7 | Cells.progesterone receptor/100 cells in Tissue by Immune stain |
| 40557-1 | Progesterone receptor Ag [Presence] in Tissue by Immune stain |
| 85325-9 | Cells.progesterone receptor/100 cells in Breast cancer specimen by Immune stain |
| 85331-7 | Progesterone receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 85339-0 | Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
| 39773-7 | Beta-2-Microglobulin/Creatinine [Molar ratio] in Urine |
| 44303-6 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 hour Urine |
| 56786-7 | Beta-2-Microglobulin.tumor marker [Mass/volume] in Serum |
| 59177-6 | Beta-2-Microglobulin/Creatinine [Ratio] in Urine |
| 87708-4 | Beta-2-Microglobulin [Mass/volume] in Serum or Plasma --post dialysis |
| 93729-2 | Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine |
| 14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 20601-1 | CD33 cells/100 cells in Unspecified specimen |
| 51155-0 | CD33 blasts/100 blasts in Bone marrow |
| 51156-8 | CD33 blasts/100 blasts in Unspecified specimen |
| 51157-6 | CD33 blasts [Units/volume] in Bone marrow |
| 51158-4 | CD33 blasts [Units/volume] in Blood |
| 51159-2 | CD33 blasts [Units/volume] in Unspecified specimen |
| 51291-3 | CD33 cells/100 cells in Tissue |
| 51292-1 | CD33 cells/100 cells in Cerebral spinal fluid |
| 51293-9 | CD33 cells/100 cells in Bone marrow |
| 51294-7 | CD33 cells/100 cells in Body fluid |
| 8102-6 | CD33 cells/100 cells in Blood |
| 10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
| 13842-0 | CD20 blasts/100 blasts in Blood |
| 14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total in Blood |
| 20595-5 | CD20 cells/100 cells in Unspecified specimen |
| 51115-4 | CD20 blasts/100 blasts in Bone marrow |
| 51116-2 | CD20 blasts/100 blasts in Unspecified specimen |
| 57418-6 | CD20 cells/100 cells in Body fluid |
| 8119-0 | CD20 cells/100 cells in Blood |
| 29596-4 | CD25 Ag [Presence] in Tissue by Immune stain |
| 32581-1 | Epidermal growth factor receptor Ag [Presence] in Tissue by Immune stain |
| 39004-7 | Epidermal growth factor receptor Ag [Presence] in Tissue |
| 42782-3 | Epidermal growth factor receptor.phosphorylated Ag [Presence] in Tissue by Immune stain |
| 14017-8 | CD22 cells/100 cells in Blood |
| 20596-3 | CD22 cells/100 cells in Unspecified specimen |
| 42875-5 | CD22 cells/100 cells in Body fluid |
| 51124-6 | CD22 blasts/100 blasts in Bone marrow |
| 51125-3 | CD22 blasts/100 blasts in Blood |
| 51126-1 | CD22 blasts/100 blasts in Unspecified specimen |
| 51127-9 | CD22 blasts [Units/volume] in Bone marrow |
| 51128-7 | CD22 blasts [Units/volume] in Blood |
| 51129-5 | CD22 blasts [Units/volume] in Unspecified specimen |
| 14228-1 | Cells.estrogen receptor/100 cells in Tissue by Immune stain |
| 40556-3 | Estrogen receptor Ag [Presence] in Tissue by Immune stain |
| 85310-1 | Estrogen receptor fluorescence intensity [Type] in Breast cancer specimen by Immune stain |
| 85329-1 | Cells.estrogen receptor/100 cells in Breast cancer specimen by Immune stain |
| 85337-4 | Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain |
| 21636-6 | BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21637-4 | BRCA1 gene.c.185 del AG [presence] in Blood or Tissue by Molecular genetics method |
| 21638-2 | BRCA1 gene c.5382insC [Presence] in Blood or Tissue by Molecular genetics method |
| 21639-0 | BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 79207-7 | BRCA1 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 21702-6 | KRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 21703-4 | KRAS gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 53620-1 | KRAS gene mutations found [Identifier] in Bone marrow by Molecular genetics method Nominal |
| 75974-6 | KRAS gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 81420-2 | KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 82535-6 | KRAS gene full mutation analysis in Blood or Tissue by Sequencing |
| 85509-8 | KRAS gene mutations found [Identifier] in Colorectal cancer specimen by Molecular genetics method Nominal |
| 40552-2 | CD117 Ag [Presence] in Tissue by Immune stain |
| 51183-2 | CD117 Ag [Presence] in Bone marrow by Immune stain |
| 51184-0 | CD117 Ag [Presence] in Blood by Immune stain |
| 51185-7 | CD117 Ag [Presence] in Unspecified specimen by Immune stain |
| 80706-5 | CD27+IgD- cells/100 CD19+CD20+ cells in Blood |
| 83052-1 | PD-L1 by clone 22C3 [Presence] in Tissue by Immune stain |
| 83053-9 | Cells.programmed cell death ligand 1/100 viable tumor cells in Tissue by Immune stain |
| 83054-7 | PD-L1 by clone 22C3 [Interpretation] in Tissue by Immune stain Narrative |
| 83055-4 | PD-L1 by clone 28-8 [Presence] in Tissue by Immune stain |
| 83056-2 | PD-L1 by clone 28-8 [Interpretation] in Tissue by Immune stain Narrative |
| 83057-0 | PD-L1 by clone SP142 [Presence] in Tissue by Immune stain |
| 85147-7 | PD-L1 by clone 22C3 in Tissue by Immune stain Report |
| 85148-5 | PD-L1 by clone 28-8 in Tissue by Immune stain Report |
| 85149-3 | PD-L1 by clone SP142 in Tissue by Immune stain Report |
| 21640-8 | BRCA2 gene c.6174delT [Presence] in Blood or Tissue by Molecular genetics method |
| 38530-2 | BRCA2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 38531-0 | BRCA2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal |
| 79208-5 | BRCA2 gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method |
| 45284-7 | DPYD gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 47958-4 | FLT3 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 54447-8 | FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method |
| 72520-0 | FLT3 gene p.Asp835+Ile836 [Presence] in Blood or Tissue by Molecular genetics method |
| 79210-1 | FLT3 gene internal tandem duplication [Presence] in Blood or Tissue by Molecular genetics method |
| 85100-6 | FLT3 gene internal tandem duplication [Presence] in Bone marrow by Molecular genetics method |
| 92843-2 | FLT3 gene p.Asp835 mutations [Presence] in Blood or Tissue by Molecular genetics method |
| 48972-4 | FGFR2 gene+FGFR3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
http://snomed.info/sct version http://snomed.info/sct/900000000000207008| Code | Display |
| 787377000 | Gross examination and sampling of tissue specimen (procedure) |
| 104157003 | Light microscopy (procedure) |
| 5880005 | Physical examination procedure (procedure) |
| 16310003 | Diagnostic ultrasonography (procedure) |
| 113091000 | Magnetic resonance imaging (procedure) |
| 77477000 | Computerized axial tomography (procedure) |
| 82918005 | Positron emission tomography (procedure) |
| 363680008 | Radiographic imaging procedure (procedure) |
| 363679005 | Imaging (procedure) |
http://unitsofmeasure.org| Code | Display |
| mm | Millimeter |
| cm | Centimeter |